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CHAPTER 1 INTRODUCTION
Tobacco is the most widely used drug of abuse during pregnancy (Behnke &
Smith, 2013; Substance Abuse and Mental Health Services Administration [SAMHSA],
2011). Smoking during pregnancy leads to significant adverse effects for the developing
fetus, in addition to negative outcomes for women and their children (Wakschlag et al.,
2003). Although a range of effective treatments exist to treat tobacco dependence and
promote long-term abstinence, most pregnant women who smoke during pregnancy
neither seek nor receive any kind of treatment (Terplan, McNamara, & Chisolm, 2012).
This gap between the need for and receipt of services has substantial and long-term
effects on the health of these pregnancies and leads to substantial unnecessary
financial burden to the health care system (Andrulis & Hopkins, 2001; Chavkin, 1990).
Further, despite efforts to reduce perinatal tobacco use, since 2000 there have been no
significant decreases in smoking prevalence among pregnant women in the United
States (Tong et al., 2013). The stability of the prevalence of perinatal smoking suggests
that efforts to reduce smoking prevalence before and during pregnancy have not been
effective (Tong et al., 2013).
Alternative approaches, able to reach and assist a higher proportion of smokers,
are needed. Complementary and alternative medicine (CAM) methods—meaning nonmainstream practices or products used as primary treatment or as a complement to
mainstream health care (National Center for Complementary and Integrative Health,
2015)—are one possible example of the kind of alternative that is needed. CAM is an
emerging approach for treating physical and mental health issues, tobacco and other
substance use. CAM methods have gained wider acceptance in the United States within
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that last few decades, with mindfulness meditation, yoga, acupuncture, massage, and
some herbal supplements, in particular, becoming accepted therapies for a variety of
physical and mental health conditions. The prenatal and postpartum periods represent a
time of significant physical, psychological, and emotional changes (Da Costa, Larouche,
Drista, & Brender, 1999), which have been shown to affect a woman’s quality of life and
ability to cope with changing roles (Gjerdigen, Froberg, & Fontaine, 1991). Therefore,
CAM interventions that influence both mind and body may be especially appealing to
and appropriate for pregnant women (Beddoe & Lee, 2008). The use of CAM methods
has also become common during pregnancy, perhaps given the hesitancy of some
women to take medications while pregnant (Hall, Griffiths, & McKenna, 2011).
CAM approaches may be ideal, low-cost treatments to help pregnant women
reduce craving to smoke, manage nicotine withdrawal symptoms, stress and negative
mood symptoms, and increase self-efficacy to quit smoking. Compared to conventional
approaches that are largely based on a mental health/substance abuse model (and
therefore associated with stigma in some communities), CAM approaches may be a
more attractive treatment option to many pregnant women, thus increasing the
proportion of women who obtain some form of assistance. Further, developing healthier
mind-body practices may encourage pregnant and parenting women to make other
healthy choices for themselves and their families. To date, however, no published study
has examined the use of CAM among pregnant smokers.
The present study therefore seeks to examine factors associated with smoking
and smoking cessation during pregnancy among two nationally representative samples
of women, with an emphasis on the extent to which CAM approaches are or might be
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relevant. It is expected that a better understanding of the characteristics of those
women who quit or reduce smoking during pregnancy compared to those who do not
will facilitate the design of effective interventions for persistent smokers during the
perinatal period. In addition, investigating the conventional mental health and CAM
treatment utilization practices among pregnant smokers may suggest future directions
for intervention. Details of the proposed study will be described following presentation of
the significance, theoretical basis, and rationale for the study.
Smoking among Women
Epidemiological data indicate that 25% of women of reproductive age and 23.6%
of men are current smokers (Substance Abuse and Mental Health Administration,
2013). The rate of smoking in the U.S. has generally declined over the last several
decades; however, the rate of tobacco use has declined among men by approximately
50% since 1960, whereas among women tobacco use has declined by only 38%
(Giovino, 2002). For the first time in history, women are as likely as men to die from
diseases caused by smoking (U.S. Department of Health and Human Services, 2014).
Importantly, rates are still above national health objectives and these declines appear to
have reached a plateau (Centers for Disease Control and Prevention, 2008; Fiore et al.,
2008).
Gender differences in tobacco-related mortality and morbidity—particularly with
respect to risk for cancer and myocardial infarction—are well-documented, and
demonstrate that female smokers are at greater risk for some adverse outcomes
compared to male smokers (Schnoll, Patterson, & Lerman, 2007). Although a number of
common factors associated with smoking hold for both men and women (e.g.,
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depression, nicotine dependence, living with other smokers) there may be risk factors
that are especially relevant to treating tobacco use among women. Previous studies
have indicated that women may have more difficulty quitting smoking and may face
more barriers to smoking cessation than men (Bock et al., 2009; Reynoso, Susabda, &
Cepeda-Benito, 2005; Schnoll et al., 2007). For example, women report lower levels of
motivation to quit, and lower confidence/self-efficacy. They also perceive greater
difficulty with quitting (Etter, Prokhorov, & Perneger, 2002). As a result, it has been
suggested that a gender-specific approach to treating tobacco dependence may be
most effective for women (Schnoll et al., 2007; Piper, Welsch, Baker, Fox, & Fiore,
2000).
Prevalence of Smoking during Pregnancy
Prenatal smoking is considered a highly stigmatized behavior (Bessa et al., 2010;
Kline, Ng, Schittini, Levin, & Susser, 1997; Markovic et al., 2000; Ostrea, Brady, Bause,
Raymundo, & Stevens, 1992), which likely hinders attempts to accurately estimate its
prevalence. Underreporting of smoking is illustrated in studies that have compared
biologically-verified smoking with self-report (Markovic et al., 2000; Russell, Crawford, &
Woodby, 2004). Although rates of smoking during pregnancy are likely underestimated
due to disclosure issues (England et al., 2007), national surveys suggest that
approximately 10-20% of pregnant women smoke at some point during pregnancy
(Alshaarawy & Anthony, 2014; SAMHSA, 2007; SAMHSA, 2010; SAMHSA, 2012; Tong
et al., 2013) Rates of smoking during pregnancy appear to decline across trimesters,
with 21.8% of women in the first trimester, 14.4% of women in their second trimester,
and 13.9% of women in their third trimester reporting smoking in the past month
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(SAMHSA, 2009). Motivation to quit smoking during pregnancy is typically high (Andres
& Day, 2000); in general, approximately half of all pregnant smokers stop for at least
part of their pregnancy and nearly all of these women quit either prior to or early in their
pregnancy without seeking any formal support or treatment (Bolling, Grant, Hamlyn, &
Thornton, 2007). Rates of cessation may differ though, depending on the sample. For
example, in a sample of low-income pregnant women receiving prenatal care in rural
southern Appalachia, Bailey (2006) found that only 27% of women quit smoking
completely by their second to third trimester. Regardless, even in more normative
samples, only about 25% of those who quit are able to maintain abstinence throughout
their pregnancy (Flick et al., 2006), and two thirds of women who do quit smoking in
pregnancy are likely to re-start following the birth of their child (Owen & Penn, 1999).
Nearly half of those women who relapse do so within two weeks of delivery (Colman &
Joyce, 2003). Thus, a significant subset of pregnant women have greater difficulty in
quitting smoking during their pregnancy.
Effects of Prenatal Smoking
The range of health, social, and financial consequences of smoking are wellknown, and become even more severe during pregnancy due to the long-term effects of
prenatal smoking on a developing fetus (Andres & Day, 2000; Lester, Andreozzi, &
Appiah, 2004). Smoking during pregnancy is therefore a maternal behavior with a costly
intergenerational impact (Wakschlag et al., 2003). Compared to women who do not
smoke, the direct medical costs of a complicated birth are estimated to be 66% higher
for smokers, likely due to a greater severity of complications and need for intensive care
(Centers for Disease Control and Prevention, 1997; Orleans et al., 2001). Smoking
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during pregnancy has been shown to add more than $700 in neonatal costs for each
exposed child, for a total annual expenditure of $367 million in the U.S. alone (Adams et
al., 2002). Pregnant women who smoke are more likely to experience complications
such as ecotopic pregnancy (U.S. Department of Health and Human Services, 2014),
placenta previa, placental abruption, and uterine bleeding than pregnant women who
are non-smokers (Ananth, Savitz, & Luther, 1996; Cnattingius, 2004). Prenatal smoking
has been linked to fetal growth retardation, low birth weight, and sudden infant death
syndrome, as well as more long-term cognitive and behavioral deficits (Andres & Day,
2000; Ness et al., 1999; Shea & Steiner, 2008; Stroud et al., 2009). Analysis of over a
million births revealed that risk of stillbirth was elevated by nearly 30% among pregnant
smokers, with risk being even higher among pregnant smokers over 35 (Aliyu, Salihu,
Wilson, Alio, & Kirby, 2008). Compared to nonsmokers, women who smoke during
pregnancy are twice as likely to give birth to a low birth weight baby (Ventura et al.,
2003). Smoking is a factor in 20% of underweight births, 8% of preterm births, and 5%
of perinatal deaths (Orleans et al., 2001).
Further, the effects of smoking extend far beyond the perinatal and neonatal
period. Tobacco exposure during the perinatal period has been linked to adverse effects
on children, including congenital defects such as orofacial cleft (U.S. Department of
Health and Human Services, 2014), asthma, and increased rates of ear infection (U.S.
Department of Health and Human Services, 2006). Tobacco exposure is also
associated with lasting neurological, behavioral, and learning difficulties, such as
greater risk of externalizing behaviors among toddlers (McCormick, 1985; SteneLarson, Borge, & Vollrath, 2009) and future educational difficulties (McCormick, 1985).
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Without question, both the health and financial costs of smoking during pregnancy are
significant and lasting.
Pregnancy-Specific Factors Related to Smoking
Sociodemographic factors, pre-pregnancy smoking behaviors and patterns, and
mental health symptoms have all been identified as correlates of prenatal smoking.
Sociodemographic Factors
Smoking during pregnancy appears to disproportionately affect women of lower
socioeconomic status, women who engage in other adverse health behaviors, and
women who are the most heavily nicotine dependent; it is also more prevalent among
women with limited resources with which to access treatment (Goldenberg, Klerman,
Windsor, & Whiteside, 2000). Rates of persistent smoking are especially high among
unmarried, low-income women with limited education (Cornelius, Leech, & Goldschmidt,
2004). Family income in some samples has accounted for approximately 8% of the
variance in smoking among pregnant women, with women from families with lower
income being more likely to continue smoking during pregnancy (Bailey, 2006). One
study found that 22% of low-income women smoked during their third trimester, as
opposed to 14% of higher income women (Adams, Melvin, & Raskind-Hood, 2008).
Results from a national survey indicated that lower income women were at a 2.8 times
greater risk of smoking during pregnancy (Ebrahim, Floyd, Merritt, Decoufle, &
Holtzman, 2000). Together these data reveal that low income, pregnant women might
be especially in need of smoking cessation interventions (Kahn, Certain, & Whitaker,
2002).
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The evidence appears to be mixed with regard to age, race, and ethnicity.
Although some investigations suggest that younger women may be more likely to
continue smoking during pregnancy (Cornelius et al., 2004; Kratz & Vaughan, 2012),
others have found that younger women are more likely to be nonsmokers or to quit
smoking during pregnancy (Coleman & Joyce, 2003; Holtrop et al., 2010; Kahn et al.,
2002; Ma, Goins, Pbert, & Ockene, 2005). Some findings suggest that European
American women are more likely to smoke during pregnancy than those of other
racial/ethnic groups (Martin et al., 2008; Muhuri & Gfroerer, 2009), and may be as much
as three times more likely to be prenatal smokers (Ebrahim et al., 2000). Hispanic
ethnicity has been found to be a protective factor in some investigations (Kratz &
Vaughan, 2012). Results among African American women have been conflicting, with
some suggesting that African American women are more likely to be nonsmokers
(Maxson, Edwards, Ingrahm, & Miranda, 2012) or to quit during pregnancy (Ma et al.,
2005), others finding that they are less likely to quit (Ockene et al., 2002), and still
others finding no association at all between African American race and prenatal
smoking (Kratz & Vaughan, 2012). Recent national estimates show that, among
pregnant women between 15 and 44, 21.8% of European American women, 14.2% of
African American women, and 6.5% of Hispanic women reported smoking in the past 30
days (SAMHSA, 2012).
Educational attainment may be one of the strongest demographic predictors of
prenatal smoking. Data from the National Epidemiological Survey on Alcohol and
Related Conditions (NESARC) indicated that educational attainment was the strongest
predictor of smoking during pregnancy out of the measured demographic factors.
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Compared to women with at least some college education, women with less than a high
school education were 7.87 times more likely to smoke during pregnancy, and women
with a high school diploma or GED were 2.80 times more likely to smoke (Gilman et al.,
2008). It is possible that women with less education may have more limited access to or
experience greater barriers to participating in smoking cessation programs, and/or that
programs available to them may be less effective (Bonollo et al., 2002; Gilman et al.,
2008; Pullon, Webster, McLeod, Benn, & Morgan, 2004).
Consistent with increased risk for smoking in the general population (e.g., Dollar,
Homish, Leonard, & Kozlowski, 2009; Homish & Leonard, 2005), close relationships
with other smokers, including spouses or romantic partners, relatives, and peers, has
been shown to be a risk factor for prenatal and postpartum smoking (Homish, Eiden,
Leonard, & Kozlowski, 2012; Lu, Tong, & Oldenburg, 2001). Ma and colleagues (2005)
found that, in a sample of pregnant women participating in a smoking cessation trial,
having a partner who smokes was associated with smoking at time of delivery. Further,
having a partner who smokes and living with other smokers were both associated with
increased likelihood of postpartum relapse among those who reported abstinence at
delivery (Ma et al., 2005). Among another sample of pregnant women participating in a
smoking cessation intervention trial who quit smoking during pregnancy, one of the
main risk factors for smoking at 1 month postpartum was having another smoker living
in the household; having a partner who continued to smoke during their pregnancy
predicted risk of smoking at 12 months postpartum (Simmons, Sutton, Quinn, Meade, &
Brandon, 2014). These findings underscore the importance of contextual factors related
to smoking maintenance and cessation.
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Pregnancy Variables
Pregnancy-related variables including number of prior pregnancies and access to
prenatal care have also been examined as potential correlates of prenatal smoking. In a
regional sample of rural low-income women, a greater number of prior pregnancies and
lack of access to adequate prenatal care were significant predictors of smoking during
pregnancy, accounting for nearly 5% and over 12% of the variance in smoking status,
respectively, even after controlling for quantity and frequency of smoking. In particular,
receipt of intermediate or inadequate prenatal care increased the probability of
continued smoking during pregnancy sevenfold (Bailey, 2006). Such pregnancy-specific
risk factors may be relevant to designing prevention and intervention efforts for prenatal
smoking.
Smoking History and Use Pattern
Smoking history and patterns of use (e.g., quantity and frequency) also appear to
predict risk for prenatal smoking. For example, Chen and colleagues (2006) found that
smoking onset prior to age 14 was a significant predictor of smoking during pregnancy,
such that women who began smoking at age 15 or later were significantly more likely to
be abstinent than women who began smoking earlier. Similarly, in a study using data
from the NESARC, early onset smoking (by age 14) was significantly associated with
smoking during pregnancy, as was smoking at least a pack per day in the year
preceding the interview (Gilman et al., 2008). In addition, among a sample of women in
southern Appalachia, those who continued to smoke during pregnancy were heavier
smokers and had smoked for a longer time compared to those who quit (Bailey, 2006).
Taking into account sociodemographic and pregnancy-related factors, the amount of
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pre-pregnancy smoking was the single best predictor of persistent smoking during
pregnancy in this sample: each quarter-pack of cigarettes smoked per day increased
the probability of prenatal smoking by 65%. Length of time smoking accounted for
another 6% of the variance in pregnancy smoking status (Bailey, 2006). Thus, it is likely
that women who have been heavier smokers for a longer period of time may have more
difficulty quitting smoking once they become pregnant.
Alcohol and Other Substance Use
As noted previously, disclosure rates for prenatal smoking are considered
underestimates given the stigmatized nature of smoking during pregnancy. Similarly,
rates of prenatal alcohol and illicit substance use are expected to be even further
hindered by this disclosure bias (Colon, Robles, & Sahai, 2001; Magura & Kang, 1996;
Ondersma et al., 2012). Notably, previous investigations have revealed significant
comorbidity between smoking and other substance use during pregnancy, with drug and
alcohol use being more prevalent among pregnant smokers than pregnant nonsmokers.
Data from the 2010 National Survey on Drug Use and Health (NSDUH) survey indicated
that 24.2% of pregnant smokers also reported illicit drug use in the past month,
compared to only 2.4% of nonsmoking pregnant women (SAMHSA, 2010). Another
population-based study conducted in Australia found that 85% of women with a
substance use disorder smoked during pregnancy, compared to only 15% of women
without a substance use disorder (Burns, Mattick, & Cooke, 2006). Among low-income
women receiving Medicaid benefits, alcohol use and drug use in the month prior to
learning of pregnancy predicted continued smoking during pregnancy, with odds ratios
of 2.81 and 5.32, respectively (Holtrop et al., 2010). Gaalema and colleagues (2013) re-

12
tested urine specimens of 115 pregnant women who were participating in clinical trials
for smoking cessation. Specimens were collected near 10 weeks and 28 weeks
gestation. Approximately 34% of specimens collected during the first trimester and 25%
of specimens collected around the beginning of the third trimester tested positive for an
illicit drug. The most commonly detected illicit drug was marijuana, present in 90% of
the positive specimens, followed by opioids (detected in 18% of positive specimens),
cocaine (present in 5% of positive specimens), benzodiazepines and methadone,
detected in 3% of specimens, respectively. These data indicate that other substance
use both during pregnancy and prior to pregnancy are strongly associated with prenatal
smoking.
Externalizing Behaviors
Several investigations have focused on antisocial or externalizing behaviors as
predictors of prenatal smoking. For example, Kodl and Wakschlag (2004) found that
women were more likely to smoke during pregnancy if they had exhibited conduct
disorder symptoms as children. Katz and Vaughan (2012) also found that past year
legal involvement (e.g., driving under the influence, having been arrested, being on
parole or probation) was significantly associated with smoking during the second and
third trimesters in a nationally representative sample of women. Further, women with
problematic or violent interpersonal relationships, disruptive interpersonal behaviors,
(e.g., lying and aggressiveness), and those who admitted to engaging in deviant
behaviors (e.g., truancy, stealing, running away from home, arrest history) were more
likely to smoke during pregnancy (Wakschlag et al., 2003). Wakschlag and colleagues
(2003) suggest that women displaying such externalizing behaviors who are unable to
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“suspend their smoking” (DiClemente, Dolan-Mullen, & Windsor, 2000) during
pregnancy may also exhibit difficulty modulating their behavior in other domains of life.
In other words, the association between persistent prenatal smoking and externalizing
behavior may reflect a broader pattern of problematic behavior among women who
have demonstrated risk in several domains of adaptive functioning.
Negative Affect, Stress and Mental Health
During the perinatal period, a significant proportion of women experience
symptoms of poor mental health, including negative affect, psychological distress,
depression and anxiety. One study of pregnant smokers found that approximately 45%
had at least one mental health disorder (Goodwin, Keyes, & Simuro, 2007). National
estimates indicate that between 7.4% and 12.8% of pregnant women between ages 15
and 44 meet criteria for major depressive disorder, which is similar to estimated rates of
depression for non-pregnant adult women (Bennett, Einarson, Taddio, Koren, &
Einarson, 2004). Perinatal distress and depression have also been associated with
negative infant outcomes, including preterm birth and low birth weight (Li, Liu, & Odouli,
2009; Mancuso, Schetter, Rini, Roesch, & Hobel, 2004).
The association between smoking and negative affect is well-established in both
the general population (Grant, Hasin, Chou, Stinson, & Dawson, 2004; Grant et al.,
2004b) and among pregnant women (Maxson et al., 2012; Zhu & Valbo, 2002).
Depressed women may be as much as four times more likely to smoke during
pregnancy (Zhu & Valbo, 2002). In fact, depressive symptoms have been shown to
predict prenatal smoking even after controlling for demographic factors and quantity and
frequency of smoking (Linares Scott, Heil, Higgins, Badger, & Bernstein, 2009).
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Pregnant women using tobacco and other substances are more likely to experience
depression than women who remain abstinent (Kuo et al., 2014). Further, studies of
treatment-seeking, pregnant women with substance use disorders indicate that 36-40%
also meet criteria for comorbid major depressive disorder (Fitzsimons, Tuten, Vaidya, &
Jones, 2007; Martin et al., 2009). A more general measure of mental health,
psychological distress, is also positively correlated with substance use during
pregnancy (Havens, Simmons, Shannon, & Hansen, 2009), with persistent smokers
endorsing higher levels of prenatal stress and symptoms of negative affect compared to
quitters and nonsmokers (Eiden et al., 2011). Prenatal cigarette smoking has been
associated with elevated depression and stress, particularly among low-income women
(Bullock, Mears, Woodcock, & Record, 2001; Ludman et al., 2000; Munafo, Heron, &
Araya, 2008). Holtrop and colleagues (2010) found that, among low-income pregnant
women receiving Medicaid, having a history of mental health issues and experiencing
high levels of stress were associated with smoking. Further, compared to nondepressed smokers, smokers with depression are less likely to report confidence in
being able to quit (Zhu & Valbo, 2002), which can impact their ability to quit smoking.
Although most studies have examined depressive symptoms, anxiety, or general
distress, a few have also looked at other features of negative mood, including anger and
hostility. In one study, pregnant smokers reported higher hostile mood and greater
maternal hostility than pregnant non-smokers (Schuetze, Lopez, Granger, & Eiden,
2008). Additionally, Eiden and colleagues (2011) examined structural equation models
including several facets of negative affect and found that maternal anger, hostility and
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aggression accounted for unique variance in persistent prenatal smoking, while
depression and stress did not.
In contrast, other studies have failed to find to a clear, direct link between
distress or mental health and smoking during pregnancy. For example, Bailey (2006)
found that smoking cessation status was not significantly associated with depression
history in a regional sample of low-income women. Despite observing associations
between mental health history, greater stress and smoking, Holtrop and colleagues
(2010) did not find an association between current symptoms of depression and
smoking during pregnancy once demographic and other factors were accounted for.
These authors posited that nicotine dependence might have played a role in their
findings, given the strong relationship between nicotine dependence and depressive
symptoms in their sample. In sum, the extent to which negative affect, stress, and/or
mental health symptoms impact prenatal smoking remains unclear.
Nicotine Dependence
Nicotine dependence (also called tobacco dependence or tobacco use disorder)
is characterized by symptoms such as nicotine craving and withdrawal (American
Psychiatric Association, 2013). Nicotine dependence appears to be another robust
predictor of persistent smoking during the perinatal period, and--as noted above--may
potentially account for the relationship between depression and smoking. In
epidemiological studies including the NESARC and the National Comorbidity Study,
nicotine dependence has been shown to be highly correlated with depression (Breslau,
Novak, & Kessler, 2004; Goodwin et al., 2007; Grant et al., 2004a). Goodwin and
colleagues (2007) found that 57.5% of pregnant smokers meeting nicotine dependence
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criteria also met criteria for at least one mental disorder, compared to 45.1% of those
who were not nicotine dependent. After adjusting for demographic factors and
comorbidity, nicotine dependence significantly predicted the odds of having any mental
health disorder (OR = 3.3), including any mood disorder (OR = 2.5), major depression
(OR = 2.07), dysthymia (OR = 6.9), or panic disorder (OR = 3.1) in the past year;
however, among non-nicotine dependent smokers, associations between smoking and
mental health disorders became non-significant after accounting for demographic
factors. Similarly, Ludman and colleagues (2000) found that stress and depressive
symptoms were unrelated to smoking cessation but were related to nicotine
dependence and demographic factors. Gilman and colleagues (2008) found that,
among current or previous year daily smokers, current year nicotine dependence was
associated with a significantly greater likelihood of smoking during pregnancy (OR =
2.63), even after taking into account sociodemographic factors, smoking history, mood
or anxiety disorders, and substance use disorders. Importantly, the association between
prenatal smoking and mood or anxiety disorders was solely attributable to nicotine
dependence. Taken together, these results suggest that nicotine dependence may be
among the top mental health barriers to smoking cessation during pregnancy (Gilman et
al., 2008).
It is important to note that many of the above factors are also correlated with
each other. For example, lower educational attainment is related to younger age at
smoking initiation, which may suggest that cessation is more difficult to achieve given
the longer duration of smoking history and greater severity of nicotine dependence
(Chassin, Presson, Rose, & Sherman, 1996; Gilman et al., 2008; Lindqvist & Aberg,
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2001; Pierce & Gilpin, 1996; Siahpush, Heller, & Singh, 2005). Therefore, further
investigation is necessary to better understand the complex and interacting risk factors
related to prenatal smoking.
Factors Associated with Changes in Smoking During Pregnancy
Smoking cessation during the perinatal period appears to involve slightly different
determinants compared to cessation among non-pregnant adults. Cessation for many of
the spontaneous pregnant quitters likely reflects a concerted effort to quit smoking for
the health of their baby, rather than a step toward a personal, longer-tem intention to
quit (Stotts, DiClemente, Carbonari, & Mullen, 1996; Wakschlag et al., 2003). Only a
handful of studies have examined the factors that are most strongly associated with
changes in smoking during pregnancy, or what factors distinguish quitters from
persistent smokers. Further, the few studies in this area have focused primarily on
treatment-seeking samples (e.g., Forray, Merry, Lin, Ruger, & Yonkers, 2015; Ma et al.,
2005; Wakschlag et al., 2003), and treatment-seekers may be more highly motivated to
quit than non-treatment-seekers. In other words, exactly what enables some women to
make changes for themselves and their growing families when others are unable to do
so is still poorly understood. This deficit in the literature impedes efforts to design
effective prevention and intervention programs.
Overall, those who successfully quit during pregnancy appear to be
characterized by a less risky constellation of sociodemographic and pre-pregnancy
smoking factors compared to persistent smokers; however, these factors are not
necessarily appropriate intervention targets. Therefore, identifying factors amenable to
change may prove crucial for designing effective interventions aimed at reaching the
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subset of pregnant women for whom existing interventions have been inaccessible or
unsuccessful. Several potential change-related factors are worth further consideration,
including self-efficacy or autonomy, improvement in mental health symptoms, and
managing nicotine dependence.
Self-efficacy and the related concept of autonomy have been the focus of several
theoretical models of health behavior change and have been considered potential
mechanisms of action for established behavioral interventions. Broadly speaking, these
models posit that individuals who have confidence or believe that they are able to make
behavior changes are more likely to do so (Bandura, 1977; Brandon, Herzog, Werner, &
Gwaltney, 2004). For example, in a large prospective cohort study examining
psychosocial factors related to pregnancy outcomes, higher self-efficacy was one factor
related to decreased odds of being a smoker (Maxson et al., 2012). Given that women
often report lower levels of self-efficacy or confidence with regard to quitting smoking
(Etter et al., 2002), interventions that boost self-efficacy may be more effective for
promoting cessation.
Some have also suggested that women’s greater difficulty with cessation may in
part be due to differences in negative affect. Women report greater levels of precessation and post-cessation stress (Peiper & Rodu, 2013; Wetter et al., 1999), greater
pretreatment depression (Killen, Fortmann, Varady, & Kraemer, 2002; Peiper & Rodu,
2013), and a greater reliance on smoking to manage symptoms of depression and
negative affect (Ward, Klesges, Zbikowski, Bliss, & Garvey, 1997; Wetter et al., 1999).
Recent analysis of NSDUH data revealed that female smokers may be more vulnerable
to depression compared to males; no differences were observed for serious
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psychological distress or anxiety disorders (Peiper & Rodu, 2013). Maxson and
colleagues (2012) found that higher depression and perceived stress were associated
with a greater likelihood of smoking but higher self-efficacy is associated with decreased
likelihood of smoking. Therefore, it is plausible that interventions that decrease
depression and stress while also enhancing self-efficacy may be more effective for
promoting smoking cessation among pregnant women.
Because nicotine dependence is a risk factor for prenatal smoking, as noted
above, management of dependence symptoms, including reducing craving and other
signs of nicotine withdrawal, is a natural target of smoking cessation interventions. To
better characterize nicotine withdrawal and craving among pregnant cigarette smokers,
Heil and colleagues (2006) examined ratings of nicotine withdrawal symptoms during
the first 5 days of a quit attempt among a small sample of treatment-seeking pregnant
smokers participating in a contingency management trial. Compared to those women
who were unable to stop smoking or substantially reduce cigarette use, abstainers
reported significantly more impatience, anger, and difficulty concentrating. In a rough
comparison to other studies of non-pregnant smokers, these authors estimated that
pregnant smokers may have elevated baseline levels of withdrawal (Heil, Higgins,
Mongeon, Badger, & Bernstein, 2006).
Additionally, biological aspects of nicotine dependence may warrant further
investigation to understand the difficulties highly-addicted pregnant women may
experience in quitting smoking. Among reproductive-age women, for example,
variations in menstrual cycle phase and corresponding hormonal fluctuations have been
associated with cigarette craving (Carpenter, Upadhyaya, LaRowe, Saladin, & Brady,
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2006; Franklin et al., 2004), as well as tobacco withdrawal and negative affect
(Carpenter et al., 2006; Perkins et al., 2000; Weinberger et al., 2015). Thus, smoking
cessation may be especially challenging for some women due to complex interactions
between underlying biological processes and behavioral determinants of smoking. It is
unclear, however, the extent to which hormonal or other physiological changes related
to pregnancy may impact or exacerbate nicotine craving (Lynch & Sofuoglu, 2010).
Weight concerns also appear to be a barrier to smoking cessation among
women, including pregnant women (Berg, Park, Chang, & Rigotti, 2008; Pomerlau,
Brouwer, & Jones, 2000). Compared to men, women endorse greater appetite and
weight control expectancies related to smoking (Wetter et al., 1999) and are twice as
likely to anticipate post-cessation weight gain (Clark et al., 2006). There is also some
evidence to support the concern that women may be more likely to gain weight than
men after quitting (Flegal, Troiano, Pamuk, Kuczmarski, & Campbell, 1995). One study
examining weight concerns among pregnant smokers found that those with high weight
and body concerns gained significantly more weight during their pregnancy compared to
those with low concerns; those with high concerns also gained weight in amounts that
exceeded the guidelines for recommended weight gain during pregnancy (Pomerlau et
al., 2000). Although weight gain is a natural part of pregnancy, some women may fear
that quitting will exacerbate weight issues and thus be more hesitant to stop smoking
(Berg et al., 2008).
Identifying factors associated with changes in smoking during pregnancy is key
to better differentiating who is more likely to quit smoking during pregnancy.
Furthermore, better understanding of these change-related factors will also help to
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distinguish the treatment needs of those women who have more difficulty quitting
smoking. Negative affect associated with nicotine withdrawal or depression and weight
concerns may be particularly significant barriers to smoking cessation in the perinatal
period, given pregnancy weight gain and perinatal distress and depression. However,
the perinatal period may present a unique and opportune time to assess and potentially
change behaviors for many women for several primary reasons: (a) women almost
invariably choose to participate in at least some prenatal care and are thus easy to
reach; (b) interventions at this stage may take advantage of a particularly salient
juncture in a woman’s life, in which she may be more open to considering behavior
change; and (c) any positive change made has the possibility of a dual impact, on the
woman’s health as well as that of her unborn child. Understanding the treatment needs
and preferences of women during the perinatal period is therefore important to
effectively target treatment and relapse prevention efforts.
Currently Available Treatments for Smoking and their Limitations
Given the immense health and financial impact of perinatal smoking,
considerable efforts have been made to design effective screening and treatment.
Importantly, a range of effective treatments exist to treat tobacco dependence and
promote long-term abstinence (Fiore et al., 2008). These treatments when utilized
successfully have been associated with small but significant overall reductions in
smoking, low birth weight, and premature birth (Lumley, Oliver, Chamberlain, & Oakley,
2004). Smoking cessation interventions have also been tailored for specific subgroups.
For the significant proportion of smokers struggling with current or past depression,
adding a psychosocial mood management component to smoking cessation treatment
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is recommended and has been shown to increase long-term cessation rates (van der
Meer, Willemsen, Smit, & Cuijpers, 2013). Antidepressants including buproprion and
nortriptyline (though not SSRIs or MAOIs) have also been shown to facilitate long-term
smoking cessation in controlled trials, but only a few trials have included pregnant
women (Hughes, Stead, Hartmann-Boyce, Cahill, & Lancaster, 2014). However,
although a number of interventions have been shown to be efficacious for smoking
during pregnancy (Lumley et al, 2004), including brief (Ferreira-Borges, 2005;
Ondersma et al., 2012) and computer-based interventions (Ondersma et al., 2011),
there is no obvious gold standard currently available for pregnant smokers (Goldenberg
et al., 2000). Additionally, evidence-based treatments remain particularly underutilized
by low-education populations (Fiore et al., 2008).
Many pregnant women in the U.S. are eligible for Medicaid (Andrulis & Hopkins,
2001) or have expanded access to treatment due to the Affordable Care Act (Johnson,
2010), and should therefore encounter fewer barriers to treatment related to cost or
insurance coverage; however, in reality, a significant proportion of pregnant women do
not obtain treatment when needed. Available approaches also fail to significantly
improve quit rates among pregnant women (Hebert, 2004), with sustained quit rates for
some effective approaches rarely exceeding 20% (Wen, Miller, Lazev, Fang, &
Hernandez, 2012). Further, available approaches also fail to even reach most women
who are in need of treatment for a variety of reasons. For example, psychosocial
smoking cessation programs are often delivered in multiple sessions and typically
involve professional counseling and ongoing support. However, drop-out rates are high
and treatment sessions are frequently rescheduled or missed, particularly among
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underserved women (Wen et al., 2012). Therefore, it can be difficult to adequately
assess the effectiveness of smoking cessation interventions for some pregnant women,
and interventions that are effective may not be as potent if only a portion of the
treatment is delivered (Wen et al., 2012). Overall, most women who smoke during
pregnancy neither seek nor receive treatment (Goldenberg et al., 2000). Among
reproductive-aged women who use drugs or alcohol, pregnant women are more likely to
need treatment, but they are not more likely to actually receive it (Terplan et al., 2012).
Thus, there is a general unmet need for treatment among pregnant women using
substances, including cigarettes.
Time and costs associated with training (Baer et al., 2004; Miller & Mount, 2001)
and implementation (Chapin & Root, 2004) are also a frequently cited barrier to
treatment. For example, physician time constraints have been a consistent barrier to
implementation of recommended guidelines among obstetricians/gynecologists (e.g.,
Chapin & Root, 2004). One analysis suggested that primary care physicians attempting
to comply with just the A and B recommendations of the United States Preventive
Services Task Force (ask about tobacco and provide augmented pregnancy-tailored
counseling for women who smoke; U.S. Preventive Services Task Force, 2009) would
need to spend an additional 4.4 hours per working day to do so (Yarnall, Pollak, Ostbye,
Krause, & Michener, 2003). Further, despite evidence of modest efficacy, even when
interventions are implemented, existing interventions do not consistently lead to
subsequent reductions in smoking among pregnant patients (Lancaster, Silagy, &
Fowler, 2000).
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Regarding pharmacological interventions for smoking cessation like nicotine
replacement therapy (NRT), evidence from existing studies is somewhat mixed and
difficult to interpret considering that compliance has been poor. Conclusions about the
safety of pharmacological interventions during pregnancy are also risky due to
insufficient data (Bauld & Coleman, 2009). It is possible that some women may be
reluctant to seek out pharmacological interventions such as NRT or antidepressant
medication during pregnancy or may believe that natural or holistic therapies provide
safer alternatives to pharmacological interventions (Adams et al., 2009; Nordeng &
Havnen, 2004; Lapi et al., 2008; Holst, Wright, Haavik, & Nordeng, 2009).
Overall, despite the existence of treatments that efficaciously treat tobacco
dependence during pregnancy, these interventions do not fully meet the needs of health
care providers or their patients. Moreover, in line with treatment principles suggested by
the National Institute on Drug Abuse, no single treatment is likely to be appropriate for
everyone (Heil, Linares Scott, & Higgins, 2009; National Institute on Drug Abuse, 2009);
therefore, pregnant smokers are in need of alternative treatment options for smoking
cessation.
Complementary and Alternative Treatments
The National Center for Complementary and Integrative Health (NCCIH) is the
branch of the National Institutes of Health that oversees research on a wide range of
health practices that are often referred to as mind-body or CAM techniques, including
(but not limited to) acupuncture, massage therapy, contemplative practice (i.e.
meditation, mindfulness), yoga, relaxation exercises, tai chi and qi gong, chiropractic,
herbs or other natural products, traditional healers, Reiki or healing touch, Ayurveda,
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traditional Chinese medicine, homeopathy, naturopathy, and hypnotherapy (NCCIH,
2015). CAM practices have been used for health promotion as well as treatment
(Clarke, Black, Stussman, Barnes, & Nahin, 2015; Davis, West, Weeks, & Sirovich,
2011). Some insurance plans may at least partially cover provider-based CAM
treatments; however, costs associated with CAM usage are generally paid out-ofpocket.
As of 2007, results from the National Health Interview Study (NHIS) indicated
that over 15% of the general population (an estimate of more than 17 million people)
reported utilizing a provider-based CAM treatment (e.g., acupuncture, Ayurveda,
biofeedback, chiropractic care, energy therapy, hypnosis, massage, and naturopathy)
within the past 12 months, reflecting an increase of nearly 3% from 2002. Of those who
endorsed utilizing provider-based CAM treatments, 19.4% (or over 1 million) were
current smokers. The results of this survey suggested that smokers used CAM
approaches in roughly the same proportions as nonsmokers, and that their
sociodemographic characteristics reflected a moderate level of education and higher
incomes compared to typical smoking populations (Hamm, Muramoto, Howerter,
Floden, & Govindarajan, 2014).
CAM approaches or mind-body therapies may hold promise as a treatment
option for pregnant smokers. In healthy women, such approaches have been found to
help lower stress, improve sleep, and reduce pain (Beddoe & Lee, 2008). Women also
appear to be greater consumers of CAM approaches (Upchurch et al., 2007); however,
there have been no thorough examinations conducted to investigate the characteristics
of individuals who are more likely to access or be interested in CAM treatments.
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Furthermore, although the use of CAM interventions has grown considerably in the last
several decades, rigorous studies demonstrating the effectiveness of these approaches
are considerably lacking. The limited evidence that does exist suggests that such
treatments, when used correctly, are efficacious for a number of physical and mental
health issues, including smoking and other substance use and stress.
Despite a lack of adequate research support for CAM treatments, data indicate
that pregnant women in the U.S. are already using a variety of mind-body treatments to
enhance well-being and manage distress, and that some prenatal care providers are
already referring pregnant patients to yoga classes, massage therapists, and other CAM
practitioners (Wang et al., 2005). Interest in CAM approaches may reflect a growing
preference for utilizing a more “holistic” approach to healthcare and not necessarily
dissatisfaction with conventional treatment approaches (e.g., Adams et al., 2009;
Gaffney & Smith, 2004; Hall et al., 2011). Additionally, preference for CAM approaches
may also be related to traditional cultural practices, but the evidence is not clear (e.g.,
Hall et al., 2011).
Though few studies have examined who is more likely to use CAM, some have
found that those who have higher education (Chuang et al., 2009) or those who used
CAM prior to pregnancy (Holst et al., 2009) may be more likely to consider using CAM
during their pregnancy. Unfortunately, due in part to the dearth of rigorous research on
CAM treatments, evidence-based guidance and safety information are not clearly
available to consumers. This is of particular concern during the perinatal period due to
potential maternal and fetal harms when treatments are used inappropriately
(Pallivalapila et al., 2015). Therefore, much CAM that is currently practiced during
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pregnancy is not considered to be evidence-based (Anderson & Johnson, 2005).
Several common CAM approaches are reviewed below.
Acupuncture and Acupressure
Acupuncture is a traditional Chinese medicine therapy utilizing fine needles that
are inserted into the skin at specific points in the body. It has gained increasing interest
as a treatment for a variety of physical and mental health issues. A national crosssectional survey conducted in 2002 revealed that lifetime and past year usage of
acupuncture was approximately 4% and 1%, respectively. Of the 1% of past year users,
52% were women (Burke, Upchurch, Dye, & Chyu, 2006). However, patterns of
acupuncture use are not yet well understood (Smith & Cochrane, 2009).
Acupuncture and acupressure (a similar treatment that uses stimulation of
specific points in the body without the use of needles) have been evaluated as potential
CAM treatments for smoking cessation (e.g., White, Rampes, Liu, Stead, & Campbell,
2014; White & Taylor, 2014) and depression (e.g., Stub, Alraek, & Liu, 2011). In
particular, some have suggested that these treatments may be effective for smoking
cessation by reducing nicotine withdrawal symptoms; however, these studies were
uncontrolled (White et al., 2014). A recent Cochrane Review of acupuncture and related
treatments for smoking cessation suggested possible short-term effects (White et al.,
2014). Specifically, of 16 studies that compared acupuncture to sham acupuncture,
acupuncture was shown to have a small short-term effect (RR = 1.22, 95% CI 1.081.38). Compared to existing conventional treatments, though, acupuncture was less
effective than NRT and not superior to psychological interventions in the short- or longterm. Systematic review of 38 studies failed to demonstrate consistent, unbiased
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evidence that these treatments provided sustained smoking cessation for six or more
months; however, the majority of studies included had methodological problems.
Overall, no firm conclusions could be drawn about the effectiveness of acupuncture and
related treatments for smoking cessation (White et al., 2014). To date, no study has
systematically examined the use of acupuncture during the perinatal period for smoking
cessation.
Research on acupuncture for the treatment of various pregnancy- and childbirthrelated health issues has also continued to grow. Smith and Cochrane (2009)
conducted a systematic review of studies on acupuncture treatment during the perinatal
period to treat nausea, emotional distress, back pain, labor pain, and breech
presentation. This review determined that evidence supporting the use of acupuncture
during pregnancy varied by the indication, with strongest evidence for the benefit of
acupuncture or acupressure in treating for pregnancy-related nausea. In a randomized
trial of acupuncture for depression, 150 pregnant women were randomly assigned to
acupuncture specific for depression (12 treatment sessions of acupuncture to
specifically address depression over an 8-week period), acupuncture not specific for
depression/control acupuncture over the same time period, and Swedish massage
(Manber et al., 2010). Compared to the combined control groups, the acupuncture for
depression intervention group reported a greater decrease in depressive symptoms and
a greater response rate, as measured by the Hamilton Rating Scale for Depression.
Smith and Cochrane (2009) also concluded that the quality of research on
acupuncture appears to be improving. In designing quality research studies on
acupuncture, finding a suitable control for acupuncture is an often-cited challenge
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(Smith & Cochrane, 2009; White et al., 2014). Since findings from some controlled trials
have found insufficient evidence supporting the efficacy of acupuncture when compared
to sham or control acupuncture, some have attributed any reported acupuncture
findings to a placebo effect (Smith & Cochrane, 2009). Notably, regardless of exact
mechanisms, these treatments appear to be popular and safe when applied correctly
(White et al., 2014). Overall, evidence for the use of acupuncture as a treatment is
mixed, and efficacy may depend on the indication. Although there is little support for
acupuncture as a treatment for smoking cessation, there appears to be stronger
evidence supporting acupuncture as a treatment for pregnancy-related nausea and
possibly for perinatal depression. More rigorous research is therefore necessary in
order to help reach definitive conclusions.
Massage Therapy
Massage therapy has been associated with a range of benefits, including pain
reduction, decreases in depression, weight gain in preterm infants, and enhanced
attentiveness and immune system functioning (Field, 2014). However, scant evidence is
available on the use of massage therapy for tobacco and other substance use. A pilot
study by Hernandez-Reif and colleagues (1999) evaluated the effect of self-massage of
the hand or ear on anxiety and withdrawal symptoms among a sample of 20 smokers
interested in smoking cessation. Compared to those in the control group, those who
utilized the 5-minute massage practice during craving episodes reported lower anxiety,
fewer withdrawal symptoms, and improved mood. At the end of the 4-week study, those
in the self-massage group also reported a significant reduction in the number of
cigarettes smoked per day; however, no biological indicators of smoking were used.
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These results suggest that further investigation is warranted regarding the use of
massage therapy to aid smoking cessation.
A handful of studies examining massage during the perinatal period have
revealed that it may promote reductions in depression, anxiety, pain, and prematurity
rates (Field et al., 1999; Field, Diego, Hernandez-Reif, Schanberg, & Kuhnm 2004;
Field, Diego, Hernandez-Reif, Deeds, & Figueiredo, 2009). For example, one study
demonstrated that, compared to a control group that received only routine prenatal care,
pregnant women who received a 20-minute massage therapy intervention twice weekly
for 12 weeks showed improvements in depression, anxiety and physical pain, as well as
greater relationship satisfaction. Additionally, infants of women in the massage group
had greater gestational age and birth weight than infants of women in the control group
(Field, Diego, Medina, Delgado, & Hernandez, 2012). In another study by Field and
colleagues (2004), pregnant women with depression who received a 20-minute
massage intervention from their significant others twice per week for 12 weeks during
their second to third trimesters had fewer symptoms of depression and lower cortisol
levels compared to relaxation and treatment-as-usual groups. The massage group also
experienced fewer obstetric and postnatal complications.
In sum, massage therapy appears to offer benefits to women and their infants,
particularly with regard to reduced depression and anxiety and enhanced infant
outcomes. No study has yet to examine, though, whether massage therapy may be
useful for promoting smoking cessation during pregnancy. In comparison to the
acupuncture literature, there appears to be somewhat stronger evidence supporting
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massage therapy as a treatment aid for smoking cessation and perinatal depression, for
example, perhaps due to the more rigorous studies conducted by Field and colleagues.
Herbal and Dietary Supplements
A nearly endless list of herbal and dietary supplements have been purported to
treat a variety of physical and mental health issues. The Dietary Supplement Health and
Education Act (DSHEA) of 1994 changed the classification of herbal medicines to
dietary supplements, allowing their sale without prior efficacy or safety testing, and
therefore dismissing manufacturers of the requirement to report serious adverse events
to the U.S. Food and Drug Administration (FDA, 2015; Marcus & Snodgrass, 2005).
Therefore, herbs and dietary supplements are not approved or regulated by the FDA,
which makes many healthcare professionals hesitant to recommend them to the general
public and particularly to pregnant women (Marcus & Snodgrass, 2005).
Research has only recently begun to examine the efficacy and safety of using
such supplements. Herbs and supplements, such as ginger, raspberry leaf, blue
cohosh, castor oil, evening primrose oil, and St. John’s Wort (Hypericum perforatum),
have

been

used

for

a

variety

of

pregnancy-related

complaints,

including

nausea/vomiting, sleep, stress or to induce labor (Dante, Bellei, Neri, & Facchinetti,
2014). Despite the uncertainty about safety and lack of adequate supporting evidence,
use of herbal medicines and dietary supplements during and throughout pregnancy is
not uncommon, particularly outside of the US. However, estimates of use vary widely;
for example, one observational study from an urban hospital in the Midwest estimated
that 4.1% of pregnant patients used herbal or alternative remedies (Refuerzo et al.,
2005). In another survey study, 51% respondents from an antenatal clinic in Australia
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reported using herbal medicines daily during the second and third trimesters (Maats &
Crowther, 2002). Another sample of Norwegian women found that 36% had used herbal
medicines during pregnancy, and the proportion of women using herbal medicines
during pregnancy increased through the first, second, and third trimesters. The most
commonly used herbal medicines in this sample included Echinacea, iron-boosting
herbs, ginger, chamomile, and cranberry. Of particular concern, 39% reported using
herbs that were considered either potentially harmful or that lacked safety information
(Nordeng & Havnen, 2004). These findings underscore the need to better understand
the safety and efficacy of herbal and dietary supplements for pregnant women,
especially because women are using them regardless of available information.
Several reviews have focused on the use of herbs and supplements for
depression, anxiety, and stress. St. John’s Wort in particular has received significant
attention as an herbal antidepressant for mild to moderate depression, and has been
shown to be of comparable efficacy to a number of common pharmaceutical
antidepressants (Schulz, 2002). Data also reveal that St. John’s Wort appears to be
safe during pregnancy and breastfeeding, but the efficacy of St. John’s Wort for treating
depressive symptoms has not yet been demonstrated among pregnant women (Dante
et al., 2014). Another review investigating the use of various herbs and supplements for
anxiety disorders, including passionflower, kava, L-lysine, L-arginine, magnesium, and
St. John’s Wort, concluded that herbal and dietary supplements may be an effective
method for treating anxiety without serious side effects. Out of the 24 studies that
investigated CAM monotherapies or combination treatments for anxiety and related
disorders, 21 were randomized controlled trials (RCT), including 18 double-blind RCTs.
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Of the 21 RCTs, 15 (or 71%) demonstrated a positive effect for herbs or supplements
with only mild to moderate side effects; however, authors also noted that positive effects
may be due to a placebo effect. The strongest evidence reviewed regarding herbal
medicine as a treatment for anxiety was in support of supplements containing
passionflower or kava, or combinations of L-Lysine and L-arginine; less evidence was
available for magnesium and St. John’s Wort (Lakhan & Viera, 2010).
A few studies have also evaluated the efficacy of St. John’s Wort for smoking
cessation. One randomized, blinded, placebo-controlled trial of 118 smokers found that
St. John’s Wort did not promote smoking abstinence or attenuate withdrawal symptoms
(Sood et al., 2010). These results indicate that St. John’s Wort is not indicated for
smoking cessation. Other herbs and dietary supplements may promote smoking
cessation, but firm conclusions cannot be drawn given the dearth of research in this
area.
Chiropractic
Chiropractic, including spinal manipulation therapy, is one of the most commonly
used CAM techniques (Shelley, Clark, & Caulfield, 2015), and is often utilized as a
treatment for low back pain (Rubinstein, Terwee, Assendelft, de Boer, & van Tulder,
2013; Rubinstein, van Middlekoop, Assendelft, de Boer, & van Tulder, 2011). Despite
claims by chiropractors that chiropractic treatment is efficacious in treating a wide range
of health issues, including low back pain, migraines, headaches, neck pain, ADHD,
asthma, infertility, and pregnancy-related discomfort (Shelley et al., 2015), many have
determined that evidence is insufficient to make such claims. Two Cochrane Review
articles indicated that chiropractic was no more effective than other interventions in
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relieving low back pain (Rubenstein et al., 2011; Rubenstein et al., 2013), and others
have also observed a similar lack of convincing evidence for chiropractic treatment
overall (e.g., Ernst & Posadzki, 2011; Posadzki & Ernst, 2011).
Regarding use of chiropractic during pregnancy, a handful of studies have
examined the use of spinal manipulation for low back pain associated with pregnancy.
In a review of several studies, Stuber and Smith (2008) concluded that chiropractic
treatment appears to be associated with improved outcomes in pregnancy-related low
back pain. However, given the low-to-moderate quality of evidence and study design
issues such as lack of control groups or randomization, it is not possible to make firm
statements regarding the efficacy or safety of chiropractic care during pregnancy.
Overall, research on chiropractic care during pregnancy is lacking, and existing studies
appear to have methodological limitations. Furthermore, no known research has
examined links between chiropractic, mental health and smoking cessation. Therefore,
at present, research does not support the use of chiropractic treatment during
pregnancy, particularly for smoking cessation or perinatal depression or distress.
Mindfulness
The emergence of and research support for third-wave cognitive behavioral
therapies—mindfulness-based stress reduction (MBSR; Kabat-Zinn, 1990), acceptance
and commitment therapy (ACT; Hayes, Strosahl, Wilson, 1999), dialectical behavior
therapy (DBT; Linehan, 1993), mindfulness-based cognitive therapy (MBCT; Segal,
Williams & Teasdale, 2002), and mindfulness-based relapse prevention (MBRP;
Witkiewitz, Marlatt, & Walker, 2005)— have helped to legitimize mindfulness as a
treatment for a variety of physical and mental health disorders, including chronic pain,

35
stress, depression, anxiety, substance use disorders, borderline personality disorder,
and eating disorders (Hayes et al., 2011). Mindfulness, according to Kabat-Zinn (1994,
p.4), means “paying attention in a particular way; on purpose, in the present moment,
and nonjudgmentally.” One particular third-wave CBT program, mindfulness-based
stress reduction (MBSR), helped to introduce the West to mind-body and contemplative
practices as a treatment approach. MBSR consists of practices including seated
meditation, body scans, everyday mindfulness activities (e.g., walking, eating), and
yoga, as well as psychoeducation, group discussion, and homework (Kabat-Zinn, 2005;
Hayes et al., 2011). Mindfulness-based cognitive therapy (MBCT) and mindfulnessbased relapse prevention (MBRP) integrate the more general approach of MBSR but
adapt and refine practices and teachings for dealing with depression, anxiety, and
craving and relapse associated with substance use disorders.
The use of meditation to treat smoking and substance use disorders is not novel.
However, there has been a lack of substantial or rigorous research on meditation and
addictions (Breslin, Zack, & McCain, 2002; Marlatt & Marques, 1977; Witkiewitz et al.,
2005). Several studies from the 1970’s describe using transcendental meditation with
substance users with promising results (Benson, 1975; Marcus, 1974; Marlatt &
Marques, 1977). For example, meditation and exercise were found to be equally
effective in curbing daily drinking (Murphy, Pagano, & Marlatt, 1986). Marlatt and
colleagues used mindfulness as the basis of an extension of their relapse prevention
cognitive behavioral treatment; they suggest that mindfulness-based relapse prevention
(MBRP) may help to disrupt the system of craving and resulting habitual use by
providing increased awareness and acceptance of craving as a response to
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environmental cues, positive outcome expectancies, and motivation to engage in an
addictive behavior that provides positive and negative reinforcement. In particular, they
conceived of mindfulness practice as a form of counterconditioning, whereby
metacognitive awareness and relaxation replace the rewards associated with engaging
in drug use. Further, they emphasized the value of MBRP as an alternative to other
more cost-prohibitive treatments, like CBT, contingency management, 12-step
programs, and motivational enhancement therapy (Witkiewitz et al., 2005).
Importantly, mindfulness-based third-wave interventions like MBRP differ from
conventional CBT for addiction in that conventional approaches emphasize avoiding
cues and diverting attention from cravings (Fiore et al., 2000; Lando, McGovern,
Barrios, & Etringer, 1990). However, because triggers are omnipresent, avoidance can
be difficult. Additionally, distraction or diverting attention requires significant cognitive
effort, which is often depleted by strong affective states (Brewer, Elwafi, & Davis, 2012).
Mindfulness-based interventions, on the other hand, tend to emphasize approaching
triggers and cravings with present moment awareness and acceptance or nonjudgment
(Bishop et al., 2004).
Several studies have examined the efficacy of mindfulness techniques for
smoking cessation. A recent study found that even a brief, single session of mindfulness
meditation can have a significant impact on smoking over a week later (Bowen &
Marlatt, 2009). Brewer and colleagues (2012) found that compared to treatment as
usual, individuals smoking a pack a day on average who received an 8-session
mindfulness training intervention showed a significantly greater reduction in cigarette
use during treatment and maintained those gains at 3-month follow-up. A recent meta-
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analysis also found support for the use of mindfulness and other mind-body practices as
an alternative, drug-free treatment for smoking cessation, despite the small number of
studies available (only 4 for mindfulness) and methodological issues with the studies
reviewed (Carim-Todd, Mitchell, & Oken, 2013). In sum, initial evidence supports the
use of mindfulness as a component of smoking cessation treatment; however, more
rigorous clinical trials are needed.
Yoga
Yoga is an ancient health and spiritual tradition that consists of a range of
different practices, including postures (asana), meditation (dhyana), breathing exercises
(pranayama), moral and ethical behavior (yama), self-discipline (niyama), sensory
awareness (pratyahara), concentration (dharana), and deep meditative awareness
(samadhi). There are various yogic styles, including Hatha, Iyengar, Ashtanga, and
Kundalini, but most incorporate some form of posture, breath, and meditation. Although
yoga has ancient roots, the practical use of yoga for the purposes of physical fitness
and treating health difficulties appears to have only gained prominence within that last
century (Alter, 2004; Evans, Tsao, Sternlieb, & Zeltzer, 2009). It is estimated that
between 2002 and 2007, 6.1% of adults in the US practiced yoga (Barnes, Bloom, &
Nahin, 2008). Additionally, yoga has been increasingly used as a treatment for physical
and mental health conditions. However, despite its growing popularity and acceptance
as a treatment, a systematic model of the mechanisms through which yoga impacts an
individual’s physical, mental, and spiritual functioning has yet to be investigated. Evans
and colleagues (2009) suggest a biopsychosocial model of yoga, which is compatible
with our existing conceptualization of well-being from a Western medicine perspective.
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In particular, their proposed biopsychosocial model focused on activation of physical
systems (e.g., musculoskeletal, cardiopulmonary, autonomic nervous and endocrine
systems), psychological benefits (e.g., enhanced coping, self-efficacy, and positive
affect), and spiritual mechanisms (e.g., acceptance, mindful awareness) that are
triggered by yoga (Evans et al., 2009).
Compared to other forms of physical activity, yoga offers an alternative strategy
to treating physical and mental health problems. In particular, various forms of yoga
have been used for chronic pain management, stress reduction, mood symptom
management, and relapse prevention (Bock et al., 2012; Mehta & Sharma, 2010; Ross
& Thomas, 2010; Smith, Hancock, Blake-Mortimer, & Eckert, 2007; Varambally &
Gangadhar, 2012). Several studies have also examined the use of various forms of
yoga practice in managing symptoms of tobacco addiction and withdrawal, ranging from
single session laboratory studies to multiple session adjunct interventions. For example,
in a single-session laboratory study individuals who participated in 30 minutes of hatha
yoga reported decreased craving to smoke, increased positive affect, and decreased
negative affect (Elibero, Van Rensburg, & Drobes, 2011). In another pilot study, patients
in a residential substance use treatment program participated in 5 sessions of yoga and
breath awareness practice, in which cigarette smoking was neither encouraged nor
discouraged, experienced statistically significant shifts in their intention to quit smoking,
with 30% moving from pre-contemplation to contemplation (McIver, O’Halloran, &
McGartland, 2004). Bock and colleagues (2012) examined the feasibility and efficacy of
vinyasa yoga as a complementary treatment for smoking cessation among a sample of
women receiving group-based CBT. Compared to a control sample of women receiving
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a general health and wellness program and CBT, women randomized to receive yoga
had a greater rates of abstinence at the end of treatment (OR = 4.56) and at 6-months
after treatment (OR = 1.54). Those who participated in the yoga supplement also
reported reduced anxiety and increased perceived health and well-being compared to
controls. In addition to these individual studies, a recent meta-analysis concluded that
there is at least initial support for yoga as a treatment for smoking cessation (CarimTodd et al., 2013).
Yoga has become popular as a way to help women cope with the significant
physical and mental or emotional changes that they experience during and following
pregnancy (Beddoe & Lee, 2008), which themselves present risks to fetal and maternal
health. For example, stress and negative mood during pregnancy have been associated
with a variety of adverse maternal and infant outcomes (Bonari, Bennett, Einarson, &
Koren, 2004; Wadhwa, Sandman, & Garite, 2001), including low birth-weight, reduced
gestation and pre-term birth (Alvarado, Medina, & Aranda, 2002), lower Apgar scores
(Pagel, Smilkstein, Regen & Montano, 1990), and smaller head circumference (Lou et
al., 1994). Stressful pregnancies have also been predictive of prenatal substance use
(Nelson et al., 2003), more difficult labor and delivery (Nielsen et al., 2000), and
postpartum depression (Da Costa, Larouche, Drista, & Brender, 2000).
During the prenatal period, yoga has been used to reduce stress, general
negative affect, perinatal depression, physical pain, and to help women prepare for
labor and delivery. Unfortunately, rigorous trials demonstrating the effectiveness of
prenatal yoga are lacking. Despite the dearth of empirical support, informal survey
evidence indicates that prenatal yoga is appealing to pregnant women. For example,
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83% of women who were surveyed at a hospital day program reported an interest in
trying prenatal yoga. In particular, women identified several common reasons for their
interest in prenatal yoga, including reducing stress, depression and anxiety symptoms,
and participating in an exercise program (Battle, Howard, & Castaneda, 2010).
In addition, there have been a handful of studies published on prenatal yoga that
provide initial support for its efficacy in improving birth outcomes. One study of first-time
mothers who participated in 6, 1-hour prenatal yoga sessions found that those who
participated in the yoga program reported higher levels of comfort during labor and 2
hours post-labor and less subjective labor pain, compared to controls. In addition,
women in the yoga condition had a shorter duration of the first stage of labor and total
time in labor (Chuntharapat et al., 2008).
In a study focusing on pregnancy outcomes, Narendran and colleagues (2005)
examined the efficacy of daily yoga practice versus moderate physical activity (walking
for 30 minutes twice a day) on pregnancy outcome. Compared to women in the walking
group, women who practiced yoga daily (beginning at 18 to 20 weeks gestation until the
end of pregnancy) had significantly lower rates of preterm birth and significantly fewer
complications,

including

intrauterine

growth

restriction

and

pregnancy-induced

hypertension. Further, women in the yoga group also gave birth to infants of significantly
higher birth weight. These findings provide preliminary support for the acceptability of
prenatal yoga, as well as the use of yoga during the prenatal period to improve birth
outcomes.
In considering the available evidence, yoga appears to have potential as a
treatment for smoking cessation during the perinatal period. Furthermore, yoga seems
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to be an important component in established mindfulness approaches. For example, the
pairing of mindfulness and yoga practices is emphasized in existing treatments for
stress and chronic pain conditions (mindfulness-based stress reduction; Kabat-Zinn,
1990), depression and anxiety (mindfulness-based cognitive therapy; Segal et al.,
2002), and addiction (mindfulness-based relapse prevention; Witkiewitz et al., 2005). To
date, three prior studies have examined a mindfulness yoga program for pregnant
women, and all demonstrated that mindfulness yoga may be an effective treatment for
reducing distress and managing mood and anxiety symptoms, including stress and
negative affect (Vietin & Astin, 2008), anxiety (Beddoe, Yang, Kennedy, Weiss, & Lee,
2009), and depressive symptoms (Muzik, Hamilton, Rosenblum, Waxler, & Hadi, 2012).
Reductions in physical pain across pregnancy were also observed (Beddoe et al.,
2009). In addition, Muzik and colleagues (2012) found a significant increase in
maternal-fetal attachment among women at risk for perinatal depression who
participated in a mindfulness yoga program. Together, these studies indicate that the
combination of mindfulness and yoga practiced during pregnancy can increase stress
tolerance and sleep quality, and decrease psychological distress, and chronic pain
intensity, which is particularly powerful during prenatal period, when womens’ bodies
are subject to physical and emotional changes, including stress and pain (Muzik et al.,
2012). However, the effectiveness of prenatal mindfulness yoga for treating tobacco or
other substance dependence has yet to be examined.
Limitations of Existing Research on CAM and Smoking Cessation during Pregnancy
Despite growing evidence supporting the efficacy of CAM approaches for a
variety of physical and mental health issues, including smoking, published studies suffer
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from a number of limitations, leaving important gaps in the literature. Adams and
colleagues (2009) identified several areas left unexplored, including: 1) nationally
representative studies using large-scale samples in order to better characterize CAM
users, prevalence rates, and types of CAM treatments used; 2) better understanding of
the decision-making process and the extent of communication between women, their
families, and their healthcare providers; 3) insight into perceived risks and the impact of
these risks on use of CAM treatments; 4) longitudinal examination of CAM usage
throughout and between pregnancies; 5) cross-cultural experiences with CAM
approaches; and 6) focus on the therapeutic encounter between women, healthcare
providers, and CAM practitioners to facilitate communication and improve women’s
health outcomes.
Similarly, research and guidelines for clinical practice regarding the use of CAM
for smoking cessation is hindered by insufficient evidence. A recent meta-analysis
concluded that--although CAM approaches appear to help promote smoking cessation-there is still a scarcity of rigorous studies, and existing studies are hampered by
methodological issues, including small sample sizes, limited study design, lack of
treatment fidelity monitoring, lack of objective study outcomes, and lack of control
conditions (Carim-Todd et al., 2013).
CAM Treatments for Prenatal Smoking and Distress
As described above, there are few currently recommended approaches to
smoking cessation for pregnant women, and none reach a majority of those in need of
treatment. The limited impact of existing conventional approaches may reflect a lack of
understanding of the characteristics and treatment needs of those women who have the
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most difficulty quitting. It is therefore necessary to improve upon treatment approaches
and access for women who continue to smoke during pregnancy. CAM techniques
appear to be increasingly gaining interest in the general population. Although adequate
research regarding the efficacy of CAM treatments for physical and mental health
issues (including smoking cessation and managing perinatal distress) is lacking, such
treatments have the potential to fill an important treatment gap. Examining the use of
conventional mental health and CAM treatments among pregnant smokers may help us
to better understand their needs and preferences. Further, a closer examination of the
characteristics of those who use these approaches may be useful in designing and
implementing interventions in healthcare and community settings.
Aims and Hypotheses
The primary goal of the present study is to explore the characteristics and
treatment utilization practices of two national samples of pregnant smokers in order to
better understand the unique treatment needs and preferences of pregnant smokers in
the United States. Analyses will place special emphasis on the prevalence of and
factors related to CAM use within this population. The present study will use data from
the National Survey on Drug Use and Health (NSDUH) and the National Health
Interview Survey (NHIS) in order to examine the following questions:
Using the NSDUH sample:
1)

What are the characteristics of pregnant women who quit smoking
during their pregnancy compared to those who do not?
Although this aim is exploratory, it is hypothesized that pregnant women who
are persistent smokers are more likely to be older, Caucasian, of lower
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socioeconomic status, smokers for a longer period of time, and to report
greater distress, lower perceived risk of smoking, and criminal justice
involvement.
Using both the NSDUH and NHIS samples:
2)

What are the rates of complementary and alternative health (CAM)
treatment utilization among pregnant smokers, and how have trends
changed across time?
It is hypothesized that CAM treatment utilization will be low, but that trends will
indicate an increase across years.

3)

What are the characteristics of pregnant smokers who have utilized
CAM treatments?
This is another exploratory aim. However, based on previous studies, it is
hypothesized that pregnant smokers who use CAM treatments will report
higher levels of education and higher family income.
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CHAPTER 2 METHOD
Survey and Sample Descriptions
National Survey on Drug Use and Health (NSDUH)
The present study used a subset of data from the 2004-2013 NSDUH. Initiated in
1971 and conducted on a yearly basis since 1990, the NSDUH collects information from
a random sample of more than 70,000 individuals, providing cross-sectional, national
estimates of alcohol and drug use for non-institutionalized U.S. civilians aged 12 and
older. NSDUH employs independent, multistage area probability sampling for all 50
states and the District of Columbia with oversampling of certain subpopulations (e.g.,
ages 12-17, African Americans, Hispanic/Latinos) in order to yield nationally
representative estimates (SAMHSA, 20014). Survey years 2004-2013 were the focus of
the current project because a question regarding use of alternative mental health
treatment, including acupuncture, herbal medicine, massage therapy, and chiropractic
adjustment was added to the survey beginning in 2004.
A total of 8,895 pregnant women (age 12-44) participated in the NSDUH during
these survey years. All pregnant women who participated between 2004 and 2013 and
reported smoking within the past year were included in analyses (N = 3,252). Further, a
subset of pregnant smokers who also reported using alternative mental health treatment
were included in analyses focusing on smoking and CAM use (N = 251).
National Health Interview Survey (NHIS)
The present study also used a subset of data from the 2002, 2007, and 2012
National Health Interview Survey (NHIS). Similar to the NSDUH, the NHIS surveys the
civilian, non-institutionalized U.S. population. Initiated in 1956, the NHIS is a cross-
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sectional survey conducted annually by the National Center for Health Statistics (NCHS)
with the purpose of collecting information on the health of the U.S. population. The
NHIS employs a complex sampling design (multistage area probability design) that is
redesigned after every decennial census to obtain a representative sampling of
approximately 87,500 individuals from households in all 50 states and the District of
Columbia, and includes oversampling of African American, Hispanic, and Asian
individuals (CDC, 2015).
Since 2002 the NHIS has included a special supplemental section on CAM
utilization every 5 years; therefore, the present study examined the three waves of the
NHIS that have included CAM questions to date (2002, 2007, and 2012). A total of 992
pregnant women over the age of 17 participated in the NHIS during these survey years.
All women who were pregnant and smoking at the time that they participated in the
survey were included (N = 106). Data for each participant who completed either the
2002, 2007, or 2012 Alternative Health/Complementary and Alternative Medicine
supplements was matched to the corresponding Sample Adult Core and Family surveys
(CDC, 2002, 2007, 2012). Only those respondents who completed all survey sections
were included in analyses.

Procedure
Data Collection
All NSDUH data were collected face-to-face by trained interviewers using
computer-assisted personal interviews (CAPI) and audio computer-assisted selfinterviews (ACASI). The use of these approaches is believed to enhance response
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validity and disclosure on sensitive topics (SAMHSA, 2014). Data files for the years
2004 through 2013 are publicly available and were obtained via the Inter-University
Consortium for Political and Social Research (ICPSR). The sponsor removed identifying
information from all data files to insure anonymity of participants.
All NHIS data were collected through face-to-face household interviews
conducted by trained interviewers from the U.S. Bureau of the Census. Interviews occur
continuously throughout the year. The NHIS questionnaire uses CAPI administered via
laptop with interviewers entering responses into the computer during the interview
(CDC, 2015). Data files for the years 2002, 2007, and 2012 are publicly available and
were obtained through the ICPSR (for years 2002 & 2007) and the CDC (for 2012 only).
NSDUH Measures
See Appendices A-K for all NSDUH measures.
Sociodemographic variables. The publicly available NSDUH dataset included
information on a range of demographic variables such as, respondent sex, age, race,
ethnicity, marital status, number of children living in the household, highest level of
education completed, employment status, family income and receipt of government
assistance (e.g., social security income, food stamps, cash assistance).
Pregnancy. All females aged 12-44 were asked whether they are currently
pregnant (“Are you currently pregnant?”), and if so, how far along they are in their
pregnancy (“How many months pregnant are you?”). Although month of pregnancy was
not included in the publicly available dataset, trimester was included as a recoded
variable.
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Perceived general health. A single item was used to assess respondents’
perceived quality of general health: “This question is about your overall health. Would
you say your health in general is: excellent, very good, good, fair, or poor?”
Smoking
Onset, frequency, recency. Respondents who endorsed ever smoking were
queried further about their smoking, including the age at which they first smoked a
cigarette, the age at which they first smoked daily, the age that they last smoked a
cigarette, whether they had ever smoked 100 cigarettes, and, if currently smoking, how
often and how much they smoke. Past month and past year cigarette use were also
available.
Change in smoking. Change or cessation in smoking was not directly queried in
the NSDUH survey. Therefore, this outcome variable was created by determining
whether pregnant women are current smokers (i.e., have smoked in the past 30 days)
or have recently quit smoking (i.e., have smoked in the past year but not in the past 30
days), and recoding these responses into a dichotomous variable.
Perceived risk of smoking. A single item addressed perceived risk of heavy
cigarette smoking: “How much do people risk harming themselves physically and or in
other ways when they smoke 1 or more packs of cigarettes per day?”
Plan to return to or continue smoking. One item asked respondents whether they
plan to be smoking in the next year: “Do you think you’ll smoke in the next 12 months?”
Nicotine Dependence Syndrome Scale (NDSS; Shiffman, Hickcox, Gnys, Paty, &
Kessel, 1995; Shiffman, Waters, & Hickox, 2004). The NDSS is a 19-item measure of
dependence on nicotine, specifically in cigarettes, that focuses on five aspects of
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dependence: smoking drive (i.e., the compulsion to smoke caused by nicotine craving
and withdrawal symptoms), nicotine tolerance, continuous smoking, behavioral priority
(i.e., preference to smoke rather than engage in other reinforcing activities), and
stereotypy (i.e., fixed patterns of smoking). Out of the 19 items, 17 were used to
calculate an average score of overall nicotine dependence (Shiffman et al., 2004). For
respondents who answered 16 of the 17 NDSS nicotine dependence questions,
imputation using the 16 answered items as covariates in a weighted least squares
regression model was implemented; as a result, an NDSS score was only calculated for
those individuals who had responses to all 17 nicotine dependence items after
imputation. Respondents were categorized as nicotine dependent if their NDSS score
was greater than or equal to 2.75 (SAMHSA, 2014).
Nicotine craving. Two NDSS items related to nicotine craving (“When you don’t
smoke for a few hours, you start to crave cigarettes.”; “You sometimes have strong
cravings for a cigarette where it feels like you’re in the grip of a force you can’t control.”)
were used to assess craving.
Smoking cessation self-efficacy. A single NDSS item related to selfefficacy/autonomy (“You feel a sense of control over your smoking — that is, you can
“take it or leave it” at any time.”) was used to assess smoking cessation self-efficacy.
Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski,
Frecker, & Fagerstrom, 1991). The FTND is a 6-item self-report measure of smoking
behaviors and nicotine dependence. It is a widely-used and valid measure of nicotine
dependency (Pomerleau, Carton, Lutzke, Flessland & Pomerleau, 1994). The NSDUH
utilized the one item from this measure that has been shown to discriminate dependent
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from nondependent smokers (SAMHSA, 2014): “How soon after you wake up do you
have your first cigarette?” Respondents endorsing either “Within the first 5 minutes after
you wake up” or “Between 6 and 30 minutes after you wake up” were categorized as
nicotine dependent.
Alcohol and other substance use. A main focus of the NSDUH is to thoroughly
assess the use and misuse of alcohol, illicit substances, and prescription medication.
Therefore, items regarding lifetime, past year, and current use of a range of substances
were included, as were items assessing DSM-IV criteria for substance abuse and
dependence.
Distress and psychopathology
The mental health module of the NSDUH is designed to collect data on serious
psychological distress and major depression. Questions related to serious psychological
distress and major depressive disorder were added to the NSDUH survey beginning in
2005. Therefore data for these mental health indicators was only available for those
who completed the survey between 2005 and 2013 (SAMHSA, 2014).
K6 (Furukawa, Kessler, Slade, & Andrews, 2003; Kessler et al., 2003). The K6 is
a well-validated, brief screener for nonspecific psychological distress. The K6 was used
to measure serious psychological distress in two time periods: 1) in the past 30 days,
and 2) during a month in the past year in which they felt more depressed, anxious, or
emotionally stressed than in the past month. Only those who indicated that in the past
year there was a worse month than the past 30 days were asked about the worst month
in the past year. Respondents with a total K6 score of 13 or greater were classified as
having had serious psychological distress (SAMHSA, 2014).

51
Major depression. DSM-IV criteria were used to determine whether respondents
met criteria for a major depressive episode in their lifetime and within the past year.
Anxiety. Respondents were asked whether they have ever had an anxiety
disorder and whether a doctor had indicated to them that they had an anxiety disorder in
the past 12 months.
Externalizing and Risky Behavior
Criminality. Items related to criminal justice involvement included: “Not counting
major traffic violations, have you ever been arrested and booked for breaking the law?”;
“In the past 12 months have you been arrested for driving under the influence of alcohol
or drugs?” Respondents were also asked whether they had been arrested and charged
with driving under the influence of alcohol or illicit drugs. Regarding probation status:
“Were you on probation at any time during the past 12 months?”
Risk taking. In addition, items related to the frequency of seeking out and
engaging in risky behavior were included: “How often do you get a real kick out of doing
things that are a little dangerous?” “How often do you like to test yourself by doing
something a little risky?” Another indicator of risk-taking, seatbelt usage, was also
assessed: “How often do you wear a seatbelt when you ride in the front passenger seat
of a car?” “How often do you wear a seatbelt when you drive a car?”
Treatment utilization
Conventional mental health and substance use treatment. A series of items
assessing the past year usage of various forms of conventional mental health and
substance use treatment were included in the mental health treatment utilization and
substance use treatment sections, respectively. Instructions for mental health treatment
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emphasized that respondents not include episodes of substance use treatment, and
instructions for substance use treatment emphasized that “questions deal with treatment
for alcohol and drug problems, not including cigarettes.”
Reasons for not receiving treatment. In addition to asking respondents about
treatment they did receive, respondents were asked about reasons they did not receive
treatment, including barriers to treatment, such as lack of insurance coverage and
perceived lack of need for treatment. Questions pertaining to mental health treatment
and substance use treatment are asked separately.
CAM treatment. In addition to questions related to the use of conventional mental
health and substance use treatment options, the NSDUH survey asked whether
respondents have used an alternative mental health treatment in the past 12 months,
specifically for help with a mental health problem. Response options for this item
included visiting four common CAM treatment providers: acupuncturist, chiropractor,
herbalist, and massage therapist.

NHIS Measures
See Appendices L-P for all NHIS measures.
Sociodemographic variables. The NHIS included a range of demographic
characteristics, including age, race, ethnicity, marital status, employment status, and
family income.
Pregnancy. A single item was included in the Sample Adult Core survey
regarding current pregnancy (“Are you currently pregnant?”). Trimester or month of
pregnancy was not assessed.
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Smoking. Smoking status was identified by responses to questions in the Sample
Adult Core survey: 1) “Have you smoked at least 100 cigarettes in your entire life?” and
2) “Do you now smoke cigarettes every day, some days, or not at all?” For current
smokers, questions related to quantity and frequency of cigarette smoking in the past 30
days were included: “On how many days in the past 30 did you smoke a cigarette?” “On
average, when you smoked during the past 30 days, about how many cigarettes did you
smoke a day?” ”On average, how many cigarettes do you now smoke a day?” In
addition, one item assessed age of regular smoking initiation (“How old were you when
you first started to smoke fairly regularly?”).
Quit status (“How long has it been since you quit smoking cigarettes?”) and past
year quit attempts (“During the past 12 months, have you stopped smoking for more
than one day because you were trying to quit smoking?”) were also included.
Alcohol use. Several items related to alcohol use were included in the NHIS,
including quantity and frequency of past year alcohol use and binge drinking.
Mental health. Respondents were asked whether a doctor or other health
professional had ever told them that they had depression or other mental health
disorders. Those who endorsed that they had been told they had either depression or
other mental health disorders were asked a follow up question to determine whether this
occurred during the past 12 months.
K6 (Furukawa et al., 2003; Kessler et al., 2003). As noted above, the K6 is a brief
measure of psychological distress. In the NHIS, respondents were asked how often they
had experienced the 6 symptoms of psychological distress during the past 30 days.
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CAM utilization. In comparison to the NSDUH CAM questions, the NHIS primarily
asked about the use of CAM in general, rather than treatment for a specific purpose
(i.e., mental health or substance use); however, respondents also had the option to
indicate whether they used a treatment for a specific health problem. Respondents were
asked about whether they utilized a range of CAM treatments, including yoga,
meditation/mindfulness practices, tai chi, qi gong, Pilates, acupuncture, Ayurveda,
biofeedback, chiropractic care, massage, energy healing therapy, chelation therapy,
craniosacral
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meditation/mindfulness practices, acupuncture, chiropractic, herbs or supplements, and
massage were examined because they: 1) represent some of the more commonly
available and utilized CAM treatments; 2) have been the focus of previous empirical
investigation; and 3) and may be relevant to pregnant smokers. Those who endorsed
using a particular CAM treatment were asked a series of follow-up questions, including
whether they used that treatment in the past 12 months and how many times they used
the treatment in the past 12 months. For some CAM treatments, additional follow-up
questions were also included.
Respondents who endorsed use of CAM treatments were also asked about
health benefits they associated with CAM treatments, including being motivated to cut
back or stop drinking alcohol or cut back or quit smoking cigarettes, reducing stress or
relaxing, sleeping better, feeling better emotionally, coping better with health problems,
and improving health overall. Additionally, respondents were queried about their
reasons for choosing CAM treatments (e.g., medications “caused side effects;” “it’s
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natural;” “it focuses on the whole person, mind, body, and spirit;” “it was part of your
upbringing”) and whether they had discussed the use of CAM with their health care
provider.
Conventional treatment utilization. The NHIS does not include specific items
related to conventional mental health and substance use treatment. However,
respondents ere asked if they had seen “a mental health professional such as a
psychiatrist, psychologist, psychiatric nurse, or clinical social worker” in the past 12
months.

Analyses
All analyses were conducted using SPSS version 22.0; the complex samples
add-on component will be utilized as appropriate. Imputations and recodes for the
NSDUH and NHIS data were conducted by the Research Triangle Institute (RTI) and
National Center for Health Statistics (NCHS), respectively, and were provided in the
publicly available data files. In cases where imputation was conducted, missing data
were either logically assigned according to responses to other survey questions when
appropriate, or replaced via statistical imputation with non-missing values (SAMHSA,
2014; CDC 2002, 2007, 2012). As recommended by RTI and NCHS, final annual survey
weights were used for both the NSDUH and NHIS data in order to support national-level
estimates. Subpopulation analyses with sample sizes that fell below 200 (i.e., substance
use treatment barriers for NSDUH sample, CAM use in both the NSDUH and NHIS
samples) did not take into account complex sample design features (West, personal
communication, May 21, 2015).
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Broadly, analyses fell into three groups: (a) descriptive analyses summarizing
sample characteristics and prevalence rates; (b) logistic regression analyses to examine
factors related to cessation in perinatal smoking; and (c) logistic regression analyses to
investigate factors related to CAM utilization.
Sample description and prevalence rates
Descriptive analyses were used to better understand sample characteristics, to
investigate prevalence rates across study waves of prenatal smoking, mental health
issues, and other substance use, and to explore utilization rates of conventional mental
health and substance use treatment and CAM treatment across the study waves. For
population-level estimates, 95% confidence intervals are also reported.
Analyses of factors associated with smoking cessation during pregnancy
Associations between potential factors related to prenatal smoking (e.g.,
sociodemographic factors, smoking patterns, substance use, mental health, and
externalizing) were first examined prior to conducting regression analyses. Those
factors that were significantly related to smoking were included initially in separate
univariate logistic regression models to predict the dichotomous outcome of cessation in
smoking during the past year. Only those variables associated with the outcome were
included in the multivariate logistic regression model to determine the factors most
strongly associated with cessation in perinatal smoking.
Analyses of factors associated with CAM usage
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variables associated with lifetime (NHIS) and past year (NSDUH and NHIS) CAM usage
were included in multivariate regression models to determine the relative importance of
variables associated with CAM utilization. Due to the smaller sample sizes for CAM use,
some factors were combined (e.g., alcohol and illicit drug dependence combined into
substance use dependence) where appropriate. Further, given the ratio of sample size
relative to the number of predictors, stepwise logistic regression was used to estimate
adjusted associations between key variables and CAM use in multivariate models.
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CHAPTER 3 RESULTS
In this study, we analyzed data from two national multi-year surveys with the
broad aim of better understanding the treatment needs and preferences of pregnant
smokers. First, the prevalence rate of smoking among pregnant women across study
waves was estimated. Next, we examined characteristics of current smokers compared
to former smokers. Then, utilization of conventional treatment and CAM treatment was
also examined, including estimating prevalence of treatment utilization and examining
the characteristics of pregnant smokers who utilized CAM. It was predicted that a
number of sociodemographic factors, smoking history and patterns, and mental health
symptoms would be associated with quitting smoking during pregnancy. It was also
predicted that pregnant smokers would endorse the use of CAM, and that, although
rates would be low, there would be a trend toward increasing rates across study years.
Finally, it was also predicted that sociodemographic and potentially mental health and
smoking-related factors would be associated with CAM use.
Description of NSDUH sample
See Table 1 for NSDUH sample characteristics. A total of 3,252 pregnant women
age 12-44 who had smoked in the past year participated in the NSDUH across the 2004
to 2013 survey years. Of these 3,252 respondents, 1,920 were current smokers who
had smoked in the past 30 days, while 1,332 had smoked in the past 12 months, but not
the past 30 days. Approximately 50% of pregnant past-year smokers were between 18
and 25 (95% CI = 57.7, 53.9). Pregnant women who endorsed smoking were primarily
White. Overall, current smokers appeared to be more socially disadvantaged than
former smokers. Current smokers were predominantly unmarried, while former smokers
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were equally likely to be either married or unmarried. Among pregnant women who
reported smoking in the past year, fewer current smokers were college graduates
compared to former smokers. In addition, nearly half of those pregnant women who
were currently smoking received some form of government assistance, whereas just
below 30% of pregnant former smokers received any government assistance. Former
smokers reported a higher rate of current employment compared to current smokers. A
greater proportion of current smokers reported a total annual family income of less than
$20,000 compared to former smokers and living below the poverty threshold in greater
rates. Conversely, a greater proportion of former smokers reported a total annual family
income of more than $75,000.
Regarding general health, a greater proportion of pregnant former smokers
reported their overall health to be “Excellent” or “Very Good”, compared to current
smokers. Measures of mental health revealed that current smokers experienced greater
distress and symptoms of poor mental health. Pregnant current smokers endorsed
higher rates of past month and past year serious psychological distress compared to
former smokers. The odds of having had serious psychological distress in the past
month were more than 2.5 times greater for current smokers (OR = 2.58; 95% CI =
1.55, 4.31), and the odds of having had serious psychological distress in the past year
were almost twice as great for current smokers (OR = 1.88; 95% CI = 1.48, 2.39).
Current and former smokers endorsed similar rates of lifetime major depression, with
approximately 20% meeting criteria for depression within their lifetime. However, former
smokers had decreased odds of having had depression in the past year (OR = 0.65;
95% CI = 0.42, 0.99). A similar difference was observed for anxiety disorders. Current
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smokers had a 1.5 times greater odds of having received a diagnosis of an anxiety
disorder from a doctor or medical professional in their lifetime. Current smokers also
had nearly double the odds of an anxiety disorder diagnosis within the past year (OR =
1.96; 95% CI = 1.31, 2.94).
Estimates of alcohol and illicit drug use were also examined. The odds of having
had a drink within the past month were 36% greater for current smokers compared to
former smokers (OR = 1.36; 95% CI = 1.01, 1.84). The odds of binge drinking (i.e.,
drinking five or more drinks on the same occasion) in the past month were 3 times
greater for current smokers (OR = 3.08; 95% CI = 2.07, 4.57), with 11.5% of current
smokers reporting past month binge drinking compared to 4.1% of former smokers.
There were no significant differences between current and former smokers with regard
to past year alcohol abuse or dependence. Compared to former smokers, current
smokers had a 3.1 times greater odds of having used illicit drugs within the past month
(OR = 3.14; 95% CI = 2.16, 4.58). An equal proportion of current and former smokers
met criteria for past year illicit substance abuse, but a greater proportion of current
smokers met criteria for past year illicit substance dependence (OR = 1.68; 95% CI =
1.24, 2.30).
Finally, facets of externalizing and risky behavior, including criminal justice
involvement, driving while intoxicated, and risk seeking, were examined. Currently
smoking pregnant women were at increased odds of ever having been arrested (OR =
1.53; 95% CI = 1.18, 1.99) and having been on probation in the past year (OR = 1.94;
95% CI = 1.31, 2.87). There was no significant difference between current and former
smokers with regard to driving under the influence of alcohol or drugs within the past
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year. On two items related to risky behaviors, current smokers endorsed greater
engagement in risky behaviors to “test” themselves (OR = 1.5; 95% CI = 1.13, 2.12), but
there was no difference between current and former smokers in terms of getting a kick
out of doing something dangerous. Finally, current smokers were less likely to wear a
seatbelt, whether as a driver (OR = 0.42; 95% CI = 0.31, 0.57) or passenger (OR = .44;
95% CI = 0.34; 0.58).
Description of NHIS sample
See Table 2 for NHIS sample characteristics. A total of 106 pregnant women age
18 and up who were currently smoking participated in the NHIS in 2002, 2007, and
2012. Of these 106 pregnant women, 79 reported smoking every day and 27 reported
smoking some days. The mean age of pregnant smokers was 26.96 (SD = 6.09).
Pregnant smokers who participated in the NHIS were primarily White, non-Hispanic and
married or living with a partner. Approximately 35% had completed high school or
received a GED. About half of the sample indicated that they were currently employed,
with over 50% reporting an annual family income of less than $35,000. Just under a
quarter were on some form of government assistance, and over 75% had health
insurance coverage.
Among the pregnant smokers in the NHIS sample, the majority reported that their
physical health was “Excellent” or “Very Good,” and that their general health was about
the same compared to last year. In terms of mental health, pregnant smokers who
participated in the NHIS were highly distressed, with 90% meeting the cutoff for past
month serious psychological distress. Approximately 30% indicated that they had been
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frequently anxious or depressed in the past year. In addition, 17.2% of pregnant
smokers in the NHIS endorsed moderate to heavy alcohol use in the past year.
Smoking prevalence
Across the NSDUH waves, past 30-day smoking prevalence appeared to
fluctuate slightly, ranging from 13.3% (2012; 95% CI = 10.9, 16.2) to 19.6% (2010; 95%
CI = 16.1, 23.7), but remained generally stable with a 16% (95% CI = 14.9, 17.2)
prevalence rate across all waves. See Figure 1. Among all pregnant women, an
examination of smoking prevalence by trimester across the study waves demonstrated
a decrease across trimesters: 22.3% (95% CI = 19.8, 24.9) in the first trimester, 13.8%
(95% CI = 12.2, 15.6) in the second trimester, and 12.2% (95% CI = 10.6, 14.1) in the
third trimester of pregnancy (see Figure 2). Within the pregnant, current smoker subset,
43.9% (95% CI = 39.9, 48.0) were in their first trimester, 30.5% (95% CI = 27.3, 34.0) in
their second trimester, and 25.5% (95% CI = 22.3, 29.0) were in their third trimester.
Finally, within the pregnant, former smoker subset, 24.6% (95% CI = 21.0, 28.5) were in
their first trimester, 41.7% (95% CI = 37.1, 46.4) were in their second trimester, and
33.7% (95% CI = 29.6, 38.1) were in their third trimester.
The mean age of beginning daily smoking was 16.14 (95% CI = 17.42, 18.31) for
current smokers and 17.86 (95% CI = 15.91, 16.37) for former smokers. In terms of
early onset of regular cigarette use, current smokers had a 2.4 times greater odds of
being an early onset regular smoker (by age 14) compared to former smokers (OR =
2.41; 95% CI =1.80, 3.23). In terms of smoking risk perception, most women considered
regular heavy smoking (e.g., one or more packs per day) to be of great risk.

63
On average, most current smokers smoked 6 to 15 cigarettes per day (36.2%;
95% CI = 33.0, 39.5). Just under a third of current smokers smoked 2 to 5 cigarettes per
day on average (29.0%; 95% CI = 25.9, 32.3). Nearly two-thirds (65.5%; 95% CI =62.5,
68.4) of current smokers met criteria for nicotine dependence within the past month.
When nicotine dependence among current smokers was examined by trimester, 73.6%
(95% CI = 68.9, 77.9) of women in their third trimester met past month criteria for
nicotine dependence, while 64.3% (95% CI = 58.0, 70.2) of second trimester and 61.5%
(95% CI = 56.2, 66.5) of first trimester women met nicotine dependence criteria.
Regarding a specific feature of nicotine dependence, craving, 25.4% (95% CI = 22.5,
28.5) of current smokers reported little to no craving for cigarettes. Notably, 32.1% (95%
CI = 28.8, 35.7) strongly indicated that they felt in control of their smoking, whereas
21.9% (95% CI = 19.5, 24.5) reported feeling as though they were not in control of their
smoking.
Compared to the NSDUH, the prevalence rate of past-30-day prenatal smoking
in the NHIS was slightly lower. However, similar to the NSDUH, the prevalence rate in
the NHIS appeared to fluctuate across study years (see Figure 3), dropping from an
estimated 11.6% (95% CI = 8.5, 15.6) in 2002 to 8.1% (95% CI = 5.2, 12.4) in 2007, and
then increasing to 10.7% (95% CI = 7.1, 15.9) in 2012; across the 3 waves, prenatal
smoking prevalence was estimated to be 10.1% (95% CI = 8.0, 12.6). Notably, the
percentage of pregnant former smokers and never smokers also appeared to fluctuate
(see Figure 4). Among pregnant women who had ever been regular smokers (i.e., those
who had ever smoked 100 cigarettes), the rate of current smoking appeared to
decrease slightly, ranging from an estimated 43.3% in 2002 to 36.1% in 2012. The
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majority of former smokers quit smoking within the past year (51.1%). The mean age at
which current smokers began regularly smoking was 15.92 (SD = 3.33). On average,
pregnant smokers who participated in the NHIS smoked 12.64 (SD = .029) cigarettes
per day, with a modal number of 10 cigarettes smoked per day.
Factors associated with smoking cessation during pregnancy
Unadjusted logistic regression analyses revealed that many factors were
significantly associated with smoking cessation during pregnancy, with the strongest
factors being greater levels of education, higher annual family income, absence of past
month serious psychological distress, past month binge drinking, and past year illicit
drug use. Age, lifetime major depression diagnosis, alcohol use disorders, and past
year DUI were not associated with perinatal smoking cessation. See Table 3 for
unadjusted odds ratios.
Variables related to smoking cessation in pregnancy were included in adjusted
analyses. The overall adjusted logistic regression model was significant and accounted
for between 29.5% (Cox and Snell R2) and 39.9% (Nagelkerke R2) of the variance in
smoking cessation during pregnancy. In the full model, several factors were no longer
significantly associated with smoking cessation: receipt of government assistance, age
onset of regular smoking, serious psychological distress (past year and past month),
past year major depression, lifetime anxiety disorder, past month and past year illicit
drug use, past year substance dependence, arrest history, probation status, risky
behavior, conventional treatment utilization, and unmet need for mental health
treatment. The strongest factors associated with smoking cessation in the overall model
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included greater education, Hispanic ethnicity, and absence of past month binge
drinking or past year anxiety disorder diagnosis. See Table 3 for adjusted odds ratios.
Prevalence rates of conventional treatment utilization
Approximately one-fifth of pregnant past-year smokers reported engaging in
conventional mental health or substance use treatment within the past year (20.2%;
95% CI = 18.1, 22.4). Currently smoking pregnant women from the NSDUH survey
reported greater likelihood of having sought conventional treatment within the past year
as compared to former smokers (OR = 1.77; 95% CI = 1.35, 2.31). Further, current
smokers were more likely to report an unmet need for mental health treatment (OR =
2.06; 95% CI = 1.45, 2.92). There was not a significant difference between current and
former smokers with regard to a substance use treatment gap, or needing treatment but
not receiving it (see Table 1).
Respondents indicated a variety of reasons for seeking treatment, as well as a
variety of barriers to seeking or receiving treatment. Among the 649 pregnant past-year
smokers who sought mental health treatment in the past 12 months, 81% (95% CI =
76.1, 85.1) indicated that they decided on their own to seek treatment; another 13.6%
(95% CI = 9.9, 18.3) of remaining treatment seekers sought mental health treatment
because someone else thought they should. Finally, 5.4% (95% CI = 3.9, 7.5) sought
mental health treatment because they were ordered to get treatment. Regarding
perceived barriers to receiving mental health treatment, current and former smokers
endorsed similar reasons for not receiving treatment with a few exceptions. A greater
proportion of former smokers indicated that an insurance deficit, such as insurance not
covering any treatment or not covering enough of the cost of treatment, prevented them
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from receiving treatment. The most common barriers to mental health treatment for both
current and former smokers included being unable to afford it, not knowing where to go
for treatment, and believing they could handle the problem without treatment. See Table
4 for perceived barriers to conventional mental health treatment.
Response rates for perceived barriers to substance use treatment were low
(unweighted count = 58). For current smokers, the most common reason for not seeking
substance use treatment was that they were not ready to stop using, followed by being
unable to afford it or not having insurance and not wanting others to find out. For former
smokers, the most common reasons for not seeking substance use treatment included
being unable to afford treatment or not having insurance coverage, transportation
difficulties, and fear that their neighbors would have a negative opinion of them. See
Table 5 for perceived barriers to conventional substance use treatment.
Within the NHIS sample, just over a tenth of pregnant smokers indicated that
they had seen a mental health professional within the past year (see Table 2). A greater
proportion of daily smokers (12.8%) reported that they had seen a mental health
professional in the past year compared to regular (but not daily) smokers (8.8%).
Prevalence rates of past year CAM utilization
Among pregnant NSDUH participants who endorsed smoking within the past
year, 251 responded to items related to alternative mental health treatment, including
156

who

received

treatment

from

several

CAM

practitioners

(acupuncturist,

chiropractor, herbalist, massage therapist). Compared to conventional treatment, fewer
pregnant past-year smokers reported engaging in alternative mental health treatment
within the past year. Within the larger sample of pregnant women who have smoked
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within the past year, the prevalence of CAM use was 6.9%: 5.6% among current
smokers, and 8.5% of former smokers utilized CAM in the past year. Across NSDUH
survey waves there appeared to be some variability in CAM treatment use. Overall,
prevalence rates for any CAM use among pregnant, past year smokers varied between
an estimated 3.7% (95% CI =1.9, 7.4) at the lowest in 2007 to 10.8% (95% CI = 3.7,
27.5) at the highest in 2011. See Figure 5.
Of those pregnant women who sought treatment from alternative mental health
treatment, current smokers were at lower odds of having seen a CAM practitioner for
alternative mental health treatment within the past year compared to former smokers
(OR = 0.54; 95% CI = 0.32, 0.91). Chiropractic care was the most commonly utilized
CAM treatment among current smokers (29.0%), whereas massage was the most
commonly utilized CAM treatment among former smokers (48.4%). See Table 6 and
Figure 6 for use rates for each CAM modality. Some reported utilizing more than one
CAM approach: 18.5% of former smokers and 4.9% of current smokers sought
treatment from practitioners of 2 different CAM modalities in the last year; 0.7% of
current smokers used 3 of the 4 CAM approaches.
NSDUH participants predominantly chose conventional mental health or
substance use treatment (17.6%; 95% CI = 15.5, 19.9). Nearly 5% sought solely CAM
treatment (4.7%; 95% CI = 3.0, 7.2). However, a small proportion of pregnant, past year
smokers utilized both conventional mental health or substance use treatment as well as
CAM treatment (2.6%; 95% CI = 1.7, 3.9). Although current smokers were greater users
of conventional treatment, and former smokers were greater users of CAM treatment,
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there was no difference in smoking status among those using both conventional and
CAM approaches.
Compared to the NSDUH sample, a greater proportion of pregnant smokers who
participated in the NHIS reported engaging in CAM use: 27.2% of pregnant current
smokers endorsed using CAM in their lifetime, with 19.1% reporting CAM use within the
past year. Herbs and supplements were the most commonly used CAM approach within
the past year, with 9.5% reporting past year use of herbs and supplements, followed by
meditation (7.9%) and deep breathing exercises (6.3%). Deep breathing exercises
(including as part of yoga or meditation practice) was the most common CAM practice
smokers had ever used, with 16.5% reporting that they had ever tried deep breathing
exercises; deep breathing was followed by meditation (12.0%) and herbs and
supplements (10.5%).
Across NHIS study waves, there was a slight decrease in the lifetime prevalence
of CAM use, dropping from 31.3% in 2002 to 25.5% in 2012. However, increases were
observed for several CAM approaches: yoga, acupuncture, and herbs and supplements
(see Figure 7). For past year CAM use, there appeared to be an increase from 19.5% in
2002 to 26.1% in 2007, but past year CAM use dropped to 19.2% in 2012. In examining
CAM treatments separately, increases across study waves in past year use were
observed for yoga, meditation, and massage. See Figure 8.
Unfortunately, survey items regarding reasons for using CAM had poor response
rates (1.8%). However, among those who responded to these items, the most
commonly reported reason for using CAM was to reduce stress levels or help with
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relaxation, followed by general wellness or disease prevention, improving overall health
or to feel better, and improving relationships with others.
Factors associated with CAM use
Characteristics associated with CAM use were examined within the NSDUH
(past year CAM use) and NHIS (lifetime and past year CAM use) samples. Separate
logistic regressions were first conducted to examine whether factors were related to
CAM. Within the NSDUH, logistic regression analyses revealed that many factors were
associated with greater likelihood of past year CAM use, with the strongest factors
including: higher annual family income (greater than $50,000), being married, White
racial status, non-reliance on government assistance, and absence of past year serious
psychological distress or mental health problems. Trimester of pregnancy, age,
education, perceived health, perceived risk of regular smoking, past month alcohol and
illicit drug use, past year illicit drug use, alcohol and illicit drug abuse, seatbelt use, risky
behavior, and past year DUI were not significantly associated with past year CAM use.
Factors significantly associated with past year CAM use in univariate analyses
were included in the full model. The overall adjusted logistic regression model was
significant and accounted for between 27.4% (Cox and Snell R2) and 37.0%
(Nagelkerke R2) of the variance in past year CAM use. Two factors were retained in the
adjusted model, with non-reliance on government assistance and absence of past year
serious psychological distress, depression, or anxiety being associated with greater
likelihood of past year CAM use. See Table 7 for unadjusted and adjusted odds ratios.
In the NHIS sample, separate logistic regression analyses indicated that none of
the factors examined were significantly associated with both lifetime and past year CAM
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use. Higher income, greater education, Hispanic ethnicity, and abstinence from alcohol
were among the strongest predictors of lifetime CAM use. All factors were entered into a
stepwise logistic regression in order to determine whether any significant factors would
emerge in an adjusted model. The overall adjusted logistic regression model of factors
associated with lifetime CAM use was significant and accounted for between 13.4%
(Cox and Snell R2) and 18.9% (Nagelkerke R2) of the variance in lifetime CAM use.
Several factors were retained in the adjusted model, with greater education and
abstinence from alcohol emerging as factors most strongly associated with lifetime CAM
use in the adjusted model. Notably, age onset of regular smoking was also retained in
the full model; however, the direction of the association changed, such that onset of
regular smoking after age 15 was associated with a lower likelihood of lifetime CAM
use. Considering the sample size restrictions, though, these results should be
interpreted with caution. See Table 9 for unadjusted and adjusted odds ratios for lifetime
CAM use among NHIS participants.
Among the univariate factors associated with past year CAM use, White racial
status, greater education, higher income, past month serious psychological distress,
and past year depression or anxiety were several of the factors strongly associated with
past year CAM use. As with lifetime CAM use, all factors were included in the adjusted
model despite being nonsignificant in univariate comparisons. The overall adjusted
logistic regression model of factors associated with past year CAM use was
nonsignificant, and no factors were retained in the overall model. See Table 8 for
unadjusted odds ratios for past year CAM use among NHIS participants.
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CHAPTER 4 DISCUSSION
The present study sought to investigate the characteristics and treatment
utilization practices of pregnant smokers who participated in two cross-sectional
national surveys, in order to better understand their treatment needs and preferences.
The estimated prevalence rate of prenatal smoking between 2002 and 2013 based on
both samples was between 8 and 20%, with somewhat lower estimates among the
NHIS participants. Estimated smoking prevalence rates appeared to be somewhat
stable across these years and did not appear to reflect a decline in the prevalence of
prenatal smoking. This highlights the urgency of considering alternate and possibly
more broadly acceptable intervention approaches.
Compared to current smokers, former smokers were more likely to be in their
second or third trimester of pregnancy, of African American or Hispanic descent, college
educated, employed, and earning a higher annual family income. Former smokers also
reported better health, greater seatbelt use, and were less likely to have used alcohol in
the past month or to have been diagnosed with an anxiety disorder in the past year.
Notably, former smokers also reported that they perceived regular, heavy smoking to be
of greater risk to one’s health. Although former smokers were less likely to have
experienced serious psychological distress, engaged in risky behaviors, been arrested
or on probation in the past year, or used illicit drugs in the past month, these factors did
not remain significant in the full model. Prior studies emphasized a link between distress
or mental health problems and persistent smoking, but these relationships did not
appear to be as strong within the present sample.
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Within the NSDUH sample, both current and former smokers endorsed distress,
major depression, and anxiety, with some comparisons reaching statistical significance
and suggesting that current smokers were more distressed; however, once other factors
were taken into consideration, many of these associations were no longer significant. A
similar pattern was observed for substance use: once other factors were accounted for,
only abstinence from alcohol within the past month was associated with smoking
cessation. Factors such as nicotine dependence, craving, and smoking self-efficacy
could not be compared between current and former smokers. Among current smokers,
however, over 65% were nicotine dependent (particularly those in the third trimester),
approximately 75% reported experiencing craving, and over 20% felt that they were not
in control of their smoking. Overall, the results of the present study support the general
finding from previous investigations that current smokers are more high-risk across a
number of sociodemographic domains. Importantly, though, these results also highlight
factors that may be well-suited as intervention targets, such as psychoeducation about
smoking risk and prenatal alcohol use, general health and safety promotion, managing
nicotine craving, and boosting smoking self-efficacy. It is possible that CAM treatments
may be well-suited to address several of these targets, including general health
promotion, managing craving, and improving self-efficacy.
A second aim was to estimate the rates of CAM use among pregnant smokers,
and to explore how rates have changed across time. Pregnant current and former
smokers endorsed conventional and CAM treatment use. Use of conventional treatment
was more common than use of CAM among NSDUH participants, whereas use of CAM
was more common than use of conventional treatment among NHIS participants;
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however, it is likely that this difference is driven by methodological differences in how
the two surveys administer treatment utilization questions. With regard to specific CAM
modalities, seeking treatment within the past year from a chiropractor or massage
therapist were most common within the NSDUH sample, whereas NHIS participants
reported that herbs and supplements, meditation, and deep breathing exercises were
the most common CAM approaches used within the past year.
Interestingly, among NSDUH participants, current smokers were greater
consumers of conventional treatment, whereas formers smokers were greater
consumers of CAM as a form of alternative mental health treatment. Further, a small
proportion of participants also endorsed both conventional and CAM treatment use
within the past year, which may suggest that some pregnant smokers are open to trying
a variety of approaches to help meet their treatment goals. It is not clear from the
present data why individuals made these treatment decisions. Thus, these findings
underscore the need to better understand how treatment preferences drive decisions to
seek specific treatments. Regardless, these findings also demonstrate that pregnant
smokers are interested in CAM approaches and that many are already using CAM as a
form of mental health treatment or for general health promotion.
NSDUH respondents also identified a number of barriers to seeking conventional
treatment for mental health and substance use. The cost of treatment emerged as a
common barrier to both mental health and substance use treatment. Other barriers
included fears about how others would respond, not knowing where to go for treatment,
not being ready for treatment, and feeling as though they could handle the problem
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without treatment. It is unclear whether similar barriers would prevent women from
seeking CAM treatments.
In terms of trends in the prevalence of CAM treatment use among pregnant
smokers across survey years, our prediction of increased CAM use over time was not
supported by the data. Instead, it appeared that the prevalence of CAM use was
variable across study years in both the NSDUH and NHIS with no evidence of a linear
trend. Considering trends of increasing use observed in the general population,
including smokers (Hamm et al., 2014), it is possible that this fluctuation in rates of CAM
use among pregnant smokers may be reflective of uncertainty about the safety and
efficacy of these modalities during pregnancy. However, within the NHIS sample, there
appeared to be increases across study years for specific treatments. In particular, rates
of participation in yoga (both lifetime and past year), acupuncture (lifetime), herbs and
supplements (lifetime), meditation (past year), and massage (past year) appeared to
increase between 2002 and 2012 among pregnant smokers.
Analyses examining factors related to CAM use among pregnant smokers were
underpowered due to limited sample sizes. These analyses were conducted without
using sample weights in order to facilitate interpretation, given that applying weights
appeared to result in artificially inflated significance values for all factors but did not
generally change the magnitude of odds ratios. Despite these restrictions, a number of
factors were found to be associated with CAM use among pregnant smokers in both
samples, including White race, having greater levels of education and higher annual
family income (a finding that is consistent with previous research in this area; Chuang et
al., 2009). Interestingly, among the NSDUH sample, lower distress or better mental
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health was associated with greater likelihood of CAM use; in contrast, higher distress or
poor mental health was associated with greater likelihood of CAM use among the NHIS
sample. This difference may reflect variability in the measurement of distress, mental
health, and/or CAM use within these surveys.
Limitations
The overall purpose of the NSDUH and NHIS surveys is to provide a general,
cross-sectional snapshot of the substance use, mental health, and physical health of the
U.S. non-institutionalized population. Due to the cross-sectional nature of the NSDUH
and NHIS, conclusions about causality cannot be made. Further, although these study
designs allows for generalizability of this study’s results to the U.S. population, they also
present some limitations. For example, certain subgroups, such as individuals who are
incarcerated, are not included in these surveys. This could result in an underestimation
of smoking, substance use, and mental health problems among incarcerated pregnant
women. Further, these surveys were not designed specifically for the subpopulation of
pregnant smokers, and therefore the choice of variables was restricted to those
included in the NSDUH and NHIS surveys. Thus, there are several relevant factors that
were not included or further assessed in these surveys.
Notably, smoking cessation during pregnancy—a primary focus of this study—
could only be assessed using the proxy measure of past 30-day cigarette use. As a
result, it was not possible to directly determine the point at which smokers may have
quit, and it is possible that some past year smokers may have quit prior to becoming
pregnant. It was also not possible to explore whether there were differences between
current and formers smokers with regard to several smoking-related factors (namely,
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nicotine dependence, craving, smoking self-efficacy, and average number of cigarettes
smoked per day), since these items were not administered unless respondents
endorsed past month cigarette use. Further, neither survey assesses smoking cessation
treatment; it is therefore uncertain whether some women may have sought or benefitted
from smoking cessation treatment.
In addition, questions related to CAM use in the NSDUH were embedded within
the alternative mental health treatment section. Consequently, the sample size for these
items was limited to those who sought alternative treatment for mental health issues
and responded to these items. As a result, it is possible that the prevalence of CAM use
within the NSDUH sample was underestimated. Despite pooling several waves of each
survey together, the sample size for some analyses within both samples was also small,
which prevented further exploration of certain aspects of treatment utilization and CAM
use. Finally, although the NSDUH makes efforts to minimize self-report bias and
enhance disclosure of stigmatized behaviors by using ACASI, the NHIS relies on only
face-to-face interviews. However, regardless of methods to minimize bias, data from
both surveys are based solely on participant self-report; thus, behaviors such as
prenatal smoking, substance use, mental health issues and criminal justice involvement
may be underreported.
Conclusions and future directions
Prenatal smoking prevalence estimates appear to be somewhat stable based on
nationally representative survey data, which suggests that prevention and intervention
efforts are not reaching enough at-risk women. Overall, the present study found several
potentially modifiable factors that may help to distinguish between women who are at
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greater risk for persistent smoking during pregnancy, including smoking risk perception,
current alcohol use, and factors related to nicotine dependence (e.g., craving, selfefficacy). Notably, at least two of these (craving and self-efficacy) have been shown to
be amenable to CAM approaches (e.g., Gwaltney et al., 2002; Vidrine et al., 2009;
Witkiewitz et al., 2005; Witkiewitz & Bowen, 2010). Further, this study also
demonstrated that a sizeable proportion of pregnant smokers are interested/already
accessing alternative treatments. Further, although CAM use appeared to be somewhat
lower in lower SES and (in some cases) depressed or anxious women, it was
nevertheless reported by at least 25% of women in these subgroups. They may thus be
a broadly acceptable approach for pregnant smokers, particularly if barriers such as
cost and accessibility are addressed.
Future investigations should further examine pregnancy-related factors that may
be associated with smoking as well as CAM use, such as receipt of prenatal care,
whether the pregnancy was planned, or the presence of pregnancy complications.
Additionally, further exploration of the intended reasons or goals for seeking out CAM—
including whether women use CAM to assist with smoking cessation or manage mental
health symptoms—is necessary in order to better understand motivations for pursuing
CAM, and whether women are pursing CAM instead of or in addition to conventional
treatment.
Several access-related issues remain to be addressed. As noted, this study
found that pregnant women, including pregnant smokers, are seeking out CAM
treatment at moderate and stable rates. However, further research is needed not only to
validate the use of these treatments for a variety of physical and mental health issues,
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but also to guide treatment recommendations and to confirm that such treatments can
be used safely during pregnancy. In particular, pilot studies and larger scale randomized
clinical trials are required to provide a foundation for the use of CAM in general and for
specific subpopulations such as pregnant women, whether as a standalone or adjunct
to conventional evidence-based treatment approaches. In addition, as previous authors
have noted (e.g., Pallivalapila et al., 2015), the lack of regulatory oversight is a
significant concern surrounding some CAM treatments. For example, evidence-based
treatment guidelines for practitioners of other CAM modalities such as acupuncture,
chiropractic care, and yoga would help to ensure that women who pursue these
approaches during pregnancy can do so safely.
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Table 1
NSDUH Sample Characteristics

Sociodemographic
Characteristics

Total

Current Smokers

Former Smokers

(n = 3,252)

(n = 1,920)

(n = 1,332)

%

95% CI

%

95% CI

%

95% CI

First

35.5%

[32.8, 38.3]

43.9%

[39.9, 48.0]

24.6%

[21.0, 28.5]

Second

35.4%

[32.5, 38.4]

30.5%

[27.3, 34.0]

41.7%

[37.1, 46.4]

Third

29.1%

[26.5, 31.8]

25.5%

[22.3, 29.0]

33.7%

[29.6, 38.1]

12 to 17

5.3%

[4.5, 6.2]

5.3%

[4.2, 6.5]

5.4%

[4.0, 7.0]

18 to 25

50.8%

[47.7, 53.9]

53.4%

[49.5, 57.4]

47.3%

[43.0, 51.7]

26 and older

43.9%

[40.7, 47.2]

41.3%

[37.2, 45.5]

47.3

[42.7, 52.0]

Non-Hispanic White

70.7%

[67.9, 73.3]

73.9%

[70.2, 77.3]

66.4%

[62.5, 70.1]

Non-Hispanic Afr. Amer.

13.6%

[11.5, 16.0]

13.7%

[11.4, 16.4]

13.3%

[10.2, 17.3]

p

Trimester
.000

Age
.063

Race/Ethnicity

Non-Hispanic Other Race

4.7%

[3.5, 6.3]

4.8%

[3.3, 7.1]

4.5%

[3.1, 6.4]

Hispanic

11.1%

[9.7, 12.7]

7.5%

[5.7, 9.9]

15.8%

[13.1, 18.8]

Never married

50.8%

[47.7, 53.9]

54.6%

[50.4, 58.7]

45.9%

[41.4, 50.4]

Married

37.6%

[34.5, 40.8]

30.2%

[26.4, 34.2]

47.3%

[42.8, 51.8]

Widowed, divorced, separated

11.6%

[9.9, 13.6]

15.3%

[12.5, 18.5]

6.8%

[4.7, 9.8]

Less than HS

27.8%

[25.6, 30.0]

33.1%

[30.2, 36.1]

20.8%

[18.0, 24.0]

HS graduate or GED

35.2%

[32.7, 37.9]

37.5%

[33.9, 41.3]

32.2%

[28.3, 36.4]

Some college

26.0%

[23.2, 29.1]

25.1%

[21.5, 29.2]

27.2%

[23.4, 31.1]

College graduate

11.0%

[9.2, 13.0]

4.3%

[2.7, 6.6]

19.8%

[16.5, 23.5]

Currently employed

48.4%

[45.5, 51.4]

52.8%

[49.7, 56.0]

57.3%

[52.7, 61.8]

Not currently employed

51.6%

[48.6, 54.5]

47.2%

[44.0, 50.3]

42.7%

[38.2, 47.3]

Less than $20,000

35.0%

[32.5, 37.6]

42.5%

[39.2, 45.8]

25.2%

[21.4, 29.3]

$20,000 to $49,999

35.8%

[33.2, 38.5]

37.8

[34.7, 41.0]

33.1%

[29.1, 37.4]

$50,000 to $74,999

14.6%

[12.9, 16.3]

12.0%

[10.0, 14.4]

17.9%

[15.5, 20.6]

$75,000 or more

14.7%

[12.6, 17.0]

7.8%

[6.0, 9.9]

23.8%

[19.7, 28.5]

Yes

40.2%

[38.0, 42.3]

48.5%

[45.3, 51.7]

29.2%

[25.5, 33.1]

No

59.8%

[57.7, 62.0]

51.5%

[48.3, 54.7]

70.8%

[66.9, 74.5]

8.5%

[7.1, 10.1]

11.2%

[9.1, 13.9]

4.8%

[3.4, 6.8]

.000

Marital Status
.000

Education
.000

Employment Status
.000

Annual Family Income
.000

Government Assistance
.000

Health Status
Fair or Poor

.000
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Good

30.1%

[27.7, 32.6]

35.1%

[31.7, 38.5]

23.6%

[20.4, 27.3]

Very Good

36.9%

[34.3, 39.6]

35.0%

[31.5, 38.6]

39.4%

[35.5, 43.5]

Excellent

24.5%

[21.9, 27.7]

18.7%

[15.9, 21.8]

32.1%

[28.0, 36.4]

By age 14

20.1%

[18.0, 22.5]

25.1%

[21.8, 28.7]

12.2%

[10.1, 14.7]

Age 15 or older

79.9%

[77.5, 82.0]

74.9%

[71.3, 78.2]

87.8%

[85.3, 89.9]

No or slight risk

11.7%

[10.1, 13.4]

14.8%

[12.9, 16.9]

7.6%

[5.2, 11.0]

Moderate risk

27.5%

[25.1, 30.0]

32.1%

[28.6, 35.7]

21.4%

[18.8, 24.3]

Great risk

60.9%

[58.2, 63.5]

53.1%

[49.6, 56.6]

71.0%

[67.4, 74.4]

No

78.6%

[76.5, 80.5]

74.1%

[71.1, 76.9]

84.3%

[81.7, 86.7]

Yes

21.4%

[19.5, 23.5]

25.9%

[23.1, 28.9]

15.7%

[13.3, 18.3]

No

89.7%

[87.2, 91.8]

86.2%

[82.6, 89.2]

94.2%

[91.0, 96.3]

Yes

10.3%

[8.2, 12.8]

13.8%

[10.8, 17.4]

5.8%

[3.7, 9.0]

No

88.6%

[86.4, 90.4]

86.7%

[83.5, 89.3]

91.0%

[87.7, 93.4]

Yes

11.4%

[9.6, 13.6]

13.3%

[10.7, 16.5]

9.0%

[6.6, 12.3]

No

80.0%

[76.8, 82.8]

79.9%

[76.3, 83.0]

80.1%

[75.0, 84.4]

Yes

20.0%

[17.2, 23.2]

20.1%

[17.0, 23.7]

19.9%

[15.6, 25.0]

No

89.5%

[87.4, 91.4]

86.9%

[83.7, 89.6]

92.9%

[90.5, 94.7]

Yes

10.5%

[8.6, 12.6]

13.1%

[10.4, 16.3]

7.1%

[5.3, 9.5]

No

84.5%

[82.2, 86.5]

82.2%

[79.0, 85.0]

87.4%

[84.1, 90.1]

Yes

15.5%

[13.5, 17.8]

17.8%

[15.0, 21.0]

12.6%

[9.9, 15.9]

No

82.6%

[80.6, 84.4]

80.7%

[78.1, 83.1]

85.1%

[81.6, 88.0]

Yes

17.4%

[15.6, 19.4]

19.3%

[16.9, 21.9]

14.9%

[12.0, 18.4]

No

91.7%

[90.2, 93.0]

88.5%

[86.2, 90.4]

95.9%

[94.3, 97.1]

Yes

8.3%

[7.0, 9.8]

11.5%

[9.6, 13.8]

4.1%

[2.9, 5.7]

No

93.6%

[92.2, 94.8]

93.4%

[91.2, 95.0]

94.0%

[91.7, 95.7]

Yes

6.4%

[5.2, 7.8]

6.6%

[5.0, 8.8]

6.0%

[4.3, 8.3]

No

92.8%

[91.3, 94.0]

92.7%

[90.8, 94.2]

92.8%

[90.4, 94.7]

Yes

7.2%

[6.0, 8.7]

7.3%

[5.8, 9.1]

7.2%

[5.3, 9.6]

Regular Smoking Onset
.000

Smoking Risk Perception
.000

SPD, Past Year*
.000

SPD, Past Month*
.000

MDE, Past Year*
.043

MDE, Lifetime*
.937

Anxiety Disorder, Past Year
.001

Anxiety Disorder, Lifetime
.020

Alcohol Use, Past Month
.042

Binge Drinking, Past Month
.000

Alcohol Abuse
.648

Alcohol Dependence

Illicit Drug Use, Past Year

.910
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No

63.5%

[61.3, 65.6]

59.9%

[56.8, 63.0]

68.1%

[64.7, 71.4]

Yes

36.5%

[34.4, 38.7]

40.1%

[37.0, 43.2]

31.9%

[28.6, 35.3]

No

87.1%

[85.6, 88.5]

82.2%

[79.9, 84.3]

93.6%

[91.2, 95.3]

Yes

12.9%

[11.5, 14.4]

17.8%

[15.7, 20.1]

6.4%

[4.7, 8.8]

No

97.7%

[96.9, 98.3]

97.7%

[96.5, 98.5]

97.7%

[96.4, 98.5]

Yes

2.3%

[1.7, 3.1]

2.3%

[1.5, 3.5]

2.3%

[1.5, 3.6]

No

92.0%

[90.6, 93.2]

90.4%

[88.4, 92.1]

94.1%

[92.4, 95.4]

Yes

8.0%

[6.8, 9.4]

9.6%

[7.9, 11.6]

5.9%

[4.6, 7.6]

No

72.1%

[69.7, 74.5]

68.5%

[65.3, 71.5]

76.9%

[72.8, 80.4]

Yes

27.9%

[25.5, 30.3]

31.5%

[28.5, 34.7]

23.1%

[19.6, 27.2]

No

92.9%

[91.4, 94.2]

91.2%

[88.8, 93.1]

95.2%

[93.6, 96.5]

Yes

7.1%

[5.8, 8.6]

8.8%

[6.9, 11.2]

4.8%

[3.5, 6.4]

No

79.3%

[76.6, 81.8]

79.8%

[77.0, 82.4]

78.6%

[74.5, 82.2]

Yes

20.7%

[18.2, 23.4]

20.2%

[17.6, 23.0]

21.4%

[17.8, 25.5]

No

84.8%

[83.0, 86.4]

82.4%

[80.0, 84.6]

87.9%

[84.9, 90.4]

Yes

15.2%

[13.6, 17.0]

17.6%

[15.4, 20.0]

12.1%

[9.6, 15.1]

Never, seldom, sometimes

24.6%

[22.4, 26.9]

31.0%

[27.7, 34.5]

16.2%

[13.6, 19.2]

Always

75.4%

[73.1, 77.6]

69.0%

[65.5, 72.3]

83.8%

[80.8, 86.4]

No

79.8%

[77.6, 81.9]

76.0%

[72.9, 78.9]

84.8%

[81.8, 87.4]

Yes

20.2%

[18.1, 22.4]

24.0%

[21.1, 27.1]

15.2%

[12.6, 18.2]

No

89.1%

[87.1, 90.7]

86.2%

[83.4, 88.6]

92.8%

[90.5, 94.5]

Yes

10.9%

[9.3, 12.9]

13.8%

[11.4, 16.6]

7.2%

[5.5, 9.5]

No

82.3%

[80.4, 84.1]

81.9%

[79.2, 84.3]

82.8%

[79.8, 85.5]

Yes

17.7%

[15.9, 19.6]

18.1%

[15.7, 20.8]

17.2%

[14.5, 20.2]

.001

Illicit Drug Use, Past Month
.000

Illicit Drug Abuse
.947

Illicit Drug Dependence
.001

Ever Arrested
.002

Probation Status
.001

DUI
.551

Risky Behavior
.006

Seatbelt Use
.000

MH or SU Treatment
.000

Unmet MH Treatment Need
.000

SU Treatment Gap
.637

CAM Use,
No alternative MH treatment

90.3%

[87.5, 92.5]

90.9%

[87.6, 93.3]

89.6%

[85.8, 92.5]

No CAM use

2.8%

[2.0, 4.0]

3.5%

[2.4, 5.2]

1.9%

[1.2, 2.9]

Yes

6.9%

[4.8, 9.7]

5.6%

[3.5, 8.7]

8.5%

[5.8, 12.4]

.017

Note. CI = confidence interval; Afr. Amer. = African American; SPD = serious psychological distress; MDE = major
depressive episode; DUI = driving under the influence of alcohol or drugs; MH = mental health; SU = substance use;
CAM = complementary and alternative medicine.
*Sample size for NSDUH waves 2005-2013 = 2,894 total (1,705 current smokers, 1,189 former smokers).
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Table 2
NHIS Sample Characteristics
Everyday

Some Days

Total

Smokers

Smokers

(n = 106)*

(n = 79)*

(n = 27)*

p

18 to 25

31.3%

29.7%

37.0%

.000

26 and older

67.9%

70.3%

63.0%

White

84.2%

85.4%

80.5%

African American

9.0%

5.7%

18.9%

Other Race

6.8%

8.9%

0.6%

No

91.6%

97.1%

74.7%

Yes

8.4%

2.9%

25.3%

Never married

12.7%

14.6%

7.0%

Living with partner

31.4%

31.2%

32.0%

Married

44.8%

42.5%

52.0%

Widowed, divorced or separated

11.1%

11.8%

9.1%

Less than HS

4.8%

5.8%

1.6%

HS, no diploma

26.8%

27.3%

25.2%

HS graduate or GED

34.9%

33.4%

39.4%

Some college

20.7%

19.0%

26.0%

College graduate

12.9%

14.6%

7.8%

Currently employed

46.6%

44.8%

52.9%

Not currently employed

52.9%

55.2%

47.1%

$0 to $34,999

50.1%

54.5%

48.0%

$35,000 to $74,999

36.6%

39.1%

37.6%

$75,000 or more

7.7%

6.4%

14.4%

Sociodemographic
Characteristics
Age

Race
.000

Hispanic Ethnicity
.000

Marital Status
.000

Education
.000

Employment Status
.000

Annual Family Income
.000
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Government Assistance
No

77.8%

73.2%

91.8%

Yes

22.2%

26.8%

8.2%

Covered

77.0%

80.0%

67.6%

Not covered

23.0%

20.0%

32.4%

Fair or Poor

9.6%

11.6%

3.8%

Good

29.8%

31.3%

25.4%

Very Good

40.5%

37.4%

50.1%

Excellent

20.0%

19.7%

20.7%

By age 14

29.6%

37.1%

6.9%

Age 15 or older

70.4%

62.9%

93.1%

No

9.9%

10.2%

8.9%

Yes

90.1%

89.8%

91.1%

No

71.0%

71.1%

70.6%

Yes

29.0%

28.9%

29.4%

Lifetime abstainer

7.4%

8.6%

3.9%

Former drinker

28.6%

26.0%

37.0%

Current infrequent drinker

22.7%

23.8%

19.7%

Current light drinker

23.7%

23.6%

24.5%

Current moderate to heavy drinker

17.2%

18.0%

14.8%

No

88.0%

87.2%

91.2%

Yes

11.8%

12.8%

8.8%

.000

Health Insurance Coverage
.000

Health Status
.000

Regular Smoking Onset
.000

SPD, Past Month
.000

Frequently Depressed or Anxious
.018

Alcohol Use Status
.000

Seen a Mental Health Professional

Note. SPD = serious psychological distress.
* Unweighted count.

.000
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Table 3
Odds Ratios and Confidence Intervals for Smoking Cessation During Pregnancy
Adjusteda

Unadjusted
Variable

OR

95% CI

OR

95% CI

Trimester
First

Ref

Ref

Second

2.44

[1.81, 3.29]

3.23

[1.88, 5.54]

Third

2.36

[1.74, 3.22]

2.88

[1.92, 4.55]

Race/Ethnicity
Ref

Non-Hispanic White

Ref

Non-Hispanic African American

1.08

[0.77, 1.52]

2.30

[1.21, 4.37]

Non-Hispanic Other Race

1.03

[0.65, 1.64]

1.73

[0.83, 3.63]

Hispanic

2.33

[1.52, 3.57]

4.71

[2.31, 9.61]

Marital Status
Never married

Ref

Ref

Married

1.87

[1.46, 2.39]

1.25

[0.79, 1.99]

Widowed, divorced, separated

0.53

[0.33, 0.88]

0.47

[0.25, 0.91]

Education
Less than HS

Ref

HS graduate

1.36

[1.04, 1.79]

1.59

[0.88, 2.90]

Some college

1.72

[1.29, 2.30]

1.58

[0.87, 2.90]

College graduate

7.32

[4.19, 12.76]

5.51

[2.01, 15.11]

Ref

Annual Family Income
Ref

Less than $20,000

Ref

$20,000-$49,999

1.48

[1.11, 1.97]

1.13

[0.66, 1.92]

$50,000-$75,000

2.51

[1.88, 3.36]

1.47

[0.90, 2.40]

$75,000 and up

5.21

[3.41, 7.96]

2.89

[1.21, 6.91]

Employment Status
Not currently employed

Ref

Currently employed

1.50

Ref
[1.22, 1.85]

1.54

[1.04, 2.27]

Government Assistance
No

Ref

Yes

2.29

Ref
[1.79, 2.93]

1.30

[0.77, 2.19]
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Health Status
Ref

Fair or Poor

Ref

Good

1.57

[0.96, 2.58]

2.40

[1.00, 5.02]

Very Good

2.62

[1.65, 4.17]

2.63

[1.25, 5.54]

Excellent

4.00

[2.53, 6.34]

3.83

[1.71, 8.58]

Regular Smoking Onset
By age 14

Ref

Age 15 or later

2.41

Ref
[1.80, 3.23]

1.21

[0.73, 1.99]

Smoking Risk Perception
No or slight risk

Ref

Ref

Moderate risk

1.30

[0.82, 2.08]

1.37

[0.75, 2.48]

Great risk

2.61

[1.69, 4.04]

2.72

[1.65, 4.49]

SPD, Past Year (2005-2013)
No

Ref

Yes

0.53

Ref
[0.42, 0.68]

1.02

[0.51, 2.06]

SPD, Past Month (2005-2013)
No

Ref

Yes

0.39

Ref
[0.23, 0.65]

0.78

[0.29, 2.09]

MDE, Past Year (2005-2013)
No

Ref

Yes

0.65

Ref
[0.42, 1.00]

0.88

[0.40, 1.92]

Anxiety Disorder, Past Year
No

Ref

Yes

0.51

Ref
[0.34, 0.77]

0.23

[0.08, 0.64]

Anxiety Disorder, Lifetime
No

Ref

Yes

0.66

Ref
[0.47, 0.94]

1.93

[0.93, 4.01]

Alcohol Use, Past Month
No

Ref

Yes

0.73

Ref
[0.54, 0.99]

0.47

[0.22, 0.99]

Binge Drinking, Past Month
No

Ref

Yes

0.33

Ref
[0.22, 0.48]

0.31

[0.12, 0.80]
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Illicit Drug Use, Past Year
No

Ref
0.32

Ref
[0.22, 0.46]

0.94

[0.56, 1.59]

Yes
Illicit Drug Use, Past Month
No

Ref

Yes

0.70

Ref
[0.57, 0.86]

0.51

[0.24, 1.07]

Illicit Drug Dependence, Past Year
No

Ref

Yes

0.59

Ref
[0.44, 0.81]

1.92

[0.77, 4.28]

Ever Arrested
No

Ref

Yes

0.66

Ref
[0.51, 0.85]

1.06

[0.67, 1.67]

Probation Status, Past Year
No

Ref

Yes

0.52

Ref
[0.35, 0.77]

0.89

[0.43, 1.85]

Risky Behavior
No

Ref

Yes

0.65

Ref
[0.47, 0.89]

0.94

[0.54, 1.61]

Seatbelt Use
Never, seldom or sometimes

Ref

Always

2.33

Ref
[1.78, 3.05]

2.24

[1.36, 3.68]

Treatment, Past Year
No

Ref

Yes

0.57

Ref
[0.43, 0.74]

0.68

[0.38, 1.23]

Unmet Treatment Need
No

Ref

Yes

0.49

Ref
[0.34, 0.69]

1.21

[0.57, 2.58]

Note. OR = odds ratio; CI = confidence interval; SPD = serious psychological distress; MDE =
major depressive episode.
a
Adjusted model goodness-of-fit (Wald X2 (37, 60) = 343.67, p < .001).
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Table 4
Perceived Barriers to Mental Health Treatment
Total

Current Smokers

Former Smokers

(n = 229)*

(n = 104)*

Barrier

%

95% CI

%

95% CI

%

95% CI

p

Fear of neighbors’ negative

10.6

[6.3, 17.2]

11.5

[6.1, 20.8]

8.3

[3.4, 18.7]

.542

4.8

[2.0, 11.0]

3.7

[0.9, 14.1]

7.4

[3.1, 16.6]

.413

7.6

[4.1, 13.5]

5.7

[3.1, 10.3]

12.2

[3.8, 32.4]

.259

2.2

[1.0, 4.7]

0.6

[0.2, 1.7]

6.1

[2.3, 15.1]

.000

8.8

[4.9, 15.4]

4.4

[1.5, 12.5]

19.7

[10.4, 34.3]

.013

Didn’t know where to go

20.1

[13.5, 28.9]

18.1

[11.3, 27.7]

25.1

[13.6, 41.5]

.341

Confidentiality concerns

10.2

[6.4, 15.8]

9.2

[4.7, 17.2]

12.8

[7.0, 22.1]

.479

Fear of being committed or

17.5

[12.2, 24.9]

15.7

[9.9, 24.2]

22.4

[12.1, 37.7]

.356

3.6

[2.0, 6.1]

3.4

[1.7, 6.4]

4.0

[1.7, 8.8]

.741

Couldn’t afford cost

48.7

[41.7, 55.8]

47.1

[38.5, 55.9]

52.6

[39.7, 65.2]

.509

Thought problem could be

19.7

[13.8, 27.2]

16.1

[10.4, 24.0]

28.7

[15.9, 46.3]

.118

6.1

[3.3, 11.1]

4.5

[2.2, 8.9]

10.2

[3.8, 24.7]

.170

Didn’t have time

11.0

[7.2, 16.5]

9.3

[5.2, 16.0]

15.3

[7.9, 27.3]

.252

No transportation, too far

3.6

[2.0, 6.3]

3.2

[1.5, 6.8]

4.6

[1.6, 12.5]

.259

opinion
Fear of negative effect on
job
Didn’t want others to find
out
Insurance didn’t cover it at
all
Insurance didn’t pay
enough

medicated
Didn’t think treatment was
needed

handled without treatment
Didn’t think treatment would
help

away, not convenient
* Unweighted counts.

88
Table 5
Perceived Barriers to Substance Use Treatment
Current

Former

Smokers

Smokers

Total

(n = 41)*

(n = 17)*

p

Fear of neighbors’ negative opinion

14.7%

13.0%

21.4%

.000

Fear of negative effect on job

10.5%

13.1%

0%

.000

Didn’t want others to find out

18.5%

21.5%

6.4%

.000

Insurance didn’t cover treatment

8.4%

8.1%

9.8%

.006

No program had preferred treatment type

0.0%

0.1%

0%

.326

Not ready to stop using

27.5%

30.7%

20.1%

.000

No openings in programs

2.9%

3.6%

0%

.000

Didn’t know where to go

18.9%

18.9%

18.9%

.496

Didn’t think treatment was needed

1.4%

0.1%

6.4%

.000

Couldn’t afford cost or no insurance

26.1%

24.4%

32.6%

.000

Thought problem could be handled without

0.9%

1.0%

0.4%

.005

Didn’t have time

0.3%

0.4%

0%

.001

No transportation, too far away, not convenient

10.1%

6.8%

23.0%

.000

Barrier

treatment

* Unweighted counts.
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Table 6
Past Year CAM Use Among Alternative Mental Health Treatment Seekers (NSDUH)

CAM Treatment Provider

Total

Current

Former Smokers

(n =251)

Smokers

(n = 108)*

p

(n = 143)*
Acupuncturist

8.3%

9.2%

7.2%

.000

Chiropractor

35.3%

29.0%

42.5%

.000

Herbalist

4.1%

6.0%

2.0%

.000

Massage therapist

36.3%

25.9%

48.4%

.000

All CAM approaches

70.9%

61.3%

82.1%

.000

Note. CAM = complementary and alternative medicine.
*Unweighted counts.
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Table 7
Odds Ratios and Confidence Intervals for Past Year CAM Use (NSDUH)
Adjusteda

Unadjusted
Variable

OR

95% CI

OR

95% CI

--

--

--

--

--

--

--

--

Race/Ethnicity
Non-Hispanic White

Ref

Non-Hispanic African American

0.15

[0.06, 0.40]

Non-Hispanic Other Race

0.47

[0.18, 1.22]

Hispanic

0.42

[0.20, 0.89]

Marital Status
Not married

Ref

Married

2.52

[1.41, 4.50]

Annual Family Income
Less than $20,000

Ref

$20,000-$49,999

2.24

[1.21, 4.15]

$50,000-$75,000

3.56

[1.46, 8.72]

$75,000 and up

3.62

[1.64, 8.00]

Employment Status
Not currently employed

Ref

Currently employed

0.30

[0.18, 0.51]

Government Assistance
No

Ref

Yes

0.18

Ref
[0.10, 0.31]

0.13

[0.06, 0.29]

--

--

Smoking, Past Month
No

Ref

Yes

0.54

[0.32, 0.91]

MH and/or SPD, Past Year (2005-2013)
No

Ref

Yes

0.20

Ref
[0.11, 0.38]

0.26

[0.11, 0.60]

--

--

SPD, Past Month (2005-2013)
No

Ref

Yes

0.26

[0.11, 0.62]
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MDE and/or Anxiety Disorder, Lifetime
No

Ref

Yes

0.36

--

--

--

--

--

--

--

--

--

--

--

--

[0.20, 0.63]

Substance Dependence, Past Year
No

Ref

Yes

0.38

[0.21, 0.68]

Ever Arrested
No

Ref

Yes

0.52

[0.30, 0.88]

Probation Status, Past Year
No

Ref

Yes

0.29

[0.12, 0.71]

Treatment, Past Year
No

Ref

Yes

0.22

[0.12, 0.37]

MH or SU Treatment Gap
No

Ref

Yes

0.42

[0.25, 0.70]

Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative
medicine; Ref = reference category; SPD = serious psychological distress; MDE = major
depressive episode; MH = mental health; SU = substance use.
a
Adjusted model goodness-of-fit: X2 (1, 2) = 44.78, p < .001.

92
Table 8
Odds Ratios and Confidence Intervals for Past Year CAM Use (NHIS)
Unadjusted
Variable

OR

95% CI

Age
18 to 25

Ref

26 and older

0.95

[0.36, 2.49]

Race
White

Ref

African American

0.21

[0.03, 1.67]

Other Race

0.27

[0.03, 2.22]

Hispanic Ethnicity
No

Ref

Yes

0.83

[0.22, 3.23]

Marital Status
Never married

Ref

Living with partner

0.37

[0.08, 1.82]

Married

1.08

[0.31, 3.69]

Widowed, divorced, separated

0.55

[0.12, 2.43]

Education
College graduate

Ref

Some college

0.90

[0.23, 3.52]

HS graduate or GED

0.29

[0.07, 1.15]

HS, no diploma

0.35

[0.09, 1.40]

Less than HS

0.28

[0.03, 2.90]

Employment Status
Currently employed

Ref

Not currently employed

0.47

[0.18, 1.20]

Annual Family Income
Less than $34,999

Ref

$35,000 to $74,999

0.71

[0.23, 2.19]

$75,000 or more

3.27

[0.60, 17.91]
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Government Assistance
No

Ref

Yes

0.84

[0.31, 2.27]

Health Insurance Coverage
Covered

Ref

Not covered

0.47

[0.13, 1.76]

Health Status
Very Good to Excellent

Ref

Fair to Good

1.49

[0.60, 3.70]

Smoking Frequency
Some days

Ref

Everyday

1.03

[0.36, 2.95]

Regular Smoking Onset
By age 14

Ref

Age 15 or older

0.51

[0.20, 1.32]

Cigarettes Per Day
16 or more

Ref

6 to 15

1.06

[0.34, 3.33]

1 to 5

0.53

[0.15, 1.90]

SPD, Past Month
No

Ref

Yes

2.84

[0.34, 23.59]

Frequently Depressed or Anxious, Past Year
No

Ref

Yes

1.73

[0.67, 4.42]

Alcohol Use Status
Current drinker

Ref

Former drinker or lifetime abstainer

1.04

[0.41, 2.66]

Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative
medicine; SPD = serious psychological distress. No factors were retained in the multivariate
model using stepwise logistic regression; therefore, adjusted ORs are not reported.
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Table 9
Odds Ratios and Confidence Intervals for Lifetime CAM Use (NHIS)
Adjusteda

Unadjusted
Variable

OR

95% CI

OR

95% CI

--

--

--

--

--

--

--

--

Age
18 to 25

Ref

26 and older

1.05

[0.43, 2.58]

Race
White

Ref

African American

0.32

[0.07, 1.54]

Other Race

0.43

[0.09, 2.12]

Hispanic Ethnicity
No

Ref

Yes

1.95

[0.62, 6.19]

Marital Status
Never married

Ref

Living with partner

0.99

[0.25, 3.87]

Married

1.16

[0.34, 3.98]

Widowed, divorced, separated

0.85

[0.21, 3.43]

Education
College graduate

Ref

Some college

0.94

[0.24, 3.58]

0.79

[0.18, 3.44]

HS graduate or GED

0.30

[0.08, 1.10]

0.17

[0.04, 0.81]

HS, no diploma

0.31

[0.08, 1.21]

0.16

[0.03, 0.80]

Less than HS

0.46

[0.07, 3.14]

0.39

[0.05, 3.20]

--

--

--

--

Employment Status
Currently employed

Ref

Not currently employed

0.76

[0.32, 1.78]

Annual Family Income
Less than $34,999

Ref

$35,000 to $74,999

0.95

[0.36, 2.52]

95
$75,000 or more

2.37

[0.44, 12.81]

Government Assistance
No

Ref

Yes

1.20

--

--

--

--

--

--

--

--

[0.49, 2.90]

Health Insurance Coverage
Covered

Ref

Not covered

1.13

[0.41, 3.11]

Health Status
Very Good to Excellent

Ref

Fair to Good

1.12

[0.48, 2.60]

Smoking Frequency
Some days

Ref

Everyday

1.21

[0.45, 3.25]

Regular Smoking Onset
By age 14

Ref

Age 15 or older

1.67

Ref
[0.69, 4.06]

0.40

[0.14, 1.15]

--

--

--

--

--

--

3.24

[1.17, 9.00]

Cigarettes Per Day
16 or more

Ref

6 to 15

0.55

[0.19, 1.56]

1 to 5

0.36

[0.12, 1.12]

SPD, Past Month
No

Ref

Yes

1.79

[0.36, 8.93]

Frequently Depressed or Anxious,
Past Year
No

Ref

Yes

1.79

[0.75, 4.29]

Alcohol Use Status
Current drinker

Ref

Former drinker or lifetime

2.04

[0.86, 4.82]

abstainer
Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative
medicine; SPD = serious psychological distress.
a
Adjusted model goodness-of-fit: X2 (1, 6) = 13.61, p < .05.
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Figure 1
NSDUH Smoking Prevalence Rates Among Pregnant Women by Year
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Figure 2
Current Smokers by Trimester Across NSDUH Survey Years
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Figure 3
Smoking Prevalence Across NHIS Years
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Figure 4
Smoking Frequency Among Pregnant Women Who Were Ever Regular Smokers,
Across NHIS Years
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Figure 5
Prevalence Rate of Any CAM Use Across NSDUH Study Years
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Figure 6
Prevalence Rate of CAM Modalities Among Alternative Mental Health Treatment
Seekers Across NSDUH Study Years
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Figure 7
Past Year Prevalence Rate of CAM Use Across NHIS Study Years
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Figure 8
Lifetime Prevalence Rate of CAM Use Across NHIS Study Years
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APPENDIX A
NSDUH Demographic Items
What is your date of birth? __/__/____
That would make you [CALCAGE] years old. Is this correct?
1 YES
2 NO
Are you of Hispanic, Latino, or Spanish origin or descent?
1 YES
2 NO
Which of these groups describes you?
1 WHITE
2 BLACK OR AFRICAN AMERICAN
3 AMERICAN INDIAN OR ALASKA NATIVE (AMERICAN INDIAN INCLUDES
NORTH AMERICAN,
CENTRAL AMERICAN, AND SOUTH AMERICAN INDIANS)
4 NATIVE HAWAIIAN
5 GUAMANIAN OR CHAMORRO
6 SAMOAN
7 OTHER PACIFIC ISLANDER
8 ASIAN (INCLUDING: ASIAN INDIAN, CHINESE, FILIPINO, JAPANESE,
KOREAN, AND VIETNAMESE)
9 OTHER (SPECIFY)
Are you now married, widowed, divorced or separated, or have you never married?
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1 MARRIED
2 WIDOWED
3 DIVORCED OR SEPARATED
4 HAVE NEVER MARRIED
What is the highest grade or year of school you have completed?
0 NEVER ATTENDED SCHOOL
1 1ST GRADE COMPLETED
2 2ND GRADE COMPLETED
3 3RD GRADE COMPLETED
4 4TH GRADE COMPLETED
5 5TH GRADE COMPLETED
6 6TH GRADE COMPLETED
7 7TH GRADE COMPLETED
8 8TH GRADE COMPLETED
9 9TH GRADE COMPLETED
10 10TH GRADE COMPLETED
11 11TH GRADE COMPLETED
12 12TH GRADE COMPLETED
13 COLLEGE OR UNIVERSITY / 1ST YEAR COMPLETED
14 COLLEGE OR UNIVERSITY / 2ND YEAR COMPLETED
15 COLLEGE OR UNIVERSITY / 3RD YEAR COMPLETED
16 COLLEGE OR UNIVERSITY / 4TH YEAR COMPLETED
17 COLLEGE OR UNIVERSITY / 5TH OR HIGHER YEAR COMPLETED
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This question is about your overall health. Would you say your health in general is
excellent, very good, good, fair, or poor?
1 EXCELLENT
2 VERY GOOD
3 GOOD
4 FAIR
5 POOR
Are you currently pregnant?
1 Yes
2 No
How many months pregnant are you? ________
Medicaid is a public assistance program that pays for medical care for low income and
disabled persons. The Medicaid program in [STATE FILL] is also called [MEDIFILL]. Are
you covered by Medicaid?
1 YES
2 NO
These next questions are about the kinds and amounts of income that you receive.
These questions refer to the calendar year [CURRENT YEAR - 1] rather than to the
past 12 months that were referred to in some earlier questions. The calendar year
[CURRENT YEAR - 1] would be from January 1st, [CURRENT YEAR - 1], through
December 31st, [CURRENT YEAR - 1].
In [CURRENT YEAR - 1], did you receive Social Security or Railroad Retirement
payments?
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1 YES
2 NO
In [CURRENT YEAR - 1], did you receive income from wages or pay earned while
working at a job or business?
1 YES
2 NO
In [CURRENT YEAR - 1], did you receive Supplemental Security Income or SSI?
1 YES
2 NO
In [CURRENT YEAR - 1], did you receive food stamps?
1 YES
2 NO
At any time during [CURRENT YEAR - 1], even for one month, did you receive any cash
assistance from a state or county welfare program such as [TANFFILL]?
1 YES
2 NO
In [CURRENT YEAR - 1], because of low income, did you receive any other kind of
welfare or public assistance, such as help with getting a job, placement in education or
job training programs, or help with transportation, child care, or housing?
1 YES
2 NO
Next, we would like to know about the total family income from all sources during
[CURRENT YEAR - 1]. Before taxes and other deductions, was the total combined
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family income during [CURRENT YEAR - 1] more or less than 20,000 dollars?
1 $20,000 OR MORE
2 LESS THAN $20,000
Of these income groups, which category best represents your total combined family
income during [CURRENT YEAR – 1] before taxes and other deductions.
1 LESS THAN $1,000 (INCLUDING LOSS)
2 $1,000 - $1,999
3 $2,000 - $2,999
4 $3,000 - $3,999
5 $4,000 - $4,999
6 $5,000 - $5,999
7 $6,000 - $6,999
8 $7,000 - $7,999
9 $8,000 - $8,999
10 $9,000 - $9,999
11 $10,000 - $10,999
12 $11,000 - $11,999
13 $12,000 - $12,999
14 $13,000 - $13,999
15 $14,000 - $14,999
16 $15,000 - $15,999
17 $16,000 - $16,999
18 $17,000 - $17,999
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19 $18,000 - $18,999
20 $19,000 - $19,999
The next questions are about working. Did you work at a job or business at any time last
week? By last week, I mean the week beginning on Sunday, [STARTDATE] and ending
on Saturday, [ENDDATE].
1 YES
2 NO
Even though you did not work at any time last week, did you have a job or business?
1 YES
2 NO
Do you usually work 35 hours or more per week at all jobs or businesses?
1 YES
2 NO
Please look at this card and tell me which one of these reasons best describes why you
did not have a job or business last week. Just give me the number.
1 LOOKING FOR WORK
2 ON LAYOFF AND NOT LOOKING FOR WORK
3 KEEPING HOUSE OR CARING FOR CHILDREN FULL TIME
4 GOING TO SCHOOL/TRAINING
5 RETIRED
6 DISABLED FOR WORK
7 DIDN’T WANT A JOB
8 SOME OTHER REASON
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Now, think about the past 12 months, from [DATEFILL] through today. Did you work at a
job or business at any time during the past 12 months?
1 YES
2 NO
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APPENDIX B
NSDUH Cigarette Use
Have you ever smoked part or all of a cigarette?
1 Yes
2 No
If one of your best friends offered you a cigarette, would you smoke it?
1 Definitely Yes
2 Probably Yes
3 Probably Not
4 Definitely Not
At any time during the next 12 months do you think you will smoke a cigarette?
1 Definitely Yes
2 Probably Yes
3 Probably Not
4 Definitely Not
How old were you the first time you smoked part or all of a cigarette? ______
Now think about the past 30 days – that is, from [DATEFILL] up to and including today.
During the past 30 days, have you smoked part or all of a cigarette?
1 Yes
2 No
How long has it been since you last smoked part or all of a cigarette?
1 More than 30 days ago but within the past 12 months
2 More than 12 months ago but within the past 3 years
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3 More than 3 years ago
During the past 30 days, that is, since [DATEFILL], on how many days did you smoke
part or all of a cigarette? # OF DAYS: __________
On the [______] days you smoked cigarettes during the past 30 days, how many
cigarettes did you smoke per day, on average?
1 Less than one cigarette per day
2 1 cigarette per day
3 2 to 5 cigarettes per day
4 6 to 15 cigarettes per day (about ½ pack)
5 16 to 25 cigarettes per day (about 1 pack)
6 26 to 35 cigarettes per day (about 1 ½ packs)
7 More than 35 cigarettes per day (about 2 packs or more)
Has there ever been a period in your life when you smoked cigarettes every day for at
least 30 days?
1 Yes
2 No
How old were you when you first started smoking cigarettes every day? AGE: _______
Have you smoked at least 100 cigarettes in your entire life?
1 Yes
2 No
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APPENDIX C
Nicotine Dependence Syndrome Scale
(NDSS; Shiffman, Hickcox, Gnys, Paty, & Kessel, 1995)
Think about your use of cigarettes during the past 30 days as you answer these next
questions.
1. After not smoking for a while, you need to smoke in order to feel less restless and
irritable.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
2. When you don’t smoke for a few hours, you start to crave cigarettes.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
3. You sometimes have strong cravings for a cigarette where it feels like you’re in the
grip of a force you can’t control.
1. Not at all true
2. Somewhat true
3. Moderately true
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4. Very true
5. Extremely true
4. You feel a sense of control over your smoking — that is, you can “take it or leave it”
at any time.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
5. You tend to avoid places that don’t allow smoking, even if you would otherwise enjoy
them.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
6. Do you have any friends who do not smoke cigarettes?
1. Yes
2. No
7. There are times when you choose not to be around your friends who don’t smoke
because they won’t like it if you smoke.
1. Not at all true
2. Somewhat true
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3. Moderately true
4. Very true
5. Extremely true
8. Even if you are traveling a long distance, you would rather not travel by airplane
because you would not be allowed to smoke.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
9. You sometimes worry that you will run out of cigarettes.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
10. You smoke cigarettes fairly regularly throughout the day.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
11. You smoke about the same amount on weekends as on weekdays.
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1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
12. You smoke just about the same number of cigarettes from day to day It’s hard for
you to say how many cigarettes you smoke per day because the number often changes.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
13. It’s normal for you to smoke several cigarettes in an hour, then not have another
one until hours later.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
14. The number of cigarettes you smoke per day is often influenced by other things–
how you are feeling, or what you are doing for example.
1. Not at all true
2. Somewhat true
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3. Moderately true
4. Very true
5. Extremely true
15. Your smoking is not affected much by other things. For example, you smoke about
the same amount whether you’re relaxing or working, happy or sad, alone or with
others.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
16. Since you started smoking, the amount you smoke has increased.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
17. Compared to when you first started smoking, you need to smoke a lot more now in
order to be satisfied.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
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5. Extremely true
18. Compared to when you first started smoking, you can smoke much, much more now
before you start to feel anything.
1. Not at all true
2. Somewhat true
3. Moderately true
4. Very true
5. Extremely true
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APPENDIX D
NSDUH Alcohol and Other Substance Use
ALCOHOL
These questions are about drinks of alcoholic beverages. Throughout these questions,
by a “drink,” we mean a can or bottle of beer, a glass of wine or a wine cooler, a shot of
liquor, or a mixed drink with liquor in it. We are not asking about times when you only
had a sip or two from a drink.

Have you ever, even once, had a drink of any type of alcoholic beverage? Please do not
include times when you only had a sip or two from a drink.
1 Yes
2 No
How long has it been since you last drank an alcoholic beverage?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago

Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve had a drink of an alcoholic beverage during the past 12 months.
What would be the easiest way for you to tell us how many days you drank alcoholic
beverages?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
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3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3 OR DK/REF] On how many days in the past 12 months did
you drink an alcoholic beverage? TOTAL # OF DAYS: ______
[IF PREVIOUS ITEM = 2 OR ALYRAVE = DK/REF] On average, how many days did
you drink an alcoholic beverage each month during the past 12 months? AVG # OF
DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1 OR ALMONAVE = DK/REF] On average, how many days did
you drink an alcoholic beverage each week during the past 12 months? AVG # OF
DAYS PER WEEK: _____

Think specifically about the past 30 days, from [DATEFILL], up to and including today.
During the past 30 days, on how many days did you drink one or more drinks of an
alcoholic beverage? # OF DAYS: _____
On the [#DAYS] days that you drank during the past 30 days, how many drinks did you
usually have each day? Count as a drink a can or bottle of beer; a wine cooler or a
glass of wine, champagne, or sherry; a shot of liquor or a mixed drink or cocktail. # OF
DRINKS: _____
During the past 30 days, that is, since [DATEFILL], on how many days did you have 5
or more drinks on the same occasion? By ‘occasion,’ we mean at the same time or
within a couple of hours of each other. # OF DAYS: _____
Have you ever had 4 or more drinks on the same occasion?
1 Yes
2 No
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During the past 30 days, that is, since [DATEFILL], on how many days did you have 4
or more drinks on the same occasion? # OF DAYS: _____

MARIJUANA
The next questions are about marijuana and hashish. Marijuana is also called pot or
grass. Marijuana is usually smoked, either in cigarettes, called joints, or in a pipe. It is
sometimes cooked in food. Hashish is a form of marijuana that is also called “hash.” It is
usually smoked in a pipe. Another form of hashish is hash oil.
Have you ever, even once, used marijuana or hashish?
1 Yes
2 No
How long has it been since you last used marijuana or hashish?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago

[IF PREVIOUS ITEM = 1 - 2] Now think about the past 12 months, from [DATEFILL]
through today. We want to know how many days you’ve used marijuana or hashish
during the past 12 months.
What would be the easiest way for you to tell us how many days you’ve used it?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
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[IF PREVIOUS ITEM = 3 OR DK/REF] On how many days in the past 12 months did
you use marijuana or hashish? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use marijuana or
hashish each month during the past 12 months? AVERAGE # OF DAYS PER MONTH:
_____
[IF PREVIOUS ITEM = 1] On average, how many days did you use marijuana or
hashish each week during the past 12 months? AVERAGE # OF DAYS PER WEEK:
_____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use marijuana or hashish?
NUMBER OF DAYS: _____

COCAINE
These questions are about cocaine, including all the different forms of cocaine such as
powder, ‘crack,’ free base, and coca paste.
Have you ever, even once, used any form of cocaine?
1 Yes
2 No
How long has it been since you last used any form of cocaine?
1 Within the past 30 days -- that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
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how many days you’ve used cocaine during the past 12 months.
What would be the easiest way for you to tell us how many days you’ve used it?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months

[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use
cocaine? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use cocaine each month
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1] On average, how many days did you use cocaine each week
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use cocaine? # OF DAYS: _____

The next questions are about ‘crack’, that is cocaine in rock or chunk form, and not the
other forms of cocaine.
Have you ever, even once, used ‘crack’?
1 Yes
2 No
How long has it been since you last used ‘crack’?
1 Within the past 30 days -- that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
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3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used ‘crack’ during the past 12 months.
What would be the easiest way for you to tell us how many days you’ve used it?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use ‘crack’?
TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use ‘crack’ each month
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1] On average, how many days did you use ‘crack’ each week
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use ‘crack’? # OF DAYS: _____

HEROIN
These next questions are about heroin.
Have you ever, even once, used heroin?
1 Yes
2 No
How long has it been since you last used heroin?
1 Within the past 30 days -- that is, since [DATEFILL]
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2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used heroin during the past 12 months.
What would be the easiest way for you to tell us how many days you’ve used it?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use heroin?
TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use heroin each month
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1] On average, how many days did you use heroin each week
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use heroin? # OF DAYS: _____

HALLUCINOGENS
The next questions are about substances called hallucinogens. These drugs often
cause people to see or experience things that are not real. A list of some common
hallucinogens is shown below. These and many other substances that people use as
hallucinogens are often known by street names, and we can’t list them all. Please take a
moment to look at the substances listed below so you know what kind of drugs the next
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questions are about.
LSD, also called ‘acid’
PCP, also called ‘angel dust’ or phencyclidine
Peyote
Mescaline
Psilocybin
‘Ecstasy’, also called MDMA
Have you ever, even once, used LSD, also called “acid”?
1 Yes
2 No
Have you ever, even once, used PCP, also called ‘angel dust’ or phencyclidine?
1 Yes
2 No
Have you ever, even once, used peyote?
1 Yes
2 No
Have you ever, even once, used mescaline?
1 Yes
2 No
Have you ever, even once, used psilocybin, found in mushrooms?
1 Yes
2 No
Have you ever, even once, used ‘Ecstasy’, also known as MDMA?
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1 Yes
2 No
How long has it been since you last used [LSFILL]?
1 Within the past 30 days -- that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used [LSFILL] during the past 12 months.
What would be the easiest way for you to tell us how many days you’ve used it?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use
[LSFILL]? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use [LSFILL] each
month during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1] On average, how many days did you use [LSFILL] each week
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use [LSFILL]? NUMBER OF
DAYS: _____

INHALANTS
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These next questions are about liquids, sprays, and gases that people sniff or inhale to
get high or to make them feel good. We are not interested in times when you inhaled a
substance accidentally — such as when painting, cleaning an oven, or filling a car with
gasoline. The questions use the word ‘inhalant’ to include all the things listed below, as
well as any other substances that people sniff or inhale for kicks or to get high. Take a
moment to look at the substances listed below so you know what kinds of liquids,
sprays, and gases these questions are about.
Amyl nitrite, ‘poppers,’ locker room odorizers, or ‘rush’
Correction fluid, degreaser, or cleaning fluid
Gasoline or lighter fluid
Glue, shoe polish, or toluene
Halothane, ether, or other anesthetics
Lacquer thinner, or other paint solvents
Lighter gases, such as butane or propane
Nitrous oxide or ‘whippits’
Spray paints
Other aerosol sprays
Have you ever, even once, inhaled amyl nitrite, ‘poppers,’ locker room odorizers, or
‘rush’ for kicks or to get high?
1 Yes
2 No
Have you ever, even once, inhaled correction fluid, degreaser, or cleaning fluid for kicks
or to get high?

129
1 Yes
2 No
Have you ever, even once, inhaled gasoline or lighter fluid for kicks or to get high?
1 Yes
2 No
Have you ever, even once, inhaled glue, shoe polish, or toluene for kicks or to get high?
1 Yes
2 No
Have you ever, even once, inhaled halothane, ether, or other anesthetics for kicks or to
get high?
1 Yes
2 No
Have you ever, even once, inhaled lacquer thinner or other paint solvents for kicks or to
get high?
1 Yes
2 No
Have you ever, even once, inhaled lighter gases, such as butane or propane for kicks or
to get high?
1 Yes
2 No
Have you ever, even once, inhaled nitrous oxide or ‘whippits’ for kicks or to get high?
1 Yes
2 No
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Have you ever, even once, inhaled spray paints for kicks or to get high?
1 Yes
2 No
Have you ever, even once, inhaled some other aerosol spray for kicks or to get high?
1 Yes
2 No
How long has it been since you last used any inhalant for kicks or to get high?
1 Within the past 30 days – that is, since [DATEFILL]
2 More than 30 days ago but with the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used an inhalant of any kind for kicks or to get high during the
past 12 months.
What would be the easiest way for you to tell us how many days you’ve done this?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use an
inhalant of any kind for kicks or to get high? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days did you use an inhalant of any
kind for kicks or to get high each month during the past 12 months?
AVERAGE # OF DAYS PER MONTH: _____
[IF PREVIOUS ITEM = 1] On average, how many days did you use an inhalant of any
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kind for kicks or to get high each week during the past 12 months? AVERAGE # OF
DAYS PER WEEK: _____
Think specifically about the past 30 days, from [DATEFILL] up to and including today.
During the past 30 days, on how many days did you use any inhalant for kicks or to get
high? NUMBER OF DAYS: _____

PAIN RELIEVERS
These questions are about the use of pain relievers. We are not interested in your use
of “over-the-counter” pain relievers such as aspirin, Tylenol, or Advil that can be bought
in drug stores or grocery stores without a doctor’s prescription. Card A shows pictures
of some different kinds of prescription pain relievers and lists the names of some others.
These pictures show only pills, but we are interested in your use of any form of
prescription pain relievers that were not prescribed for you or that you took only for the
experience or feeling they caused.
Have you ever, even once, used any of these pain relievers when they were not
prescribed for you or that you took only for the experience or feeling they caused?
1 Yes
2 No
How long has it been since you last used any prescription pain reliever that was not
prescribed for you or that you took only for the experience or feeling it caused?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
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Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used any prescription pain reliever that was not prescribed for
you or that you took only for the experience or feeling it caused during the past 12
months.
What would be the easiest way for you to tell us how many days you used a prescription
pain reliever in either of these ways?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any
prescription pain reliever that was not prescribed for you or that you took only for the
experience or feeling it caused? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12
months did you use any prescription pain reliever that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH:
_____
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12
months did you use any prescription pain reliever that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK:
_____

TRANQUILIZERS
These next questions ask about the use of tranquilizers. Tranquilizers are usually
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prescribed to relax people, to calm people down, to relieve anxiety, or to relax muscle
spasms. Some people call tranquilizers ‘nerve pills.’ Card B shows pictures of some
different kinds of prescription tranquilizers. These pictures show only pills, but we are
interested in your use of any form of prescription tranquilizers that were not prescribed
for you or that you took only for the experience or feeling they caused.
Have you ever, even once, used any of these tranquilizers when they were not
prescribed for you or that you took only for the experience or feeling they caused?
1 Yes
2 No
How long has it been since you last used any prescription tranquilizer that was not
prescribed for you or that you took only for the experience or feeling it caused?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used any prescription tranquilizer that was not prescribed for
you or that you took only for the experience or feeling it caused during the past 12
months.
What would be the easiest way for you to tell us how many days you used a prescription
tranquilizer in either of these ways?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
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[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any
prescription tranquilizer that was not prescribed for you or that you took only for the
experience or feeling it caused? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12
months did you use any prescription tranquilizer that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH:
_____
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12
months did you use any prescription tranquilizer that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK:
_____

STIMULANTS
These next questions ask about the use of drugs such as amphetamines that are known
as stimulants, ‘uppers,’ or ‘speed.’ People sometimes take these drugs to lose weight,
to stay awake, or for attention deficit disorders. We are not interested in the use of
“over-the-counter” stimulants such as Dexatrim or No-Doz that can be bought in drug
stores or grocery stores without a doctor’s prescription. Card C shows pictures of some
different kinds of prescription stimulants and lists the names of some others. These
pictures show only pills, but we are interested in your use of any form of prescription
stimulants that were not prescribed for you or that you took only for the experience or
feeling they caused.
Have you ever, even once, used any of these stimulants when they were not prescribed
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for you or that you took only for the experience or feeling they caused?
1 Yes
2 No
How long has it been since you last used any prescription stimulant that was not
prescribed for you or that you took only for the experience or feeling it caused?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used any prescription stimulant that was not prescribed for you
or that you took only for the experience or feeling it caused during the past 12 months.
What would be the easiest way for you to tell us how many days you used a prescription
stimulant in either of these ways?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any
prescription stimulant that was not prescribed for you or that you took only for the
experience or feeling it caused? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12
months did you use any prescription stimulant that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH:
_____
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[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12
months did you use any prescription stimulant that was not prescribed for you or that
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK:
_____

SEDATIVES
These next questions ask about the use of sedatives or barbiturates. These drugs are
also called “downers” or “sleeping pills.” People take these drugs to help them relax or
to help them sleep. We are not interested in the use of “over-the-counter” sedatives
such as Sominex, Unisom, Nytol, or Benadryl that can be bought in drug stores or
grocery stores without a doctor’s prescription. Card D shows pictures of some different
kinds of prescription sedatives and lists the names of some others. These pictures show
only pills, but we are interested in your use of any prescription sedatives that were not
prescribed for you, or that you took only for the experience or feeling they caused.

Have you ever, even once, used any of these sedatives when they were not prescribed
for you or that you took only for the experience or feeling they caused?
1 Yes
2 No
How long has it been since you last used any prescription sedative that was not
prescribed for you or that you took only for the experience or feeling it caused?
1 Within the past 30 days — that is, since [DATEFILL]
2 More than 30 days ago but within the past 12 months
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3 More than 12 months ago
Now think about the past 12 months, from [DATEFILL] through today. We want to know
how many days you’ve used any prescription sedative that was not prescribed for you
or that you took only for the experience or feeling it caused during the past 12 months.
What would be the easiest way for you to tell us how many days you used a prescription
sedative in either of these ways?
1 Average number of days per week during the past 12 months
2 Average number of days per month during the past 12 months
3 Total number of days during the past 12 months
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any
prescription sedative that was not prescribed for you or that you took only for the
experience or feeling it caused? TOTAL # OF DAYS: _____
[IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12
months did you use any prescription sedative that was not prescribed for you or that you
took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH:
_____
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12
months did you use any prescription sedative that was not prescribed for you or that you
took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK: _____
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APPENDIX E
NSDUH Risk Section
How often do you get a real kick out of doing things that are a little dangerous?
1 Never
2 Seldom
3 Sometimes
4 Always
How often do you like to test yourself by doing something a little risky?
1 Never
2 Seldom
3 Sometimes
4 Always
How often do you wear a seatbelt when you ride in the front passenger seat of a car?
1 Never
2 Seldom
3 Sometimes
4 Always
How often do you wear a seatbelt when you drive a car?
1 Never
2 Seldom
3 Sometimes
4 Always
5 I don’t drive
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APPENDIX F
NSDUH Substance Dependence and Abuse
Think about your use of alcohol during the past 12 months as you answer these next
questions. During the past 12 months, was there a month or more when you spent a lot
of your time getting or drinking alcohol?
1 Yes
2 No
During the past 12 months, was there a month or more when you spent a lot of time
getting over the effects of the alcohol you drank?
1 Yes
2 No
During the past 12 months, did you try to set limits on how often or how much alcohol
you would drink?
1 Yes
2 No
Were you able to keep to the limits you set, or did you often drink more than you
intended to?
1 Usually kept to the limits set
2 Often drank more than intended
During the past 12 months, did you need to drink more alcohol than you used to in order
to get the effect you wanted?
1 Yes
2 No
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During the past 12 months, did you notice that drinking the same amount of alcohol had
less effect on you than it used to?
1 Yes
2 No
During the past 12 months, did you want to or try to cut down or stop drinking alcohol?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] During the past 12 months, were you able to cut down or stop
drinking alcohol every time you wanted to or tried to?
1 Yes
2 No
[IF EITHER OF THE PREVIOUS TWO ITEMS = 2] During the past 12 months, did you
cut down or stop drinking at least one time?
1 Yes
2 No
Please look at the symptoms listed below. During the past 12 months, did you have 2 or
more of these symptoms after you cut back or stopped drinking alcohol?
• Sweating or feeling that your heart was beating fast
• Having your hands tremble
• Having trouble sleeping
• Vomiting or feeling nauseous
• Seeing, hearing, or feeling things that weren’t really there
• Feeling like you couldn’t sit still
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• Feeling anxious
• Having seizures or fits
1 Yes
2 No
Please look at the symptoms listed below. During the past 12 months, did you have 2 or
more of these symptoms at the same time that lasted for longer than a day after you cut
back or stopped drinking alcohol?
• Sweating or feeling that your heart was beating fast
• Having your hands tremble
• Having trouble sleeping
• Vomiting or feeling nauseous
• Seeing, hearing, or feeling things that weren’t really there
• Feeling like you couldn’t sit still
• Feeling anxious
• Having seizures or fits
1 Yes
2 No
During the past 12 months, did you have any problems with your emotions, nerves, or
mental health that were probably caused or made worse by drinking alcohol?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought
drinking was causing you to have problems with your emotions, nerves, or mental
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health?
1 Yes
2 No
[IF EITHER OF THE PREVIOUS TWO ITEMS= 2] During the past 12 months, did you
have any physical health problems that were probably caused or made worse by
drinking alcohol?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought
drinking was causing you to have physical problems?
1 Yes
2 No
This question is about important activities such as working, going to school, taking care
of children, doing fun things such as hobbies and sports, and spending time with friends
and family. During the past 12 months, did drinking alcohol cause you to give up or
spend less time doing these types of important activities?
1 Yes
2 No
Sometimes people who drink alcohol have serious problems at home, work or school —
such as:
• neglecting their children
• missing work or school
• doing a poor job at work or school
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• losing a job or dropping out of school
During the past 12 months, did drinking alcohol cause you to have serious problems like
this either at home, work, or school?
1 Yes
2 No
During the past 12 months, did you regularly drink alcohol and then do something where
being drunk might have put you in physical danger?
1 Yes
2 No
During the past 12 months, did drinking alcohol cause you to do things that repeatedly
got you in trouble with the law?
1 Yes
2 No
During the past 12 months, did you have any problems with family or friends that were
probably caused by your drinking?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought
your drinking caused problems with family or friends?
1 Yes
2 No
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For each of the drugs of abuse below that respondents endorsed using in the past 12
months, respondents are asked the following:
•

Marijuana or hashish

•

Cocaine or crack

•

Heroin

•

Hallucinogens

•

Inhalants

•

Prescription pain relievers

•

Prescription tranquilizers

•

Prescription stimulants

•

Prescription sedatives

Think about your use of _______ during the past 12 months as you answer these next
questions. During the past 12 months, was there a month or more when you spent a lot
of your time getting or using _______?
1 Yes
2 No
[IF PREVIOUS ITEM = 2] During the past 12 months, was there a month or more when
you spent a lot of your time getting over the effects of the _______ you used?
1 Yes
2 No
During the past 12 months, did you try to set limits on how often or how much _______
you would use?
1 Yes
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2 No
[IF PREVIOUS ITEM = 1] Were you able to keep to the limits you set, or did you often
use _______ more than you intended to?
1 Usually kept to the limits set
2 Often used more than intended
During the past 12 months, did you need to use more _______ than you used to in
order to get the effect you wanted?
1 Yes
2 No
[IF PREVIOUS ITEM =2] During the past 12 months, did you notice that using the same
amount of _______ had less effect on you than it used to?
1 Yes
2 No
During the past 12 months, did you want to or try to cut down or stop using _______?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] During the past 12 months, were you able to cut down or stop
using _______ every time you wanted to or tried to?
1 Yes
2 No
During the past 12 months, did you have any problems with your emotions, nerves, or
mental health that were probably caused or made worse by your use of _______?
1 Yes
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2 No
[IF PREVIOUS ITEM = 1] Did you continue to use _______ even though you thought it
was causing you to have problems with your emotions, nerves, or mental health?
1 Yes
2 No
[IF EITHER OF THE PREVIOUS 2 ITEMS = 2] During the past 12 months, did you have
any physical health problems that were probably caused or made worse by your use of
_______?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] Did you continue to use _______ even though you thought it
was causing you to have physical problems?
1 Yes
2 No
This question is about important activities such as working, going to school, taking care
of children, doing fun things such as hobbies and sports, and spending time with friends
and family. During the past 12 months, did using _______ cause you to give up or
spend less time doing these types of important activities?
1 Yes
2 No
Sometimes people who use _______ have serious problems at home, work or school —
such as:
• neglecting their children
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• missing work or school
• doing a poor job at work or school
• losing a job or dropping out of school
During the past 12 months, did using _______ cause you to have serious problems like
this either at home, work, or school?
1 Yes
2 No
During the past 12 months, did you regularly use _______ and then do something
where using marijuana or hashish might have put you in physical danger?
1 Yes
2 No
During the past 12 months, did using _______ cause you to do things that repeatedly
got you in trouble with the law?
1 Yes
2 No
During the past 12 months, did you have any problems with family or friends that were
probably caused by your use of _______?
1 Yes
2 No
Did you continue to use _______ even though you thought it caused problems with
family or friends?
1 Yes
2 No
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APPENDIX G
NSDUH Special Topics
The next questions are about encounters with the police or the court system.

Not counting minor traffic violations, have you ever been arrested and booked for
breaking the law? Being ‘booked’ means that you were taken into custody and
processed by the police or by someone connected with the courts, even if you were
then released.
1 Yes
2 No
Not counting minor traffic violations, how many times during the past 12 months have
you been arrested and booked for breaking a law? _____

In the past 12 months, were you arrested and booked for driving under the influence of
alcohol or drugs?
1 Yes
2 No
Were you on probation at any time during the past 12 months?
1 Yes
2 No
Were you on parole, supervised release, or other conditional release from prison at any
time during the past 12 months?
1 Yes
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2 No
During the past 12 months, have you driven a vehicle while you were under the
influence of a combination of alcohol and illegal drugs used together?
1 Yes
2 No
During the past 12 months, have you driven a vehicle while you were under the
influence of alcohol?
1 Yes
2 No
During the past 12 months, have you driven a vehicle while you were under the
influence of illegal drugs?
1 Yes
2 No
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APPENDIX H
K6 (Furukawa, Kessler, Slade, & Andrews, 2003; Kessler et al., 2003)
During the past 30 days, about how often did you feel nervous?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During the past 30 days, about how often did you feel hopeless?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During the past 30 days, about how often did you feel restless or fidgety?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During the past 30 days, about how often did you feel so sad or depressed that nothing
could cheer you up?
1 All of the time
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2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During the past 30 days, about how often did you feel that everything was an effort?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During the past 30 days, about how often did you feel down on yourself, no good or
worthless?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
The last questions asked about how you have been feeling during the past 30 days.
Now think about the past 12 months. Was there a month in the past 12 months when
you felt more depressed, anxious, or emotionally stressed than you felt in the past 30
days?
1 Yes
2 No
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[IF YES TO PREVIOUS ITEM] Think of one month in the past 12 months when you
were the most depressed, anxious, or emotionally stressed. During that month, how
often did you feel nervous?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During that same month when you were at your worst emotionally, how often did you
feel hopeless?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During that same month when you were at your worst emotionally, how often did you
feel restless or fidgety?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During that same month when you were at your worst emotionally, how often did you
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feel so sad or depressed that nothing could cheer you up?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During that same month when you were at your worst emotionally, how often did you
feel that everything was an effort?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
During that same month when you were at your worst emotionally, how often did you
feel down on yourself, no good, or worthless?
1 All of the time
2 Most of the time
3 Some of the time
4 A little of the time
5 None of the time
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APPENDIX I
NSDUH Anxiety and Depression
Which, if any, of these conditions did a doctor or other medical professional tell you that
you had in the past 12 months?
1 Anxiety disorder
2 Asthma
3 Bronchitis
4 Cirrhosis of the liver
5 Depression
6 Diabetes
7 Heart disease
8 Hepatitis
9 High blood pressure
10 HIV/AIDS
11 Lung cancer
12 Pancreatitis
13 Pneumonia
14 Sexually transmitted disease, such as chlamydia, gonorrhea, herpes or
syphilis
15 Sinusitis
16 Sleep apnea
17 Stroke
18 Tinnitus
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19 Tuberculosis
20 Ulcer or ulcers
95 None of the above - I have not had any of these conditions in the past 12
months

ADULT DEPRESSION
[Questions administered only to respondents 18 years of age and older]
ASC21 Have you ever in your life had a period of time lasting several days or longer
when most of the day you felt sad, empty or depressed?
1 Yes
2 No
ASC22 [IF ASC21 = 2] Have you ever had a period of time lasting several days or
longer when most of the day you were very discouraged about how things were going in
your life?
1 Yes
2 No
ASC23 [IF ASC22 = 2] Have you ever had a period of time lasting several days or
longer when you lost interest in most things you usually enjoy like work, hobbies, and
personal relationships?
1 Yes
2 No
AD01 [IF ASC21 =1] During times when you felt sad, empty, or depressed most of the
day, did you ever feel discouraged about how things were going in your life?
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1 Yes
2 No
AD01a [IF AD01 = 1] During the times when you felt sad, empty, or depressed, did you
ever lose interest in most things like work, hobbies, and other things you usually enjoy?
1 Yes
2 No
AD01b [IF AD01 = 2] During the times when you felt sad, empty, or depressed, did you
ever lose interest in most things like work, hobbies, and other things you usually enjoy?
1 Yes
2 No
AD02 [IF ASC22 = 1] During times when you felt discouraged about how things were
going in your life, did you ever lose interest in most things like work, hobbies, and other
things you usually enjoy?
1 Yes
2 No
AD09 [IF ASC23= 1] Did you ever have a period of time like this that lasted most of the
day nearly every day for two weeks or longer?
1 Yes
2 No
DEFINE FEELFILL:
IF (AD01a = 1), THEN FEELFILL = “were sad, discouraged, or lost interest in most
things”
IF (AD01a = 2), THEN FEELFILL = “were sad or discouraged”
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IF (AD01b = 1), THEN FEELFILL = “were sad or lost interest in most things”
IF (AD02 = 1), THEN FEELFILL = “were discouraged or lost interest in most things”
IF (AD02 = 2 OR DK/REF), THEN FEELFILL = “were discouraged about the way things
were going in your life”
IF (AD09 = 1), THEN FEELFILL = “lost interest in most things”
ELSE, FEELFILL = BLANK
DEFINE FEELNOUN:
IF (AD01a = 1), THEN FEELNOUN = “sadness, discouragement, or lack of interest”
IF (AD01a = 2 OR DK/REF), THEN FEELNOUN = “sadness or discouragement”
IF (AD01b = 1), THEN FEELNOUN = “sadness or lack of interest”
IF (AD01b = 2 OR DK/REF), THEN FEELNOUN = “sadness”
IF (AD02 = 1), THEN FEELNOUN = “discouragement or lack of interest”
IF (AD02 = 2 OR DK/REF), THEN FEELNOUN = “discouragement”
IF (AD09 = 1), THEN FEELNOUN = “lack of interest in most things”
ELSE FEELNOUN = BLANK
DEFINE NUMPROBS
IF AD01a NE BLANK OR AD01b = 1 OR AD02 = 1, THEN NUMPROBS = “these
problems”
IF AD01b = (2 OR DK/REF) OR AD02 = (2 OR DK/REF) OR AD09 = 1, THEN
NUMPROBS = “this problem”
ELSE NUMPROBS = BLANK
DEFINE WASWERE:
IF AD01a NE BLANK OR AD01b = 1 OR AD02 = 1, THEN WASWERE = “were”
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IF AD01b = (2 OR DK/REF) OR AD02 = (2 OR DK/REF) OR AD09 = 1, THEN
WASWERE = “was”
ELSE WASWERE = BLANK

AD12 [IF AD01a NE BLANK OR AD01b NE BLANK OR AD02 NE BLANK] Think about
the times when you [FEELFILL]. Did you ever have a period of time like this that lasted
most of the day, nearly every day, for two weeks or longer?
1 Yes
2 No
AD16 [IF AD09 = 1 OR AD12 = 1] Think of times lasting two weeks or longer when
[NUMPROBS] with your mood [WASWERE] most severe and frequent. During those
times, how long did your [FEELNOUN] usually last?
1 Less than 1 hour
2 At least 1 hour but no more than 3 hours
3 At least 3 hours but no more than 5 hours
4 5 hours or more
AD17 [IF AD16 = 2, 3, OR 4] Still thinking of times lasting two weeks or longer when
[NUMPROBS] with your mood [WASWERE] most severe and frequent, how severe was
your emotional distress during those times?
1 Mild
2 Moderate
3 Severe
4 Very severe
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AD18 [IF AD16 = 2, 3, OR 4] Again, think of times lasting two weeks or longer when
[NUMPROBS] with your mood [WASWERE] most severe and frequent.
How often, during those times, was your emotional distress so severe that nothing could
cheer you up?
1 Often
2 Sometimes
3 Rarely
4 Never
AD19 [IF AD16 = 2, 3, OR 4] Once again, please think of times lasting two weeks or
longer when [NUMPROBS] with your mood [WASWERE] most severe and frequent.
How often, during those times, was your emotional distress so severe that you could not
carry out your daily activities?
1 Often
2 Sometimes
3 Rarely
4 Never
AD21 [IF AD16 = (2, 3, OR 4) AND NOT (AD17 = 1 AND AD18 = 4 AND AD19 = 4)
AND (ASC21=1 OR ASC22=1 OR ASC23=1) AND AD09 NE (2) People who have
problems with their mood often have other problems at the same time. These problems
may include things like changes in:
• sleep
• appetite
• energy
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• the ability to concentrate and remember
• feelings of low self-worth
Did you ever have any of these problems during a period of time when you [FEELFILL]
for two weeks or longer?
1 Yes
2 No
AD22 [IF AD21 = 1] Think again about these other problems we just mentioned. They
include things like changes in
• sleep
• appetite
• energy
• the ability to concentrate and remember
• feelings of low self-worth
Please think of a time when you [FEELFILL] for two weeks or longer and you also had
the largest number of these other problems at the same time. Is there one particular
time like this that stands out in your mind as the worst one you ever had?
1 Yes
2 No
AD22c [IF AD22 = 2 OR DK/REF] Then think of the most recent time when you
[FEELFILL] for two weeks or longer and you also had the largest number of these other
problems at the same time.

DEFINE TIMEFILL:
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IF AD22a NE BLANK, THEN TIMEFILL = ‘worst’
IF AD22c NE BLANK, THEN TIMEFILL = ‘most recent’
AD24a [IF AD22a NE BLANK] In answering the next questions, think about the period of
time when your [FEELNOUN] and other problems were the worst.
[IF AD22c NE BLANK] In answering the next questions, think about the most recent
period of time when you [FEELFILL] and had other problems at the same time.
During that time, did you feel sad, empty, or depressed most of the day nearly every
day?
1 Yes
2 No
AD24c [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of
time, did you feel discouraged about how things were going in your life most of the day
nearly every day?
1 Yes
2 No
AD24e [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of
time, did you lose interest in almost all things like work and hobbies and things you like
to do for fun?
1 Yes
2 No
AD24f [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of
time, did you lose the ability to take pleasure in having good things happen to you, like
winning something or being praised or complimented?

162
1 Yes
2 No
AD26a [IF ANY AD24a – AD24f = 1] The next questions are about changes in appetite
and weight.
[IF AD22a NE BLANK] In answering the next questions, think about the period of time
when your [FEELNOUN] and other problems were the worst.
[IF AD22c NE BLANK] In answering the next questions, think about the most recent
period of time when you [FEELFILL] and had other problems at the same time.
Did you have a much smaller appetite than usual nearly every day during that time?
1 Yes
2 No
AD26b [IF AD26a = 2] Did you have a much larger appetite than usual nearly every
day?
1 Yes
2 No
AD26c [IF AD26a = 2] Did you gain weight without trying to during that [TIMEFILL]
period of time?
1 Yes
2 No
AD26c1 [IF AD26c = 1 AND (AD22a ≤ 21 OR AD22c ≤ 21)] Did you gain weight without
trying to because you were growing?
1 Yes
2 No
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AD26c2 [IF AD26c = 1 AND AD26c1 NE YES AND QD01 = 9] Did you gain weight
without trying to because you were pregnant?
1 Yes
2 No
AD26d [IF AD26c = 1 AND AD26c1 NE YES AND AD26c2 NE YES] How many pounds
did you gain? Please enter your answer as a whole number. # OF
POUNDS:__________
AD26e [IF (AD26a = 1 OR AD26c=(2 OR DK/REF)] Did you lose weight without trying
to?
1 Yes
2 No
AD26e1 [IF AD26e = 1] Did you lose weight without trying to because you were sick or
on a diet?
1 Yes
2 No
AD26f [IF AD26e1 = 2 OR DK/REF] How many pounds did you lose? Please enter your
answer as a whole number. # OF POUNDS:__________
AD26g [IF AD26a NE BLANK]
[IF AD22a NE BLANK] Again, please think about the period of time when your
[FEELNOUN] and other problems were the worst.
[IF AD22c NE BLANK] Again, please think about the most recent period of time when
you [FEELFILL] and had other problems at the same time.
Did you have a lot more trouble than usual falling asleep, staying asleep, or waking too
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early nearly every night during that [TIMEFILL] period of time?
1 Yes
2 No
AD26h [IF AD26g = 2 OR DK/REF] During that [TIMEFILL] period of time, did you sleep
a lot more than usual nearly every night?
1 Yes
2 No
AD26j [IF AD26a NE BLANK] During that [TIMEFILL] period of time, did you feel tired or
low in energy nearly every day, even when you had not been working very hard?
1 Yes
2 No
AD26l [IF AD26a NE BLANK] Did you talk or move more slowly than is normal for you
nearly every day?
1 Yes
2 No
AD26m [IF AD26l = 1] Did anyone else notice that you were talking or moving slowly?
1 Yes
2 No
AD26n [IF AD26l = 2 OR DK/REF] Were you so restless or jittery nearly every day that
you paced up and down or couldn't sit still?
1 Yes
2 No
AD26o [AD26n = 1] Did anyone else notice that you were restless?
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1 Yes
2 No
AD26p [IF AD26a NE BLANK] The next questions are about changes in your ability to
concentrate, and your feelings about yourself.
[IF AD22a NE BLANK] Again, in answering these questions, think about the period of
time when your [FEELNOUN] and other problems were the worst.
[IF AD22c NE BLANK] Again, in answering these questions, think about the most recent
period of time when you [FEELFILL] and had other problems at the same time.
During that [TIMEFILL] time, did your thoughts come much more slowly than usual or
seem confused nearly every day?
1 Yes
2 No
AD26r [IF AD26a NE BLANK] Did you have a lot more trouble concentrating than usual
nearly every day?
1 Yes
2 No
AD26s [IF AD26a NE BLANK] Were you unable to make decisions about things you
ordinarily have no trouble deciding about?
1 Yes
2 No
AD26u [IF AD26a NE BLANK] Did you feel that you were not as good as other people
nearly every day?
1 Yes
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2 No
AD26v [IF AD26u = 1] Did you feel totally worthless nearly every day?
1 Yes
2 No
AD26aa [IF AD26a NE BLANK] The next questions are about thoughts of death or
suicide.
[IF AD22a NE BLANK] Again, in answering these questions, think about the period of
time when your [FEELNOUN] and other problems were the worst.
[IF AD22c NE BLANK] Again, in answering these questions, think about the most recent
period of time when you
[FEELFILL] and had other problems at the same time.
Did you often think a lot about death, either your own, someone else’s, or death in
general?
1 Yes
2 No
AD26bb [IF AD26a NE BLANK] During that period, did you ever think that it would be
better if you were dead?
1 Yes
2 No
AD26cc [IF AD26a NE BLANK] Did you think about committing suicide?
1 Yes
2 No
AD26dd [IF AD26cc = 1] Did you make a suicide plan?
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1 Yes
2 No
AD26ee [IF AD26cc = 1] Did you make a suicide attempt?
1 Yes
2 No

You mentioned having some of the problems I just asked you about. During that
[TIMEFILL] period of time, how much did your [FEELNOUN] and these other problems
interfere with your work, your social life, or your personal relationships?
1 Not at all
2 A little
3 Some
4 A lot
5 Extremely
AD28a [IF AD28 NE (BLANK OR 1)] During that [TIMEFILL] period of time, how often
were you unable to carry out your daily activities because of these problems with your
mood?
1 Often
2 Sometimes
3 Rarely
4 Never
AD38 [IF AD28 NE BLANK ] In the past 12 months, did you have a period of time when
you felt [FEELNOUN] for two weeks or longer while also having some of the other
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problems we asked about?
1 Yes
2 No
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APPENDIX J
NSDUH Mental Health Treatment Utilization
These next questions are about treatment and counseling for problems with emotions,
nerves or mental health. Please do not include treatment for alcohol or drug use.

During the past 12 months, have you stayed overnight or longer in a hospital or other
facility to receive treatment or counseling for any problem you were having with your
emotions, nerves, or mental health?
1) Yes
2) No
Where did you stay overnight or longer to receive mental health treatment or counseling
during the past 12 months?
1) A private or public psychiatric hospital
2) A psychiatric unit of a general hospital
3) A medical unit of a general hospital
4) Another type of hospital
5) A residential treatment center
6) Some other type of facility
The list below includes some of the services where people can get outpatient treatment
or counseling for problems with their emotions, nerves, or mental health. During the
past 12 months, did you receive outpatient treatment or counseling for any problem you
were having with your emotions, nerves, or mental health at any of the places listed
below? Please do not include treatment for alcohol or drug use.
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•

An outpatient mental health clinic or center

•

The office of a private therapist, psychologist, psychiatrist, social worker, or
counselor that was not part of a clinic.

•

A doctor’s office that was not part of a clinic

•

An outpatient medical clinic

•

A partial day hospital or day treatment program

•

Some other place
1) Yes
2) No

Where did you receive outpatient mental health treatment or counseling during the past
12 months?
1) An outpatient mental health clinic or center
2) The office of a private therapist, psychologist, psychiatrist, social worker, or
counselor that was not part of a clinic.
3) A doctor’s office that was not part of a clinic
4) An outpatient medical clinic
5) A partial day hospital or day treatment program
6) Some other place
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APPENDIX K
NSDUH Substance Use Treatment Utilization
During the past 12 months, did any doctor or other health care professional ask, either
in person or on a form, if you:
a. Smoke cigarettes or use any other tobacco products? 1. Yes 2. No
b. Drink alcohol? 1. Yes 2. No
c. Use illegal drugs? 1. Yes 2. No
During the past 12 months, did any doctor or other health care professional advise you
to quit smoking cigarettes or quit using any other tobacco products?
1 Yes
2 No
Please think about all of the talks you have had with a doctor or other health care
professional during the past 12 months when you answer this question. Choose the
statement or statements below that describe any discussions you may have had in
person with a doctor or other health professional about your alcohol use.
1. The doctor asked how much I drink.
2. The doctor asked how often I drink.
3. The doctor asked if I have any problems because of my drinking.
4. The doctor advised me to cut down on my drinking.
5. The doctor offered to give me more information about alcohol use and
treatment for problems with alcohol use.
95 The doctor didn’t discuss my alcohol use with me in the past 12 months.
During the past 12 months, did any doctor or other health care professional talk to you
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about your use of [FILLMARIJUANA/COCAINE/CRACK/HEROIN/INHALANTS/
HALLUCINOGENS/METHAMPHETAMINE]?
1 Yes
2 No

These next questions deal with treatment for alcohol and drug problems, not including
cigarettes. Please report treatment or counseling designed to help you reduce or stop
your alcohol or drug use. Please include detoxification and any other treatment for
medical problems associated with your alcohol or drug use.
Have you ever received treatment or counseling for your use of alcohol or any drug, not
counting cigarettes?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] During the past 12 months, that is, since [DATEFILL], have
you received treatment or counseling for your use of alcohol or any drug, not counting
cigarettes?
1 Yes
2 No
[IF PREVIOUS ITEM = 1] During the past 12 months when you received treatment, was
the treatment for alcohol use only, drug use only, or both alcohol and drug use?
1 Alcohol use only
2 Drug use only
3 Both alcohol and drug use
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DEFINE TXFILL1:
IF PREVIOUS ITEM= 1, TXFILL1 = alcohol use
IF PREVIOUS ITEM = 2, TXFILL1 = drug use
IF PREVIOUS ITEM = 3 OR DK/REF, TXFILL1 = alcohol or drug use
During the past 12 months, have you received treatment for your [TXFILL1] in a hospital
overnight as an inpatient?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a
residential drug or alcohol rehabilitation facility where you stayed overnight?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a drug or
alcohol rehabilitation facility as an outpatient?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a mental
health center or facility as an outpatient?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in an
emergency room?
1 Yes
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2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a private
doctor’s office?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a prison
or jail?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in a selfhelp group such as Alcoholics Anonymous or Narcotics Anonymous?
1 Yes
2 No
During the past 12 months, have you received treatment for your [TXFILL1] in some
other place besides these that have been listed?
1 Yes
2 No
Please type in a description of the place where you received treatment or counseling for
your [TXFILL1] other than the places just mentioned. ___________
Are you currently receiving treatment or counseling for your [TXFILL1]?
1 Yes
2 No
During the past 12 months, did you need treatment or counseling for your alcohol or
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drug use?
1 Yes
2 No
During the past 12 months, did you need additional treatment or counseling for your
alcohol or drug use?
1 Yes
2 No
During the past 12 months, for which of the following drugs did you need additional
treatment or counseling? [TXFILL2]
1 Alcohol
2 Marijuana or hashish
3 Cocaine or ‘crack’
4 Heroin
5 Hallucinogens
6 Inhalants
7 Prescription pain relievers
8 Prescription tranquilizers
9 Prescription stimulants
10 Prescription sedatives
11 Some other drug
During the past 12 months, did you make an effort to get treatment or counseling for
your use of [TXFILL2]?
1 Yes
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2 No
Which of these statements explain why you did not get the treatment or counseling you
needed for your use of [TXFILL2]?
1 You had no health care coverage, and you couldn’t afford the cost.
2 You did have health care coverage, but it didn’t cover treatment for [TXFILL2],
or didn’t cover the full cost.
3 You had no transportation to a program, or the programs were too far away, or
the hours were not convenient.
4 You didn’t find a program that offered the type of treatment or counseling you
wanted.
5 You were not ready to stop using [TXFILL2].
6 There were no openings in the programs.
7 You did not know where to go to get treatment.
8 You were concerned that getting treatment or counseling might cause your
neighbors or community to have a
negative opinion of you.
9 You were concerned that getting treatment or counseling might have a
negative effect on your job.
10 Some other reason or reasons.
[IF PREVIOUS ITEM = 10] Which of these statements explain why you did not get the
treatment or counseling you needed for your use of [TXFILL2]?
1 You didn't think you needed treatment at the time.
2 You thought you could handle the problem without treatment.
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3 You didn't think treatment would help.
4 You didn't have time (because of job, childcare, or other commitments).
5 You didn't want others to find out that you needed treatment.
6 Some other reason or reasons.
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APPENDIX L
NHIS Demographic Items
How old are you? ______
Are you now married, widowed, divorced, separated, never married, or living with a
partner?
1 Married
2 Widowed
3 Divorced
4 Separated
5 Never Married
6 Living with partner
The next few questions are about employment status.
Which of the following were you doing last week?
1 Working for pay at a job or business
2 With a job or business but not at work
3 Looking for work
4 Working, but not for pay, at a family-owned job or business
5 Not working at a job or business and not looking for work
Did you receive income in [last calendar year] from wages and salaries?
1 Yes
2 No
Did you receive income in [last calendar year] from self-employment including business
and farm income?
1 Yes
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2 No

Did [you receive Supplemental Security Income (SSI)?
1 Yes
2 No
At any time during [last calendar year], even for one month, did you receive any CASH
assistance from a state or county welfare program, such as (* fill specific program
name)?
1 Yes
2 No
At any time during [last calendar year], did you receive any OTHER kind of welfare
assistance such as help with getting a job, placement in education or job training
programs, or help with transportation or child care?
1 Yes
2 No
Did you receive income from child support?
1 Yes
2 No
Did you receive income from other sources such as alimony, contributions from
family/others, VA payments, Worker’s Compensation, or unemployment compensation?
1 Yes
2 No
What is your best estimate of your total income from all sources, before taxes, in [last
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calendar]? _____
Was your total family income from all sources less than [fill based on poverty threshold]
or [ fill based on poverty threshold] or more?
1 Less than [$10,500/$11,500/$13,500/$15,000/$18,000/$23,000/$27,000]
2 [$10,500/$11,500/$13,500/$15,000/$18,000/$23,000/$27,000] or more
Is this house/apartment owned or being bought, rented, or occupied by some other
arrangement by you or someone in your family?
1 Owned or being bought
2 Rented
3 Other arrangement
Are you paying lower rent because the Federal, State, or local government is paying
part of the cost?
1 Yes
2 No
At any time during [last calendar year], did you receive food stamp benefits?
1 Yes
2 No
At any time during [last calendar year] did you receive benefits from the WIC program,
that is, the Women, Infants and Children program?
1 Yes
2 No
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APPENDIX M
NHIS Cigarette Use
These next questions are about cigarette smoking.
Have you smoked at least 100 cigarettes in your ENTIRE LIFE?
1 Yes
2 No
How old were you when you FIRST started to smoke fairly regularly? ____________
Do you NOW smoke cigarettes every day, some days or not at all?
1 Every day
2 Some days
3 Not at all
[If not currently smoking] How long has it been since you quit smoking cigarettes?
____________
[If currently smoking] On the average, how many cigarettes do you now smoke a day?
____________
On how many of the PAST 30 DAYS did you smoke a cigarette? ____________
On the average, when you smoked during the PAST 30 DAYS, about how many
cigarettes did you smoke a day? ____________
During the PAST 12 MONTHS, have you stopped smoking for more than one day
BECAUSE YOU WERE TRYING TO QUIT SMOKING?
1 Yes
2 No
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APPENDIX N
NHIS Alcohol Use
These next questions are about drinking alcoholic beverages. Included are liquor such
as whiskey or gin, beer, wine, wine coolers, and any other type of alcoholic beverage
In ANY ONE YEAR, have you had at least 12 drinks of any type of alcoholic beverage?
1 Yes
2 No
In the past year, how often did you drink any type of alcoholic beverage? How many
days per week, per month or per year did you drink? ______
In the PAST YEAR, on those days that you drank alcoholic beverages, on the average,
how many drinks did you have? _____
In the PAST YEAR, on how many DAYS did you have 5 or more drinks of any alcoholic
beverage? _____
How many days per week, per month or per year did you have 5 or more drinks in a
single day? _____
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APPENDIX O
NHIS Mental Health (includes K6; Furukawa et al., 2003; Kessler et al., 2003)
Have you EVER been told by a doctor or other health professional that you had
...Phobia or fears?
1 Yes
2 No
DURING THE PAST 12 MONTHS have you had
...Phobia or fears?
1 Yes
2 No
Have you EVER been told by a doctor or other health professional that you had
...Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder
(ADD)?
1 Yes
2 No
Have you EVER been told by a doctor or other health professional that you had
…Bipolar Disorder?
1 Yes
2 No
Have you EVER been told by a doctor or other health professional that you had
…Depression?
1 Yes
2 No
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DURING THE PAST 12 MONTHS have you had
…Depression?
1 Yes
2 No
Have you EVER been told by a doctor or other health professional that you had
…Other mental health disorders?
1 Yes
2 No
DURING THE PAST 12 MONTHS have you had
…Other mental health disorders?
1 Yes
2 No
DURING THE PAST 12 MONTHS, have you had
…Excessive use of alcohol or tobacco?
1 Yes
2 No
DURING THE PAST 12 MONTHS, have you had
…Substance abuse, other than alcohol or tobacco?
1 Yes
2 No
DURING THE PAST 12 MONTHS, have you
…Frequently felt anxious, nervous, or worried?
1 Yes
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2 No
DURING THE PAST 12 MONTHS, have you
…Frequently felt stressed?
1 Yes
2 No
DURING THE PAST 30 DAYS, how often did you feel
... So sad that nothing could cheer you up?
1 ALL of the time
2 MOST of the time
3 SOME of the time
4 A LITTLE of the time
5 NONE of the time
During the PAST 30 DAYS, how often did you feel
... Nervous?
1 ALL of the time
2 MOST of the time
3 SOME of the time
4 A LITTLE of the time
5 NONE of the time
During the PAST 30 DAYS, how often did you feel
... Restless or fidgety?
1 ALL of the time
2 MOST of the time
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3 SOME of the time
4 A LITTLE of the time
5 NONE of the time
During the PAST 30 DAYS, how often did you feel
... Hopeless?
1 ALL of the time
2 MOST of the time
3 SOME of the time
4 A LITTLE of the time
5 NONE of the time
During the PAST 30 DAYS, how often did you feel
...That everything was an effort?
1 ALL of the time
2 MOST of the time
3 SOME of the time
4 A LITTLE of the time
5 NONE of the time
During the PAST 30 DAYS, how often did you feel
...Worthless?
1 ALL of the time
2 MOST of the time
3 SOME of the time
4 A LITTLE of the time
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5 NONE of the time
We just talked about a number of feelings you had during the PAST 30 DAYS.
Altogether, how MUCH did these feelings interfere with your life or activities: a lot,
some, a little, or not at all?
1 A lot
2 Some
3 A little
4 Not at all
DURING THE PAST 12 MONTHS, have you seen or talked to any of the following
health care providers about your own health?
...A mental health professional such as a psychiatrist, psychologist, psychiatric nurse, or
clinical social worker.
1 Yes
2 No
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APPENDIX P
NHIS Complementary and Alternative Medicine Utilization
Have you EVER used any of these therapies for your health?
Chiropractic or Osteopathic Manipulation?
1 Yes
2 No
Have you EVER seen a provider or practitioner for chiropractic or osteopathic
manipulation for yourself?
DURING THE PAST 12 MONTHS, did you see a practitioner for chiropractic or
osteopathic manipulation?
DURING THE PAST 12 MONTHS, use chiropractic or osteopathic manipulation?
Do you know the exact number of times you saw a practitioner for
chiropractic/osteopathic manipulation in the past 12 months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for
chiropractic/osteopathic manipulation? _____
Massage?
1 Yes
2 No
Have you EVER seen a provider or practitioner for massage for yourself?
1 Yes
2 No
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DURING THE PAST 12 MONTHS, did you see a practitioner for massage?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you use massage?
1 Yes
2 No
Do you know the exact number of times you saw a practitioner for massage in
the past 12 months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for
massage? _____
Acupuncture?
1 Yes
2 No
Have you EVER seen a provider or practitioner for acupuncture for yourself?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you see a practitioner for acupuncture?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you use acupuncture?
1 Yes
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2 No
Do you know the exact number of times you saw a practitioner for acupuncture in
the past 12 months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for
acupuncture? _____

Herbs or supplements
Herbs or other non-vitamin supplements are pills, capsules, tablets, or liquids that have
been labeled as a DIETARY SUPPLEMENT. This does NOT include vitamin or mineral
supplements, homeopathic treatments, or drinking herbal or green teas.
Have you EVER taken any herbal or other non-vitamin supplements listed on this card
for yourself?
1 Yes
2 No
DURING THE PAST 12 MONTHS, have you taken any herbal or other non-vitamin
supplements listed on this card for yourself?
1 Yes
2 No
01 Combination herb pill
02 Acai (pills, gelcaps)
03 Bee Pollen and other Bee products
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04 Chondroitin
05 Co-enzyme Q10 (CoQ10)
06 Cranberry (pills or capsules)
07 Digestive Enzymes (lactaid)
08 Echinacea
09 Fish Oil or omega 3 or DHA fatty acid or EPA fatty acid supplements
10 Garlic supplements (pills, gelcaps)
11 Ginkgo Biloba
12 Ginseng
13 Glucosamine
14 Green tea pills (not brewed tea) or EGCG (pills)
15 Melatonin
16 Milk Thistle (silymarin)
17 MSM (Methylsulfonylmethane)
18 Probiotics or Prebiotics
19 SAM-e
20 Saw Palmetto
21 Valerian
22 Other herbs or non-vitamin supplements
Did you take any of these DURING THE PAST 30 DAYS?
1 Yes
2 No
Have you ever seen a practitioner for herbs or other non-vitamin supplements?

192
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you see a practitioner for herbs or other nonvitamin supplements?
1 Yes
2 No
Do you know the exact number of times you saw a practitioner for herbs or other nonvitamin supplements in the past 12 months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for herbs
or other non-vitamin supplements? _____

Meditation
Have you EVER used meditation, guided imagery, or progressive relaxation?
1 Yes
2 No
Have you EVER used any of the following for your own health or treatment?
Mantra Meditation, including Transcendental Meditation ®, Relaxation Response,
and Clinically Standardized Meditation?
1 Yes
2 No
Mindfulness meditation, including Vipassana (vih-PAS-sah-nah), Zen Buddhist
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meditation, Mindfulness-based Stress Reduction, and Mindfulness-based
Cognitive Therapy
1 Yes
2 No
Spiritual meditation including Centering Prayer and Contemplative Meditation
1 Yes
2 No
Guided imagery
1 Yes
2 No
Progressive relaxation
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you use...
Mantra Meditation, including Transcendental Meditation ®, Relaxation Response,
and Clinically Standardized Meditation?
1 Yes
2 No
Mindfulness meditation, including Vipassana (vih-PAS-sah-nah), Zen Buddhist
meditation, Mindfulness-based Stress Reduction, and Mindfulness-based
Cognitive Therapy
1 Yes
2 No
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Spiritual meditation including Centering Prayer and Contemplative Meditation?
1 Yes
2 No
Guided imagery?
1 Yes
2 No
Progressive relaxation?
1 Yes
2 No
DURING THE PAST 12 MONTHS, which of these did you use the most?
1 Mantra meditation
2 Mindfulness meditation
3 Spiritual meditation
4 Guided imagery
5 Progressive relaxation
Did you do breathing exercises as part of meditation? Breathing exercises may involve
actively controlling the way air is drawn in, or the rate or depth of breathing.
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you see a practitioner or take a class for
meditation?
1 Yes
2 No
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Do you know the exact number of times you saw a practitioner or took a class for
meditation in the past 12 months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see a practitioner or take a
class for meditation? _____

Have you EVER practiced any of the following?
...Yoga?
DURING THE PAST 12 MONTHS, did you practice Yoga for yourself?
1 Yes
2 No
Did you do breathing exercises as part of Yoga? Breathing exercises may involve
actively controlling the way air is drawn in, or the rate or depth of breathing.
1 Yes
2 No
Did you do meditation as part of Yoga?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you take a Yoga class or in some way receive
formal training? Attending only one session does not count.
1 Yes
2 No
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Do you know the exact number of times you saw an instructor for Yoga in the past 12
months?
1 Yes
2 No
DURING THE PAST 12 MONTHS, how many times did you see an instructor for Yoga?
_____

Did you see a practitioner for/use [modality] for any of these reasons?
For general wellness or general disease prevention?
1 Yes
2 No
To improve your energy?
1 Yes
2 No
To improve your immune function?
1 Yes
2 No
To improve your athletic or sports performance?
1 Yes
2 No
To improve your memory or concentration?
1 Yes
2 No
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Did seeing a practitioner for/using [modality] motivate you to:
Eat healthier?
1 Yes
2 No
Eat more organic foods?
1 Yes
2 No
Cut back or stop drinking alcohol?
1 Yes
2 No
Cut back or stop smoking cigarettes?
1 Yes
2 No
Exercise more regularly?
1 Yes
2 No
Did {seeing a practitioner for/using [modality] lead to any of these outcomes?
Give you a sense of control over your health?
1 Yes
2 No
Help to reduce your stress level or to relax?
1 Yes
2 No
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Help you to sleep better?
1 Yes
2 No
Make you feel better emotionally?
1 Yes
2 No
Make it easier to cope with health problems?
1 Yes
2 No
Improve your overall health and make you feel better?
1 Yes
2 No
Improve your relationships with others?
1 Yes
2 No
Improve your attendance at a job or school]?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you see a practitioner for/use [modality] for one
or more specific health problems, symptoms, or conditions?
1 Yes
2 No
Did you receive any of the following medical treatments for [condition]?
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Prescription medications?
1 Yes
2 No
Over-the-counter medications?
1 Yes
2 No
Surgery?
1 Yes
2 No
Physical therapy?
1 Yes
2 No
Mental health counseling?
1 Yes
2 No
DURING THE PAST 12 MONTHS, did you see a practitioner for/use [modality] for any
of these reasons?
These medical treatments were too expensive?
1 Yes
2 No
[modality] combined with these medical treatments would help you?
1 Yes
2 No
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These medical treatments do not work for the health problem you want to treat or
prevent?
1 Yes
2 No
[Prescription medications/Over the counter medications/Prescription or over-thecounter medications] cause side effects?
1 Yes
2 No
You can do it on your own?
1 Yes
2 No
It is natural?
1 Yes
2 No
It focuses on the whole person, mind, body, and spirit?
1 Yes
2 No
It treats the cause and not just the symptoms?
1 Yes
2 No
It was part of your upbringing?
1 Yes
2 No
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Did you {see a practitioner for/use [modality] because it was recommended by any of
the following people?
A medical doctor?
1 Yes
2 No
A family member?
1 Yes
2 No
A friend?
1 Yes
2 No
A co-worker?
1 Yes
2 No
Not including the practitioner you saw for] [fill2: modality] DURING THE PAST 12
MONTHS, did you let your personal health care provider know about your use of [fill3:
modality]?
1 Yes
2 No
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Tobacco is the most widely used drug of abuse during pregnancy. Despite efforts
to reduce perinatal tobacco use, its prevalence has remained steady over at least the
past decade, suggesting that efforts to reduce smoking prevalence before and during
pregnancy have not been effective. Although a range of effective treatments exist, most
pregnant smokers neither seek nor receive any kind of treatment. Complementary and
alternative medicine (CAM) treatments may be ideal as alternative, low-cost approaches
capable of reaching and assisting a greater proportion of pregnant women with smoking
cessation. This study examined characteristics and treatment utilization practices of
pregnant smokers in two national samples —the National Survey on Drug Use and
Health and the National Health Interview Survey—in order to better understand the
unique treatment needs and preferences of pregnant smokers, and to explore the
prevalence and predictors of CAM use within this population. Results suggest that
smoking in pregnancy is stable, but that several potentially modifiable factors that may
help identify women who are at greater risk for persistent smoking during pregnancy,
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including smoking risk perception, current alcohol use, and factors related to nicotine
dependence. Findings of this study also demonstrated that a sizeable proportion of
pregnant smokers are already accessing CAM treatments, particularly among those of
greater socioeconomic status. Further research is needed not only to validate the use of
CAM treatments, but also to guide safety and treatment recommendations during
pregnancy.
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